{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:17:11Z","timestamp":1793593031039,"version":"4.5.0"},"reference-count":1455,"publisher":"Centers for Disease Control MMWR Office","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7004a1","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T06:23:54Z","timestamp":1626935034000},"page":"1-187","source":"Crossref","is-referenced-by-count":2443,"title":["Sexually Transmitted Infections Treatment Guidelines, 2021"],"prefix":"10.15585","volume":"70","author":[{"given":"Kimberly A.","family":"Workowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Muzny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Reno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Zenilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail A.","family":"Bolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1","article-title":"Sexually transmitted diseases treatment guidelines, 2015.","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6805a1","article-title":"Recommendations for providing quality sexually transmitted diseases clinical services, 2020.","volume":"68","author":"Barrow","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R3","unstructured":"CDC. A guide to taking a sexual history. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/std\/treatment\/sexualhistory.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2020.10371","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"324","author":"Henderson","year":"2020","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/jama.280.13.1161","article-title":"Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial.","volume":"280","author":"Kamb","year":"1998","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R6","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.2013.280034","article-title":"Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.","volume":"310","author":"Metsch","year":"2013","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R7","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1097\/OLQ.0000000000000327","article-title":"The role of behavioral counseling in sexually transmitted disease prevention program settings.","volume":"43","author":"Brookmeyer","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/OLQ.0b013e31824b3110","article-title":"Routine brief risk-reduction counseling with biannual STD testing reduces STD incidence among HIV-infected men who have sex with men in care.","volume":"39","author":"Patel","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R9","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1371\/journal.pmed.0050135","article-title":"Effect of a brief video intervention on incident infection among patients attending sexually transmitted disease clinics.","volume":"5","author":"Warner","year":"2008","journal-title":"PLoS Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amepre.2018.04.026","article-title":"Biomedical and behavioral outcomes of Keep It Up!: an ehealth HIV prevention program RCT.","volume":"55","author":"Mustanski","year":"2018","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices.","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.15585\/mmwr.mm6806a6","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for persons experiencing homelessness.","volume":"68","author":"Doshani","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"key-10.15585\/mmwr.rr7004a1-202107211802-R14","doi-asserted-by":"publisher","first-page":"CD003255","DOI":"10.1002\/14651858.CD003255","article-title":"Condom effectiveness in reducing heterosexual HIV transmission.","author":"Weller","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1586\/14737167.2016.1102635","article-title":"Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples.","volume":"16","author":"Giannou","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/QAI.0000000000000461","article-title":"Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States.","volume":"68","author":"Smith","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/QAD.0000000000001832","article-title":"Per-partner condom effectiveness against HIV for men who have sex with men.","volume":"32","author":"Johnson","year":"2018","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/sextrans-2012-050618","article-title":"Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries.","volume":"88","author":"Crosby","year":"2012","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R19","first-page":"454","article-title":"Effectiveness of condoms in preventing sexually transmitted infections.","volume":"82","author":"Holmes","year":"2004","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.olq.0000187908.42622.fd","article-title":"Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.","volume":"33","author":"Warner","year":"2006","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R21","doi-asserted-by":"publisher","first-page":"e24721","DOI":"10.1371\/journal.pone.0024721","article-title":"HBV infection in relation to consistent condom use: a population-based study in Peru.","volume":"6","author":"Bernabe-Ortiz","year":"2011","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.AOG.0000139512.37582.17","article-title":"Bacterial vaginosis and risk of pelvic inflammatory disease.","volume":"104","author":"Ness","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1086\/600878","article-title":"Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China.","volume":"49","author":"Martin","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R24","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women.","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ijc.11473","article-title":"Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia.","volume":"107","author":"Bleeker","year":"2003","journal-title":"Int J Cancer"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ijc.11474","article-title":"Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial.","volume":"107","author":"Hogewoning","year":"2003","journal-title":"Int J Cancer"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/OLQ.0b013e3181a396eb","article-title":"A systematic review of epidemiologic studies assessing condom use and risk of syphilis.","volume":"36","author":"Koss","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/sextrans-2014-051581","article-title":"How often do condoms fail? A cross-sectional study exploring incomplete use of condoms, condom failures and other condom problems among black and white MSM in southern U.S.A.","volume":"90","author":"Hern\u00e1ndez-Romieu","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R29","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1080\/09540121.2012.668285","article-title":"Condom use problems during anal sex among men who have sex with men (MSM): findings from the Safe in the City study.","volume":"24","author":"D\u2019Anna","year":"2012","journal-title":"AIDS Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00007435-199909000-00007","article-title":"The real problem with male condoms is nonuse.","volume":"26","author":"Steiner","year":"1999","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R31","unstructured":"Kowal D, Hatcher RA, Nelson AL, et al., eds. Contraceptive technology. 21st ed. Atlanta, GA: Managing Contraception; 2017."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1071\/SH11037","article-title":"A review of the effectiveness and acceptability of the female condom for dual protection.","volume":"9","author":"Gallo","year":"2012","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/09540120902730005","article-title":"Anal use of the female condom: does uncertainty justify provider inaction?","volume":"21","author":"Mantell","year":"2009","journal-title":"AIDS Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2105\/AJPH.82.5.669","article-title":"Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms.","volume":"82","author":"Rosenberg","year":"1992","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/sti.2010.047142","article-title":"The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2.","volume":"87","author":"de Bruyn","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R36","doi-asserted-by":"publisher","first-page":"e3488","DOI":"10.1371\/journal.pone.0003488","article-title":"The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial.","volume":"3","author":"Ramjee","year":"2008","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/1471-0528.12606","article-title":"Multipurpose prevention technologies: maximising positive synergies.","volume":"121","author":"Lusti-Narasimhan","year":"2014","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","article-title":"HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.","volume":"394","author":"Ahmed","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/13625187.2018.1508650","article-title":"A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.","volume":"23","author":"Young Holt","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1473-3099(02)00396-1","article-title":"Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.","volume":"2","author":"Wilkinson","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.","volume":"376","author":"McCormack","year":"2010","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R42","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.","volume":"359","author":"Van Damme","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R44","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","article-title":"SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.","volume":"3","author":"Feldblum","year":"2008","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/jcph.292","article-title":"Topical microbicides and HIV prevention in the female genital tract.","volume":"54","author":"Cottrell","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R46","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1056\/NEJMoa1410649","article-title":"Tenofovir gel for the prevention of herpes simplex virus Type 2 infection.","volume":"373","author":"Abdool Karim","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R47","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R48","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women.","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R49","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S1473-3099(18)30428-6","article-title":"Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.","volume":"18","author":"Delany-Moretlwe","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R50","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women.","volume":"375","author":"Baeten","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R51","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women.","volume":"375","author":"Nel","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R52","first-page":"614","article-title":"MTN-017: a rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel.","volume":"64","author":"Cranston","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R53","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/clinids\/19.2.274","article-title":"Effects of recent sexual activity and use of a diaphragm on the vaginal microflora.","volume":"19","author":"Hooton","year":"1994","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/oxfordjournals.aje.a008958","article-title":"Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.","volume":"144","author":"Fihn","year":"1996","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R55","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","article-title":"An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.","volume":"30","author":"Polis","year":"2016","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R56","doi-asserted-by":"publisher","first-page":"e25257","DOI":"10.1002\/jia2.25257","article-title":"Acquisition of sexually transmitted infections among women using a variety of contraceptive options: a prospective study among high-risk African women.","volume":"22","author":"Kiweewa","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/OLQ.0000000000000975","article-title":"Hormonal contraceptives and the acquisition of sexually transmitted infections: an updated systematic review.","volume":"46","author":"McCarthy","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R58","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016.","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R59","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6504a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016.","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R60","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/humrep\/des140","article-title":"The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience.","volume":"27","author":"Cleland","year":"2012","journal-title":"Hum Reprod"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R61","first-page":"CD001324","article-title":"Interventions for emergency contraception.","volume":"1","author":"Shen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1363\/4418412","article-title":"What do we know about males and emergency contraception? A synthesis of the literature.","volume":"44","author":"Marcell","year":"2012","journal-title":"Perspect Sex Reprod Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R63","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":"Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R64","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":"Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R65","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":"Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R66","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1056\/NEJMoa0802556","article-title":"Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.","volume":"360","author":"Tobian","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1086\/595566","article-title":"Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa.","volume":"199","author":"Auvert","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R68","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1086\/597208","article-title":"Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa.","volume":"199","author":"Sobngwi-Tambekou","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R69","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/QAD.0b013e3283504a3f","article-title":"The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study.","volume":"26","author":"Gray","year":"2012","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R70","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/QAD.0b013e328352d116","article-title":"Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection.","volume":"26","author":"Mehta","year":"2012","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R71","unstructured":"World Health Organization\/UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications [Internet]. Geneva, Switzerland: WHO\/UNAIDS Technical Consultation on Male Circumcision and HIV Prevention: Research Implications for Policy and Programming; 2007. https:\/\/www.who.int\/hiv\/pub\/malecircumcision\/research_implications\/en\/"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R72","unstructured":"American Urological Association. Circumcision policy statement [Internet]. Linthicum, MD: American Urological Association; 2017. https:\/\/www.auanet.org\/guidelines\/guidelines\/circumcision"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R73","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1016\/S2214-109X(18)30567-9","article-title":"Circumcision to prevent HIV and other sexually transmitted infections in men who have sex with men: a systematic review and meta-analysis of global data.","volume":"7","author":"Yuan","year":"2019","journal-title":"Lancet Glob Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.","volume":"64","author":"Grohskopf","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R75","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R76","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R77","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R78","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R79","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.","volume":"4","author":"Molina","year":"2017","journal-title":"Lancet HIV"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R80","unstructured":"CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 update: a clinical practice guideline. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R81","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/OLQ.0000000000000980","article-title":"Proportion of incident human immunodeficiency virus cases among men who have sex with men attributable to gonorrhea and chlamydia: a modeling analysis.","volume":"46","author":"Jones","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R82","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/cid\/cit437","article-title":"HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry.","volume":"57","author":"Pathela","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R83","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/cid\/civ289","article-title":"The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men.","volume":"61","author":"Pathela","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R84","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","article-title":"Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force.","volume":"321","author":"Chou","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R87","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","article-title":"No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting.","volume":"61","author":"Volk","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa0904849","article-title":"Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.","volume":"362","author":"Celum","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R89","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/S0140-6736(08)60920-4","article-title":"Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.","volume":"371","author":"Celum","year":"2008","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R90","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","article-title":"Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study.","volume":"42","author":"Bolan","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R91","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/cid\/ciz866","article-title":"Doxycycline prophylaxis for bacterial sexually transmitted infections.","volume":"70","author":"Grant","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R92","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1473-3099(05)70298-X","article-title":"Intravaginal practices, bacterial vaginosis, and women\u2019s susceptibility to HIV infection: epidemiological evidence and biological mechanisms.","volume":"5","author":"Myer","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R93","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R94","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R95","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R96","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3018(18)30132-2","article-title":"Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.","volume":"5","author":"Bavinton","year":"2018","journal-title":"Lancet HIV"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R97","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.","volume":"393","author":"Rodger","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R98","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, AIDSinfo. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/inline-files\/AdultandAdolescentGL.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R99","unstructured":"Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12\u201315, 2012."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R100","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1371\/journal.pone.0012662","article-title":"Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort.","volume":"5","author":"Philip","year":"2010","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R101","doi-asserted-by":"publisher","first-page":"e45718","DOI":"10.1371\/journal.pone.0045718","article-title":"Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men.","volume":"7","author":"Vallabhaneni","year":"2012","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R102","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/OLQ.0b013e3182401a2f","article-title":"The impact of HIV seroadaptive behaviors on sexually transmissible infections in HIV-negative homosexual men in Sydney, Australia.","volume":"39","author":"Jin","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R103","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/OLQ.0b013e31826e870d","article-title":"Association between serosorting and bacterial sexually transmitted infection among HIV-negative men who have sex with men at an urban lesbian, gay, bisexual, and transgender health center.","volume":"39","author":"Hotton","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/OLQ.0b013e31827938a1","article-title":"Randomized controlled trial on the effectiveness of counseling messages for avoiding unprotected sexual intercourse during sexually transmitted infection and reproductive tract infection treatment among female sexually transmitted infection clinic patients.","volume":"40","author":"Anderson","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R105","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00007435-200306000-00004","article-title":"Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV.","volume":"30","author":"Golden","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R106","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/apc.2016.0027","article-title":"Integrating HIV testing as an outcome of STD partner services for men who have sex with men.","volume":"30","author":"Katz","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R107","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/QAI.0000000000001952","article-title":"STD partner services to monitor and promote HIV pre-exposure prophylaxis use among men who have sex with men.","volume":"80","author":"Katz","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R108","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1097\/QAD.0000000000000031","article-title":"HIV partner services are associated with timely linkage to HIV medical care.","volume":"27","author":"Bocour","year":"2013","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R109","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/PHH.0000000000000483","article-title":"Improving retention in HIV care through New York\u2019s expanded partner services Data-to-Care pilot.","volume":"23","author":"Tesoriero","year":"2017","journal-title":"J Public Health Manag Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R110","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/bmj.39079.460741.7C","article-title":"Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review.","volume":"334","author":"Trelle","year":"2007","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R111","article-title":"Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection.","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R112","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/OLQ.0b013e318151498f","article-title":"Partner notification of sexually transmitted infections: a large cohort of Mexican American and African American women.","volume":"35","author":"Thurman","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R113","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00007435-200301000-00015","article-title":"Partner notification for HIV and syphilis: effects on sexual behaviors and relationship stability.","volume":"30","author":"Kissinger","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R114","unstructured":"Smith SG, Zhang X, Basile KC, The National Intimate Partner and Sexual Violence Survey: 2015 data brief\u2014updated release. Atlanta GA: US Department of Health and Human Services, CDC, National Center for Injury Prevention and Control; 2018. https:\/\/www.cdc.gov\/violenceprevention\/pdf\/2015data-brief508.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R115","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.2105\/AJPH.2007.112128","article-title":"A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification.","volume":"99","author":"Wilson","year":"2009","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R116","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/OLQ.0b013e3182240366","article-title":"Chlamydia partner services for females in California family planning clinics.","volume":"38","author":"Yu","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R117","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/OLQ.0b013e3182756f20","article-title":"Implementation and effectiveness of an expedited partner therapy program in an urban clinic.","volume":"39","author":"Mickiewicz","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R118","unstructured":"Kachur R, Strona FV, Kinsey J, Collins D. Introducing technology into partner services: a toolkit for programs. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https:\/\/www.cdc.gov\/std\/program\/ips\/ips-toolkit-12-28-2015.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R119","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/OLQ.0000000000000864","article-title":"The use of technology for sexually transmitted disease partner services in the United States: a structured review.","volume":"45","author":"Kachur","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R120","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/10810730.2015.1128020","article-title":"Advancing partner notification through electronic communication technology: a review of acceptability and utilization research.","volume":"21","author":"Pellowski","year":"2016","journal-title":"J Health Commun"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R121","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/OLQ.0000000000000751","article-title":"Expedited partner therapy: pharmacist refusal of legal prescriptions.","volume":"45","author":"Borchardt","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R122","doi-asserted-by":"publisher","first-page":"504.e1","DOI":"10.1016\/j.ajog.2018.01.036","article-title":"Pharmacy-level barriers to implementing expedited partner therapy in Baltimore, Maryland.","volume":"218","author":"Qin","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R123","first-page":"A107","article-title":"Do prescriptions for expedited partner therapy get filled? Findings from a multi-jurisdictional evaluation, US, 2017\u20132018.","volume":"95","author":"Schillinger","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R124","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/OLQ.0000000000001163","article-title":"Do prescriptions for expedited partner therapy for chlamydia get filled? Findings from a multi-jurisdictional evaluation, United States, 2017\u20132019.","volume":"47","author":"Slutsker","year":"2020","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R125","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.","volume":"352","author":"Golden","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00007435-200301000-00011","article-title":"Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial.","volume":"30","author":"Schillinger","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R127","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1086\/432476","article-title":"Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.","volume":"41","author":"Kissinger","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R128","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/humrep\/den475","article-title":"Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.","volume":"24","author":"Cameron","year":"2009","journal-title":"Hum Reprod"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R129","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/01.olq.0000204511.84485.4c","article-title":"Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial.","volume":"33","author":"Kissinger","year":"2006","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R130","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/OLQ.0b013e3181dd1691","article-title":"A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.","volume":"37","author":"Schwebke","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R131","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/OLQ.0b013e3181d8920f","article-title":"The effectiveness of patient-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco.","volume":"37","author":"Stephens","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R132","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/OLQ.0b013e318223fcbc","article-title":"A randomized, controlled trial of inSPOT and patient-delivered partner therapy for gonorrhea and chlamydial infection among men who have sex with men.","volume":"38","author":"Kerani","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R133","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/428043","article-title":"Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy.","volume":"40","author":"Stekler","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R134","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/OLQ.0b013e3181761993","article-title":"Patient delivered partner therapy for chlamydial infection\u2014what would be missed?","volume":"35","author":"McNulty","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R135","doi-asserted-by":"publisher","first-page":"A107","DOI":"10.1136\/sextrans-2019-sti.272","article-title":"STI and HIV infections among MSM reporting exposure to gonorrhea or chlamydia: implications for expedited partner therapy.","volume":"95","author":"Schillinger","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R136","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/OLQ.0b013e3181d70a03","article-title":"Baseline infection with a sexually transmitted disease is highly predictive of reinfection during follow-up in Malagasy sex workers.","volume":"37","author":"Turner","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R137","doi-asserted-by":"publisher","first-page":"564","DOI":"10.7326\/0003-4819-145-8-200610170-00005","article-title":"High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening.","volume":"145","author":"Peterman","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R138","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1001\/jama.2019.6587","article-title":"Screening for HIV infection: US Preventive Services Task Force recommendation statement.","volume":"321","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R139","unstructured":"Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, AIDSinfo; 2014. https:\/\/npin.cdc.gov\/publication\/recommendations-use-antiretroviral-drugs-pregnant-hiv-1-infected-women-maternal-health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R140","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1097\/AOG.0000000000002825","article-title":"ACOG Committee opinion no. 752: prenatal and perinatal human immunodeficiency virus testing.","volume":"132","author":"Committee on Obstetric Practice HIV Expert Work Group","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R141","unstructured":"CDC. Sexually transmitted disease surveillance 2019 [Internet]. Atlanta GA: US Department of Health and Human Services, CDC; 2021. https:\/\/www.cdc.gov\/std\/statistics\/2019\/default.htm"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R142","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10995-018-2592-0","article-title":"State requirements for prenatal syphilis screening in the United States, 2016.","volume":"22","author":"Warren","year":"2018","journal-title":"Matern Child Health J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R143","unstructured":"Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R144","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/OLQ.0000000000000569","article-title":"Suboptimal prenatal syphilis testing among commercially insured women in the United States, 2013.","volume":"44","author":"Neblett Fanfair","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R145","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/OLQ.0000000000000656","article-title":"Provider adherence to syphilis testing recommendations for women delivering a stillbirth.","volume":"44","author":"Patel","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R146","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/OLQ.0000000000000638","article-title":"Effectiveness of prenatal screening and treatment to prevent congenital syphilis, Louisiana and Florida, 2013\u20132014.","volume":"44","author":"Matthias","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R147","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/AOG.0000000000000997","article-title":"Third-trimester prenatal syphilis screening: a cost-effectiveness analysis.","volume":"126","author":"Albright","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R148","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/jama.2019.9365","article-title":"Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R149","doi-asserted-by":"publisher","first-page":"902","DOI":"10.7326\/M14-1981","article-title":"Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R150","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.15585\/mmwr.mm6642a3","article-title":"Increased risk for mother-to-infant transmission of hepatitis C virus among Medicaid recipients\u2014Wisconsin, 2011\u20132015.","volume":"66","author":"Watts","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R151","doi-asserted-by":"publisher","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","article-title":"Hepatitis C virus infection among women giving birth\u2014Tennessee and United States, 2009\u20132014.","volume":"66","author":"Patrick","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R152","doi-asserted-by":"publisher","first-page":"e20173273","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy.","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R153","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/ppe.12481","article-title":"Enhanced identification of maternal hepatitis C virus infection using existing public health surveillance systems.","volume":"32","author":"Gowda","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R154","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/NPM-15915024","article-title":"Hepatitis C virus universal screening versus risk based selective screening during pregnancy.","volume":"8","author":"Waruingi","year":"2015","journal-title":"J Neonatal Perinatal Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R155","doi-asserted-by":"publisher","first-page":"ofy043","DOI":"10.1093\/ofid\/ofy043","article-title":"Risk-based hepatitis C screening in pregnancy is less reliable than universal screening: a retrospective chart review.","volume":"5","author":"Boudova","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R156","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R157","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7326\/0003-4819-159-5-201309030-00672","article-title":"Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R158","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R159","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2020.2684","article-title":"Screening for bacterial vaginosis in pregnant persons to prevent preterm delivery: US Preventive Services Task Force recommendation statement.","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R160","unstructured":"American Academy of Pediatrics Committee on Fetus and Newborn; American College of Obstetrics and Gynecology Committee on Obstetric Practice. Guidelines for perinatal care. Kilpatrick SJ, Papile LA, eds. 8th ed. Itasca, IL: American Academy of Pediatrics and Washington, DC: American College of Obstetrics and Gynecology; 2017."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R161","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jama.2018.11785","article-title":"Screening for syphilis infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R162","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.2016.16776","article-title":"Serologic screening for genital herpes infection: US Preventive Services Task Force recommendation statement.","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R163","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2019.2593","article-title":"Screening for HIV infection in pregnant women: u","volume":"321","author":"Selph","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R164","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2019.1655","article-title":"Screening for Hepatitis B infection in pregnant women: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"322","author":"Henderson","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R165","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/sextrans-2019-054045","article-title":"Trends in factors indicating increased risk for STI among key subpopulations in the United States, 2002\u20132015.","volume":"96","author":"Leichliter","year":"2020","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R166","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1542\/peds.2012-2580","article-title":"Standards for health information technology to ensure adolescent privacy.","volume":"130","author":"Committee on Adolescence","year":"2012","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R167","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/01.AOG.0000446825.08715.98","article-title":"ACOG Committee Opinion no. 599: Committee on Adolescent Health Care: adolescent confidentiality and electronic health records.","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R168","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jadohealth.2015.10.015","article-title":"Meaningful use of a confidential adolescent patient portal.","volume":"58","author":"Thompson","year":"2016","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R169","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jadohealth.2015.12.009","article-title":"Confidentiality protections for adolescents and young adults in the health care billing and insurance claims process.","volume":"58","author":"Society for Adolescent Health and Medicine; American Academy of Pediatrics","year":"2016","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R170","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/OLQ.0000000000000967","article-title":"Extragenital gonorrhea and chlamydia among men and women according to type of sexual exposure.","volume":"46","author":"Bamberger","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R171","doi-asserted-by":"publisher","first-page":"5758387","DOI":"10.1155\/2016\/5758387","article-title":"Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature.","volume":"2016","author":"Chan","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R172","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.amepre.2016.01.007","article-title":"Cost-effectiveness of opt-out chlamydia testing for high-risk young women in the U.S.","volume":"51","author":"Owusu-Edusei","year":"2016","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R173","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1542\/peds.2009-0892","article-title":"Association between sexually transmitted diseases and young adults\u2019 self-reported abstinence.","volume":"127","author":"DiClemente","year":"2011","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R174","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R175","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000001263","article-title":"Practice bulletin no. 157: cervical cancer screening and prevention.","volume":"127","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2016","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R176","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/AOG.0b013e31826e4609","article-title":"Cervical carcinoma rates among young females in the United States.","volume":"120","author":"Benard","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R177","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R178","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1001\/jama.2019.6390","article-title":"Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement.","volume":"321","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R179","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0140-6736(12)60835-6","article-title":"Comprehensive clinical care for men who have sex with men: an integrated approach.","volume":"380","author":"Mayer","year":"2012","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R180","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/01.qai.0000134740.41585.f4","article-title":"Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States.","volume":"39","author":"Buchbinder","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R181","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1097\/QAD.0000000000001139","article-title":"Trends in condom use among MSM in the United States: the role of antiretroviral therapy and seroadaptive strategies.","volume":"30","author":"Paz-Bailey","year":"2016","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R182","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/sextrans-2016-052676","article-title":"Sexual networks and infection transmission networks among men who have sex with men as causes of disparity and targets of prevention.","volume":"93","author":"Spicknall","year":"2017","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R183","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/QAI.0b013e318247925e","article-title":"A comparison of sexual behavior patterns among men who have sex with men and heterosexual men and women.","volume":"60","author":"Glick","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R184","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/sti.2007.025627","article-title":"Biological and demographic causes of high HIV and sexually transmitted disease prevalence in men who have sex with men.","volume":"83","author":"Goodreau","year":"2007","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R185","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2105\/AJPH.2012.300808","article-title":"Sex, drugs (methamphetamines), and the Internet: increasing syphilis among men who have sex with men in California, 2004\u20132008.","volume":"103","author":"Chew Ng","year":"2013","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R186","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/OLQ.0b013e31827763ea","article-title":"Epidemiologic characteristics of an ongoing syphilis epidemic among men who have sex with men, San Francisco.","volume":"40","author":"Bernstein","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R187","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2011.300383","article-title":"Repeat syphilis among men who have sex with men in California, 2002\u20132006: implications for syphilis elimination efforts.","volume":"102","author":"Cohen","year":"2012","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R188","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014.","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R189","doi-asserted-by":"publisher","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005\u20132010.","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R190","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/003335491212700308","article-title":"A tale of two gonorrhea epidemics: results from the STD Surveillance Network.","volume":"127","author":"Newman","year":"2012","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R191","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.annepidem.2017.02.003","article-title":"Lifetime risk of a diagnosis of HIV infection in the United States.","volume":"27","author":"Hess","year":"2017","journal-title":"Ann Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R192","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review.","volume":"28","author":"Patel","year":"2014","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R193","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/01.aids.0000216374.61442.55","article-title":"Risk factors for HIV infection among men who have sex with men.","volume":"20","author":"Koblin","year":"2006","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R194","doi-asserted-by":"publisher","first-page":"e34972","DOI":"10.1371\/journal.pone.0034972","article-title":"High and persistent HIV seroincidence in men who have sex with men across 47 U.S. cities.","volume":"7","author":"Ackers","year":"2012","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R195","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/QAI.0b013e318195bd2b","article-title":"Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs.","volume":"50","author":"Zetola","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R196","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/cid\/ciu450","article-title":"Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.","volume":"59","author":"Solomon","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R197","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R198","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R199","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/sti.2005.015040","article-title":"High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India.","volume":"82","author":"Reynolds","year":"2006","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R200","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/QAD.0000000000002147","article-title":"Undisclosed HIV infection among MSM in a behavioral surveillance study.","volume":"33","author":"Hoots","year":"2019","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R201","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13063-016-1286-4","article-title":"An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.","volume":"17","author":"Dolling","year":"2016","journal-title":"Trials"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R202","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10461-017-1701-1","article-title":"Behavioral changes following uptake of HIV pre-exposure prophylaxis among men who have sex with men in a clinical setting.","volume":"22","author":"Oldenburg","year":"2018","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R203","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10461-018-2252-9","article-title":"Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting.","volume":"23","author":"Monta\u00f1o","year":"2019","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R204","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","article-title":"Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis.","volume":"67","author":"Traeger","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R205","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/cid\/cix439","article-title":"Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study.","volume":"65","author":"Jenness","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R206","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/QAD.0000000000002522","article-title":"Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.","volume":"34","author":"Tang","year":"2020","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R207","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/OLQ.0000000000000614","article-title":"New human immunodeficiency virus diagnosis independently associated with rectal gonorrhea and chlamydia in men who have sex with men.","volume":"44","author":"Barbee","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R208","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion.","volume":"53","author":"Bernstein","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R209","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/sextrans-2015-052214","article-title":"An estimate of the proportion of symptomatic gonococcal, chlamydial and non-gonococcal non-chlamydial urethritis attributable to oral sex among men who have sex with men: a case-control study.","volume":"92","author":"Barbee","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R210","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00007435-199705000-00007","article-title":"Sexually transmitted diseases in men who have sex with men. Acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD\/HIV prevention.","volume":"24","author":"Lafferty","year":"1997","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R211","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1086\/648427","article-title":"Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men.","volume":"49","author":"Bernstein","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R212","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/cid\/ciu184","article-title":"Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men\u2014STD Surveillance Network, United States, 2010\u20132012.","volume":"58","author":"Patton","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R213","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.","volume":"41","author":"Kent","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R214","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1258\/ijsa.2012.011378","article-title":"The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006\u20132010.","volume":"23","author":"Koedijk","year":"2012","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R215","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/OLQ.0000000000000093","article-title":"Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients.","volume":"41","author":"Barbee","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R216","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/OLQ.0000000000000384","article-title":"Patterns of extragenital chlamydia and gonorrhea in women and men who have sex with men reporting a history of receptive anal intercourse.","volume":"43","author":"Danby","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R217","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/OLQ.0b013e3181a44b8c","article-title":"High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women.","volume":"36","author":"van der Helm","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R218","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/sti.2008.031443","article-title":"Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men.","volume":"84","author":"Alexander","year":"2008","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R219","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/OLQ.0b013e318227713e","article-title":"Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men.","volume":"38","author":"Freeman","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R220","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/OLQ.0b013e318284e544","article-title":"The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV Infection.","volume":"40","author":"Chesson","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R221","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/OLQ.0000000000000896","article-title":"Bacterial sexually transmitted infection screening rates by symptomatic status among men who have sex with men in the United States: a hierarchical Bayesian analysis.","volume":"46","author":"Jenness","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R222","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/OLQ.0b013e3181e50058","article-title":"STD screening of HIV-infected MSM in HIV clinics.","volume":"37","author":"Hoover","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R223","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/cid\/ciy571","article-title":"Syphilis testing among sexually active men who have sex with men and who are receiving medical care for human immunodeficiency virus in the United States: Medical Monitoring Project, 2013\u20132014.","volume":"68","author":"de Voux","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R224","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/OLQ.0b013e3181ca3c0a","article-title":"Frequent testing of highly sexually active gay men is required to control syphilis.","volume":"37","author":"Gray","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R225","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/1471-2458-13-606","article-title":"Screen more or screen more often? Using mathematical models to inform syphilis control strategies.","volume":"13","author":"Tuite","year":"2013","journal-title":"BMC Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R226","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/sextrans-2014-052001","article-title":"Go big or go home: impact of screening coverage on syphilis infection dynamics.","volume":"92","author":"Tuite","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R227","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/sextrans-2017-053201","article-title":"Can enhanced screening of men with a history of prior syphilis infection stem the epidemic in men who have sex with men? A mathematical modelling study.","volume":"94","author":"Tuite","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R228","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/QAI.0000000000001514","article-title":"Gonorrhea and chlamydia case detection increased when testing increased in a multisite US HIV cohort, 2004\u20132014.","volume":"76","author":"Raifman","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R229","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/OLQ.0000000000000320","article-title":"Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care.","volume":"42","author":"Barbee","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R230","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/095646240001100502","article-title":"Rectal gonorrhoea in homosexual men: source of infection.","volume":"11","author":"McMillan","year":"2000","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R231","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/0956462417727669","article-title":"Saliva use in sex: associations with use of smartphone dating applications in men who have sex with men.","volume":"29","author":"Chow","year":"2018","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R232","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0956462417748717","article-title":"The frequency of kissing as part of sexual activity differs depending on how men meet their male casual sexual partners.","volume":"29","author":"Cornelisse","year":"2018","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R233","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1001\/jama.2020.22980","article-title":"Screening for hepatitis B virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R234","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.23808","article-title":"Is sexual contact a major mode of hepatitis C virus transmission?","volume":"52","author":"Tohme","year":"2010","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R235","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/cid\/cis694","article-title":"Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.","volume":"55","author":"Wandeler","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R236","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/cid\/cit054","article-title":"Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center.","volume":"56","author":"Garg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R237","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/QAD.0b013e32832e5631","article-title":"Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic.","volume":"23","author":"Urbanus","year":"2009","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R238","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/cid\/cis382","article-title":"Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.","volume":"55","author":"Linas","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R239","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/apc.2011.0106","article-title":"Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk.","volume":"25","author":"Taylor","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R240","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1001\/jama.291.21.2555","article-title":"Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.","volume":"291","author":"Kaul","year":"2004","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R241","doi-asserted-by":"publisher","first-page":"e1917134","DOI":"10.1001\/jamanetworkopen.2019.17134","article-title":"Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis.","volume":"2","author":"Ong","year":"2019","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R242","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1097\/QAI.0000000000001404","article-title":"Trends in Internet use among men who have sex with men in the United States.","volume":"75","author":"Paz-Bailey","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R243","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s10461-017-1882-7","article-title":"Swipe right: dating website and app use among men who have sex with men.","volume":"22","author":"Badal","year":"2018","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R244","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/OLQ.0000000000000784","article-title":"A network analysis of sexually transmitted diseases and online hookup sites among men who have sex with men.","volume":"45","author":"Chan","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R245","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/sextrans-2013-051494","article-title":"Sex on demand: geosocial networking phone apps and risk of sexually transmitted infections among a cross-sectional sample of men who have sex with men in Los Angeles County.","volume":"90","author":"Beymer","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R246","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s10461-018-2286-z","article-title":"Disclosure of HIV serostatus and pre-exposure prophylaxis use on internet hookup sites among men who have sex with men.","volume":"23","author":"Medina","year":"2019","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R247","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/003335491613100210","article-title":"Online hookup sites for meeting sexual partners among men who have sex with men in Rhode Island, 2013: a call for public health action.","volume":"131","author":"Chan","year":"2016","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R248","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QAI.0000000000000930","article-title":"Reaching suburban men who have sex with men for STD and HIV services through online social networking outreach: a public health approach.","volume":"72","author":"Lampkin","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R249","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10461-014-0942-5","article-title":"Acceptability and feasibility of using established geosocial and sexual networking mobile applications to promote HIV and STD testing among men who have sex with men.","volume":"19","author":"Sun","year":"2015","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R250","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1056\/NEJM197411282912223","article-title":"Letter: Shigella enteritis venereally transmitted.","volume":"291","author":"Dritz","year":"1974","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R251","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/510593","article-title":"Case-control study of shigellosis in San Francisco: the role of sexual transmission and HIV infection.","volume":"44","author":"Arag\u00f3n","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R252","doi-asserted-by":"publisher","first-page":"21097","DOI":"10.2807\/1560-7917.ES2015.20.15.21097","article-title":"Intensified shigellosis epidemic associated with sexual transmission in men who have sex with men\u2014Shigella flexneri and S. sonnei in England, 2004 to end of February 2015.","volume":"20","author":"Simms","year":"2015","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R253","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/sextrans-2015-052014","article-title":"Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed with Shigella flexneri 3a in England and Wales.","volume":"91","author":"Gilbart","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R254","doi-asserted-by":"publisher","first-page":"24","DOI":"10.14745\/ccdr.v42i02a01","article-title":"Are enteric infections sexually transmitted in British Columbia?","volume":"42","author":"Narayan","year":"2016","journal-title":"Can Commun Dis Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R255","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/sextrans-2016-052962","article-title":"What is the overlap between HIV and shigellosis epidemics in England: further evidence of MSM transmission?","volume":"94","author":"Mohan","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R256","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/sextrans-2016-053057","article-title":"Prevalence and characteristics of gastrointestinal infections in men who have sex with men diagnosed with rectal chlamydia infection in the UK: an \u2018unlinked anonymous\u2019 cross-sectional study.","volume":"94","author":"Hughes","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R257","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3201\/eid0808.010534","article-title":"Shigellosis linked to sex venues, Australia.","volume":"8","author":"O\u2019Sullivan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R258","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1258\/0956462041558221","article-title":"Shigellosis\u2014a re-emerging sexually transmitted infection: outbreak in men having sex with men in Berlin.","volume":"15","author":"Marcus","year":"2004","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R259","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciu478","article-title":"Two concurrent enteric disease outbreaks among men who have sex with men, Minneapolis-St Paul area.","volume":"59","author":"Danila","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R260","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7883\/yoken.65.277","article-title":"Shigella sonnei outbreak among men who have sex with men in Tokyo.","volume":"65","author":"Okame","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R261","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/hiv.12191","article-title":"Shigella flexneri serotype 1 infections in men who have sex with men in Vancouver, Canada.","volume":"16","author":"Wilmer","year":"2015","journal-title":"HIV Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R262","first-page":"922","article-title":"Shigella sonnei outbreak among men who have sex with men\u2014San Francisco, California, 2000\u20132001.","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R263","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3201\/eid0506.990614","article-title":"HIV infection as a risk factor for shigellosis.","volume":"5","author":"Baer","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R264","doi-asserted-by":"publisher","first-page":"20946","DOI":"10.2807\/1560-7917.ES2014.19.43.20946","article-title":"Identification of verocytotoxin-producing Escherichia coli O117:H7 in men who have sex with men, England, November 2013 to August 2014.","volume":"19","author":"Simms","year":"2014","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R265","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7326\/0003-4819-101-2-187","article-title":"Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men.","volume":"101","author":"Quinn","year":"1984","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R266","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3201\/eid2209.151695","article-title":"Multidrug-resistant Campylobacter coli in men who have sex with men, Quebec, Canada, 2015.","volume":"22","author":"Gaudreau","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R267","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/infdis\/jix123","article-title":"Hepatitis A outbreak among men who have sex with men in a country of low endemicity of hepatitis A infection.","volume":"215","author":"Chen","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R268","doi-asserted-by":"publisher","first-page":"e3222","DOI":"10.1371\/journal.pntd.0003222","article-title":"Prevalent and incident HIV diagnoses among Entamoeba histolytica-infected adult males: a changing epidemiology associated with sexual transmission\u2014Taiwan, 2006\u20132013.","volume":"8","author":"Lo","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R269","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3201\/eid1407.080017","article-title":"Invasive amebiasis in men who have sex with men, Australia.","volume":"14","author":"Stark","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R270","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/QCO.0000000000000423","article-title":"Recent epidemiology of sexually transmissible enteric infections in men who have sex with men.","volume":"31","author":"Mitchell","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R271","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/sextrans-2016-052695","article-title":"Motivations and values associated with combining sex and illicit drugs (\u2018chemsex\u2019) among gay men in South London: findings from a qualitative study.","volume":"93","author":"Weatherburn","year":"2017","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R272","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S1473-3099(15)00002-X","article-title":"Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study.","volume":"15","author":"Baker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R273","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3201\/eid2209.160624","article-title":"Elevated risk for antimicrobial drug-resistant Shigella infection among men who have sex with men, United States, 2011\u20132015.","volume":"22","author":"Bowen","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R274","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/cid\/civ570","article-title":"Long-lasting outbreak of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subspecies jejuni from 2003 to 2013 in men who have sex with men, Quebec, Canada.","volume":"61","author":"Gaudreau","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R275","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/OLQ.0b013e31822e6179","article-title":"Sexually transmitted infections and risk behaviors among African American women who have sex with women: does sex with men make a difference?","volume":"38","author":"Muzny","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R276","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1023\/A:1011958816438","article-title":"Differences in sexual risk behaviors between college students with same-sex and opposite-sex experience: results from a national survey.","volume":"30","author":"Eisenberg","year":"2001","journal-title":"Arch Sex Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R277","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/01.olq.0000175417.17078.21","article-title":"Sexual risk factors among self-identified lesbians, bisexual women, and heterosexual women accessing primary care settings.","volume":"32","author":"Koh","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R278","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2105\/AJPH.2005.080531","article-title":"Dimensions of sexual orientation and HIV-related risk among adolescent females: evidence from a statewide survey.","volume":"98","author":"Goodenow","year":"2008","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R279","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/OLQ.0000000000000194","article-title":"Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk.","volume":"41","author":"Muzny","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R280","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2105\/AJPH.2014.302037","article-title":"Sexual identity, partner gender, and sexual health among adolescent girls in the United States.","volume":"104","author":"Riskind","year":"2014","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R281","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/sextrans-2011-050404","article-title":"Sexual behaviour and risk reduction strategies among a multinational sample of women who have sex with women.","volume":"88","author":"Schick","year":"2012","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R282","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1071\/SH09072","article-title":"Do women use dental dams? Safer sex practices of lesbians and other women who have sex with women.","volume":"7","author":"Richters","year":"2010","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R283","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijgo.2012.08.011","article-title":"Use of barrier protection for sexual activity among women who have sex with women.","volume":"120","author":"Rowen","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R284","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/1524839910390314","article-title":"Becoming visible: assessing the availability of online sexual health information for lesbians.","volume":"13","author":"Lindley","year":"2012","journal-title":"Health Promot Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R285","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/00224499.2012.657264","article-title":"Preventive care\u2019s forgotten women: life course, sexuality, and sexual health among homosexually and bisexually active women in France.","volume":"50","author":"Chetcuti","year":"2013","journal-title":"J Sex Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R286","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/sextrans-2014-051745","article-title":"Correlates of a lifetime history of sexually transmitted infections among women who have sex with women in Toronto, Canada: results from a cross-sectional internet-based survey.","volume":"91","author":"Logie","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R287","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1071\/SH14181","article-title":"Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and men.","volume":"11","author":"Muzny","year":"2014","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R288","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/OLQ.0b013e31828caf34","article-title":"Sexual behaviors, perception of sexually transmitted infection risk, and practice of safe sex among southern African American women who have sex with women.","volume":"40","author":"Muzny","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R289","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2105\/AJPH.2013.301733","article-title":"Health and health risks among sexual minority women: an examination of 3 subgroups.","volume":"104","author":"Przedworski","year":"2014","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R290","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/lgbt.2016.0083","article-title":"Understanding the influence of stigma and medical mistrust on engagement in routine healthcare among Black women who have sex with women.","volume":"4","author":"Brenick","year":"2017","journal-title":"LGBT Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R291","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/sti.76.5.345","article-title":"Sexually transmitted infections and risk behaviours in women who have sex with women.","volume":"76","author":"Fethers","year":"2000","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R292","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1086\/339884","article-title":"Characterization of vaginal flora and bacterial vaginosis in women who have sex with women.","volume":"185","author":"Marrazzo","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R293","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/sti.72.1.60","article-title":"Sexually acquired metronidazole-resistant trichomoniasis in a lesbian couple.","volume":"72","author":"Kellock","year":"1996","journal-title":"Genitourin Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R294","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OLQ.0b013e31824f1c49","article-title":"Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships.","volume":"39","author":"Muzny","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R295","first-page":"209","article-title":"Likely female-to-female sexual transmission of HIV\u2014Texas, 2012.","volume":"63","author":"Chan","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R296","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1086\/345462","article-title":"Female-to-female transmission of human immunodeficiency virus.","volume":"36","author":"Kwakwa","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R297","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00006250-200209000-00029","article-title":"Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis.","volume":"100","author":"Marrazzo","year":"2002","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R298","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1001\/archinte.159.22.2730","article-title":"Lesbians\u2019 sexual history with men: implications for taking a sexual history.","volume":"159","author":"Diamant","year":"1999","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R299","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/OLQ.0b013e3181db2e18","article-title":"Women who have sex with women in the United States: prevalence, sexual behavior and prevalence of herpes simplex virus type 2 infection\u2014results from national health and nutrition examination survey 2001\u20132006.","volume":"37","author":"Xu","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R300","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/jwh.2017.6866","article-title":"Do sexual minorities receive appropriate sexual and reproductive health care and counseling?","volume":"28","author":"Everett","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R301","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1086\/314494","article-title":"Genital human papillomavirus infection in women who have sex with women.","volume":"178","author":"Marrazzo","year":"1998","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R302","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2105\/AJPH.91.6.947","article-title":"Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women.","volume":"91","author":"Marrazzo","year":"2001","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R303","first-page":"481","article-title":"Lesbians and cervical screening.","volume":"50","author":"Bailey","year":"2000","journal-title":"Br J Gen Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R304","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/sextrans-2014-051558","article-title":"A study of human papillomavirus on vaginally inserted sex toys, before and after cleaning, among women who have sex with women and men.","volume":"90","author":"Anderson","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R305","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/01.OLQ.0000091151.52656.E5","article-title":"Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians.","volume":"30","author":"Marrazzo","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R306","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/sextrans-2012-050893","article-title":"The clinical spectrum of Trichomonas vaginalis infection and challenges to management.","volume":"89","author":"Muzny","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R307","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/cid\/ciu446","article-title":"Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.","volume":"59","author":"Muzny","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R308","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2105\/AJPH.2009.169631","article-title":"Chlamydia trachomatis infection among women reporting sexual activity with women screened in family planning clinics in the Pacific Northwest, 1997 to 2005.","volume":"101","author":"Singh","year":"2011","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R309","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1177\/0956462415604092","article-title":"Chlamydia trachomatis infection in African American women who exclusively have sex with women.","volume":"27","author":"Muzny","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R310","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","article-title":"The prevalence of bacterial vaginosis in the United States, 2001\u20132004; associations with symptoms, sexual behaviors, and reproductive health.","volume":"34","author":"Koumans","year":"2007","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R311","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/sti.2006.022277","article-title":"Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting.","volume":"83","author":"Evans","year":"2007","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R312","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1071\/SH17087","article-title":"Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis.","volume":"15","author":"Olson","year":"2018","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R313","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/sextrans-2018-053824","article-title":"Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women.","volume":"95","author":"Muzny","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R314","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/infdis\/jit664","article-title":"The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study.","volume":"209","author":"Bradshaw","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R315","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/596632","article-title":"Distribution of genital Lactobacillus strains shared by female sex partners.","volume":"199","author":"Marrazzo","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R316","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/infdis\/jis242","article-title":"Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.","volume":"205","author":"Marrazzo","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R317","doi-asserted-by":"publisher","first-page":"706540","DOI":"10.1155\/2012\/706540","article-title":"Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study.","volume":"2012","author":"Mitchell","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R318","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/OLQ.0b013e31822e6121","article-title":"Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing Lactobacilli and Gardnerella vaginalis.","volume":"38","author":"Mitchell","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R319","doi-asserted-by":"publisher","first-page":"e30633","DOI":"10.1371\/journal.pone.0030633","article-title":"Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women.","volume":"7","author":"Fethers","year":"2012","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R320","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/cis1030","article-title":"Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.","volume":"56","author":"Bradshaw","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R321","doi-asserted-by":"publisher","first-page":"e11139","DOI":"10.1371\/journal.pone.0011139","article-title":"Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study.","volume":"5","author":"Marrazzo","year":"2010","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R322","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/cid\/ciu1130","article-title":"Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV.","volume":"60","author":"Vodstrcil","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R323","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/infdis\/jiy243","article-title":"Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study.","volume":"218","author":"Muzny","year":"2018","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R324","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/sti.2011.049213","article-title":"A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial.","volume":"87","author":"Marrazzo","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R325","doi-asserted-by":"publisher","first-page":"e57688","DOI":"10.1371\/journal.pone.0057688","article-title":"Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women.","volume":"8","author":"Bradshaw","year":"2013","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R326","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/COH.0000000000000030","article-title":"HIV epidemics among transgender women.","volume":"9","author":"Poteat","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R327","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.socscimed.2015.11.010","article-title":"Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions.","volume":"147","author":"White Hughto","year":"2015","journal-title":"Soc Sci Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R328","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1089\/lgbt.2013.0042","article-title":"Satisfaction and healthcare utilization of transgender and gender non-conforming individuals in NYC: a community-based participatory study.","volume":"1","author":"Radix","year":"2014","journal-title":"LGBT Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R329","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2105\/AJPH.2012.301109","article-title":"Correlates of HIV infection among transfemales, San Francisco, 2010: results from a respondent-driven sampling study.","volume":"103","author":"Rapues","year":"2013","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R330","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12160-013-9565-8","article-title":"Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus.","volume":"47","author":"Sevelius","year":"2014","journal-title":"Ann Behav Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R331","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11199-012-0216-5","article-title":"Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color.","volume":"68","author":"Sevelius","year":"2013","journal-title":"Sex Roles"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R332","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1177\/0956462415602418","article-title":"Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males.","volume":"27","author":"Reisner","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R333","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7.","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgenderism"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R334","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(16)00683-8","article-title":"Transgender people: health at the margins of society.","volume":"388","author":"Winter","year":"2016","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R335","doi-asserted-by":"publisher","first-page":"e107104","DOI":"10.1371\/journal.pone.0107104","article-title":"Do ask, do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American community health centers.","volume":"9","author":"Cahill","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R336","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1089\/lgbt.2015.0136","article-title":"Inclusion of sexual orientation and gender identity in Stage 3 Meaningful Use Guidelines: a huge step forward for LGBT health","volume":"3","author":"Cahill","year":"2016","journal-title":"LGBT Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R337","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/OLQ.0000000000000952","article-title":"Increased ascertainment of transgender and non-binary patients using a 2-step versus 1-step gender identity intake question in an STD clinic setting.","volume":"46","author":"Tordoff","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R338","unstructured":"Grant JM, Mottet LA, Tanis J. National transgender discrimination survey report on health and health care. Washington, DC: National Center for Transgender Equality and the National Gay and Lesbian Task Force; 2010. https:\/\/cancer-network.org\/wp-content\/uploads\/2017\/02\/National_Transgender_Discrimination_Survey_Report_on_health_and_health_care.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R339","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/MLR.0000000000000583","article-title":"Discrimination and delayed health care among transgender women and men: implications for improving medical education and health care delivery.","volume":"54","author":"Jaffee","year":"2016","journal-title":"Med Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R340","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/lgbt.2017.0093","article-title":"The role of discrimination in care postponement among trans-feminine individuals in the U.S. National Transgender Discrimination Survey.","volume":"5","author":"Glick","year":"2018","journal-title":"LGBT Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R341","first-page":"A64","article-title":"Trans and gender diverse people\u2019s experiences of sexual health care are associated with sexual health screening uptake.","volume":"95","author":"Callander","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R342","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/1475-6773.13229","article-title":"Discrimination in the United States: experiences of lesbian, gay, bisexual, transgender, and queer Americans.","volume":"54","author":"Casey","year":"2019","journal-title":"Health Serv Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R343","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians.","volume":"30","author":"Potter","year":"2015","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R344","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2018.304727","article-title":"Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006\u20132017.","volume":"109","author":"Becasen","year":"2019","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R345","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S1473-3099(12)70315-8","article-title":"Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.","volume":"13","author":"Baral","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R346","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/0956462417744098","article-title":"High incidence of extra-genital gonorrheal and chlamydial infections among high-risk men who have sex with men and transgender women in Peru.","volume":"29","author":"Allan-Blitz","year":"2018","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R347","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/sextrans-2018-053835","article-title":"High burden of chlamydia and gonorrhoea in pharyngeal, rectal and urethral sites among Thai transgender women: implications for anatomical site selection for the screening of STI.","volume":"95","author":"Hiransuthikul","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R348","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12879-017-2332-x","article-title":"The PICASSO Cohort: baseline characteristics of a cohort of men who have sex with men and male-to-female transgender women at high risk for syphilis infection in Lima, Peru.","volume":"17","author":"Kojima","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R349","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/OLQ.0000000000000917","article-title":"Chlamydia, gonorrhea, and human immunodeficiency virus infection among transgender women and transgender men attending clinics that provide sexually transmitted disease services in six US cities: results from the Sexually Transmitted Disease Surveillance Network.","volume":"46","author":"Pitasi","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R350","unstructured":"James S, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 US transgender survey. Washington, DC: National Center for Transgender Equality; 2016. https:\/\/transequality.org\/sites\/default\/files\/docs\/usts\/USTS-Full-Report-Dec17.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R351","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.sxmr.2017.11.005","article-title":"Feminizing genital gender-confirmation surgery.","volume":"6","author":"Hadj-Moussa","year":"2018","journal-title":"Sex Med Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R352","doi-asserted-by":"publisher","first-page":"4907208","DOI":"10.1155\/2018\/4907208","article-title":"Primary sigmoid vaginoplasty in transwomen: technique and outcomes.","volume":"2018","author":"Salgado","year":"2018","journal-title":"BioMed Res Int"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R353","doi-asserted-by":"publisher","first-page":"ofz470","DOI":"10.1093\/ofid\/ofz470","article-title":"Chlamydia trachomatis infection of the neovagina in transgender women.","volume":"6","author":"Radix","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R354","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0956462416685658","article-title":"Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman.","volume":"28","author":"Elfering","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R355","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/OLQ.0000000000000476","article-title":"Prevalence of neovaginal high-risk human papillomavirus among transgender women in the Netherlands.","volume":"43","author":"van der Sluis","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R356","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1258\/ijsa.2008.008213","article-title":"Condylomata gigantea in a male transsexual.","volume":"20","author":"Yang","year":"2009","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R357","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/0956462414542476","article-title":"Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod.","volume":"26","author":"Matsuki","year":"2015","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R358","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00007435-199407000-00005","article-title":"Gonococcal infection of the neovagina in a male-to-female transsexual.","volume":"21","author":"Bodsworth","year":"1994","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R359","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s001050050354","article-title":"Pruritus of the artificial vagina of a transsexual patient caused by gonococcal infection","volume":"46","author":"Haustein","year":"1995","journal-title":"Hautarzt"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R360","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12957-018-1372-z","article-title":"Adenocarcinoma arising in sigmoid colon neovagina 53\u00a0years after construction.","volume":"16","author":"Yamada","year":"2018","journal-title":"World J Surg Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R361","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jso.1067","article-title":"Mucinous adenocarcinoma arising in a neovagina using the sigmoid colon thirty years after operation: a case report.","volume":"77","author":"Hiroi","year":"2001","journal-title":"J Surg Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R362","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/LGT.0000000000000110","article-title":"Lesions of the neovagina\u2014a review.","volume":"19","author":"Heller","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R363","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1097\/QAI.0000000000001222","article-title":"HIV-related sexual risk among transgender men who are gay, bisexual, or have sex with men.","volume":"74","author":"Scheim","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R364","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jana.2009.06.001","article-title":"\u201cThere\u2019s no pamphlet for the kind of sex I have\u201d: HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men.","volume":"20","author":"Sevelius","year":"2009","journal-title":"J Assoc Nurses AIDS Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R365","doi-asserted-by":"publisher","first-page":"883","DOI":"10.15585\/mmwr.mm6633a3","article-title":"HIV testing among transgender women and men\u201427 states and Guam, 2014\u20132015.","volume":"66","author":"Pitasi","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R366","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/apc.2010.0059","article-title":"A mixed methods study of the sexual health needs of New England transmen who have sex with nontransgender men.","volume":"24","author":"Reisner","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R367","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline.","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R368","unstructured":"Deutsch M, ed. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. San Francisco, CA: University of California San Francisco, Department of Family and Community Medicine, Center of Excellence for Transgender Care; 2016. https:\/\/transcare.ucsf.edu\/sites\/transcare.ucsf.edu\/files\/Transgender-PGACG-6-17-16.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R369","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s11606-013-2753-1","article-title":"Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.","volume":"29","author":"Peitzmeier","year":"2014","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R370","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.amepre.2014.07.031","article-title":"Pap test use is lower among female-to-male patients than non-transgender women.","volume":"47","author":"Peitzmeier","year":"2014","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R371","doi-asserted-by":"publisher","first-page":"e0190172","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R372","unstructured":"CDC. Surveillance for viral hepatitis\u2014United States, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2017surveillance\/pdfs\/2017HepSurveillanceRpt.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R373","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1258\/ijsa.2011.011194","article-title":"A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons.","volume":"23","author":"Kouyoumdjian","year":"2012","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R374","unstructured":"CDC. Evaluation of large jail STD screening programs, 2008\u20132009. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. https:\/\/www.cdc.gov\/std\/publications\/JailScreening2011.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R375","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/OLQ.0b013e31815615bb","article-title":"The contribution of a urine-based jail screening program to citywide male chlamydia and gonorrhea case rates in New York City.","volume":"36","author":"Pathela","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R376","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/OLQ.0b013e31815d6de8","article-title":"Sex and age correlates of chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy.","volume":"36","author":"Joesoef","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R377","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/00007435-199704000-00006","article-title":"New approaches to syphilis control. Finding opportunities for syphilis treatment and congenital syphilis prevention in a women\u2019s correctional setting.","volume":"24","author":"Blank","year":"1997","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R378","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/aje\/kws240","article-title":"Investigating the potential public health benefit of jail-based screening and treatment programs for chlamydia.","volume":"177","author":"Owusu-Edusei","year":"2013","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R379","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/01.olq.0000431353.88464.ab","article-title":"Screening for sexually transmitted diseases in short-term correctional institutions: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.","volume":"40","author":"Spaulding","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R380","unstructured":"CDC. Male chlamydia screening consultation, March 28\u201329, 2006, meeting report. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. https:\/\/www.cdc.gov\/std\/chlamydia\/chlamydiascreening-males.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R381","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/OLQ.0000000000000106","article-title":"Opt-out screening for Chlamydia trachomatis and Neisseria gonorrhoeae in female detainees at Cook County jail in Chicago, IL.","volume":"41","author":"Cole","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R382","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/1078345815600447","article-title":"Comparison of opt-in versus opt-out testing for sexually transmitted infections among inmates in a county jail.","volume":"21","author":"Shaikh","year":"2015","journal-title":"J Correct Health Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R383","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/PHH.0000000000000183","article-title":"Establishing an HIV screening program led by staff nurses in a county jail.","volume":"21","author":"Spaulding","year":"2015","journal-title":"J Public Health Manag Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R384","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/QAI.0000000000000889","article-title":"Comparing HIV case detection in prison during opt-in vs. opt-out testing policies.","volume":"71","author":"Rosen","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R385","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1108\/IJPH-07-2018-0043","article-title":"A cross-sectional evaluation of opt-in testing for sexually transmitted and blood-borne infections in three Canadian provincial correctional facilities: a missed opportunity for public health?","volume":"15","author":"Gratrix","year":"2019","journal-title":"Int J Prison Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R386","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/OLQ.0b013e3181de4113","article-title":"Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates.","volume":"37","author":"Sutcliffe","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R387","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/OLQ.0b013e3181bcd3fc","article-title":"Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay.","volume":"37","author":"Freeman","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R388","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/OLQ.0b013e31820bc86c","article-title":"Sexually transmitted infections and hepatitis in men with a history of incarceration.","volume":"38","author":"Sosman","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R389","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/OLQ.0000000000000026","article-title":"Prevalence and factors associated with Trichomonas vaginalis infection among high-risk women in Los Angeles.","volume":"40","author":"Javanbakht","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R390","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/OLQ.0b013e31826e8847","article-title":"Prevalence and predictors of Trichomonas infection in newly incarcerated women.","volume":"39","author":"Nijhawan","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R391","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/OLQ.0b013e31822ea147","article-title":"The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women.","volume":"38","author":"Nijhawan","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R392","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/OLQ.0b013e318154bdb2","article-title":"Prevalence and predictors of sexually transmitted infection among newly incarcerated females.","volume":"35","author":"Willers","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R393","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/jwh.2009.1469","article-title":"Preventive healthcare for underserved women: results of a prison survey.","volume":"19","author":"Nijhawan","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R394","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.2105\/AJPH.2004.052498","article-title":"Cancer screening among jail inmates: frequency, knowledge, and willingness.","volume":"95","author":"Binswanger","year":"2005","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R395","doi-asserted-by":"publisher","first-page":"e0205593","DOI":"10.1371\/journal.pone.0205593","article-title":"Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated.","volume":"13","author":"Brinkley-Rubinstein","year":"2018","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R396","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11904-018-0389-9","article-title":"The path to implementation of HIV pre-exposure prophylaxis for people involved in criminal justice systems.","volume":"15","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R397","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/09540120802017586","article-title":"HIV, STD, and hepatitis risk behaviors of young men before and after incarceration.","volume":"21","author":"Morrow","year":"2009","journal-title":"AIDS Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R398","doi-asserted-by":"publisher","first-page":"e175621","DOI":"10.1001\/jamapediatrics.2017.5621","article-title":"Effect of including alcohol and cannabis content in a sexual risk-reduction intervention on the incidence of sexually transmitted infections in adolescents: a cluster randomized clinical trial.","volume":"172","author":"Bryan","year":"2018","journal-title":"JAMA Pediatr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R399","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/03630242.2014.932893","article-title":"Efficacy of an HIV\/STI sexual risk-reduction intervention for African American adolescent girls in juvenile detention centers: a randomized controlled trial.","volume":"54","author":"DiClemente","year":"2014","journal-title":"Women Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R400","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2105\/AJPH.2014.302105","article-title":"Efficacy of an adapted HIV and sexually transmitted infection prevention intervention for incarcerated women: a randomized controlled trial.","volume":"105","author":"Fogel","year":"2015","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R401","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jpag.2016.11.002","article-title":"The effect of interprofessional student-led reproductive health education on youths in juvenile detention.","volume":"30","author":"Son","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R402","doi-asserted-by":"publisher","first-page":"6878","DOI":"10.1016\/j.vaccine.2012.09.006","article-title":"Implementation of a hepatitis A\/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007\u20132010.","volume":"30","author":"Costumbrado","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R403","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2105\/AJPH.2018.304499","article-title":"Human papillomavirus vaccine knowledge and intention among adult inmates in Kansas, 2016\u20132017.","volume":"108","author":"Allison","year":"2018","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R404","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/1078345814530869","article-title":"Risk, feasibility, and cost evaluation of a prisoner condom access pilot program in one California state prison.","volume":"20","author":"Lucas","year":"2014","journal-title":"J Correct Health Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R405","doi-asserted-by":"publisher","first-page":"e0144869","DOI":"10.1371\/journal.pone.0144869","article-title":"Modelling the impact of condom distribution on the incidence and prevalence of sexually transmitted infections in an adult male prison system.","volume":"10","author":"Scott","year":"2015","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R406","doi-asserted-by":"publisher","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","article-title":"Clinical and epidemiologic features of primary HIV infection.","volume":"125","author":"Schacker","year":"1996","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R407","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11908-017-0588-3","article-title":"Primary HIV infection: clinical presentation, testing, and treatment.","volume":"19","author":"Henn","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R408","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1056\/NEJMoa1508952","article-title":"Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.","volume":"374","author":"Robb","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R409","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3201\/eid2203.151607","article-title":"Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening.","volume":"22","author":"Hoenigl","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R410","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","article-title":"Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study.","volume":"71","author":"Legarth","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R411","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","article-title":"Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care.","volume":"73","author":"Marcus","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R412","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission.","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R413","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2018.8431","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA Panel.","volume":"320","author":"Saag","year":"2018","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R414","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.2105\/AJPH.2015.302778","article-title":"HIV testing and HIV service delivery to populations at high risk attending sexually transmitted disease clinics in the United States, 2011\u20132013.","volume":"105","author":"Seth","year":"2015","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R415","unstructured":"Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012\u20132017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18\u201321, 2019."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R416","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/QAI.0b013e318230e1ca","article-title":"Men who have sex with men have a 140-fold higher risk for newly diagnosed HIV and syphilis compared with heterosexual men in New York City.","volume":"58","author":"Pathela","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R417","doi-asserted-by":"publisher","first-page":"706","DOI":"10.7326\/0003-4819-157-10-201211200-00007","article-title":"Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.","volume":"157","author":"Chou","year":"2012","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R418","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R419","doi-asserted-by":"publisher","first-page":"830","DOI":"10.15585\/mmwr.mm6631a3","article-title":"Recommendations for HIV screening of gay, bisexual, and other men who have sex with men\u2014United States, 2017.","volume":"66","author":"DiNenno","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R420","first-page":"985","article-title":"HIV-2 infection surveillance\u2014United States, 1987\u20132009.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R421","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1086\/429411","article-title":"Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.","volume":"191","author":"Wawer","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R422","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1001\/jama.286.14.1713","article-title":"Sexual transmission during the incubation period of primary HIV infection.","volume":"286","author":"Pilcher","year":"2001","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R423","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/S2352-3018(19)30030-X","article-title":"Providers should discuss U=U with all patients living with HIV.","volume":"6","author":"Calabrese","year":"2019","journal-title":"Lancet HIV"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R424","doi-asserted-by":"publisher","first-page":"e1988","DOI":"10.1371\/journal.pone.0001988","article-title":"Interactive \u201cVideo Doctor\u201d counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings.","volume":"3","author":"Gilbert","year":"2008","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R425","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cit665","article-title":"Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.","volume":"58","author":"Aberg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R426","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1086\/514548","article-title":"The clinical diagnosis of genital ulcer disease in men.","volume":"25","author":"DiCarlo","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R427","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0140-6736(91)90473-3","article-title":"Serum-free media for isolation of Haemophilus ducreyi.","volume":"338","author":"Lockett","year":"1991","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R428","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QCO.0000000000000226","article-title":"Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen.","volume":"29","author":"Lewis","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R429","doi-asserted-by":"publisher","first-page":"CD012492","DOI":"10.1002\/14651858.CD012492.pub2","article-title":"Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults.","volume":"12","author":"Romero","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R430","first-page":"181","article-title":"Human immunodeficiency virus, genital ulcers and the male foreskin: synergism in HIV-1 transmission.","volume":"69","author":"Jessamine","year":"1990","journal-title":"Scand J Infect Dis Suppl"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R431","unstructured":"Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R432","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1586\/14787210.2014.892414","article-title":"Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi\u2014a disappearing pathogen?","volume":"12","author":"Lewis","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R433","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S2214-109X(14)70019-1","article-title":"Haemophilus ducreyi as a cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort study.","volume":"2","author":"Mitj\u00e0","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R434","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3201\/eid2010.140573","article-title":"Haemophilus ducreyi associated with skin ulcers among children, Solomon Islands.","volume":"20","author":"Marks","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R435","doi-asserted-by":"publisher","first-page":"e0003496","DOI":"10.1371\/journal.pntd.0003496","article-title":"A cross-sectional study of \u2018yaws\u2019 in districts of Ghana which have previously undertaken azithromycin mass drug administration for trachoma control.","volume":"9","author":"Ghinai","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R436","first-page":"1","article-title":"Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14\u201349: United States, 2015\u20132016.","volume":"304","author":"McQuillan","year":"2018","journal-title":"NCHS Data Brief"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R437","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/sti.2008.033902","article-title":"Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992\u20132006.","volume":"85","author":"Ryder","year":"2009","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R438","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.OLQ.0000092387.58746.C7","article-title":"Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.","volume":"30","author":"Roberts","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R439","doi-asserted-by":"publisher","first-page":"847","DOI":"10.7326\/0003-4819-121-11-199412010-00004","article-title":"Recurrence rates in genital herpes after symptomatic first-episode infection.","volume":"121","author":"Benedetti","year":"1994","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R440","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00007435-200302000-00015","article-title":"Natural history of genital herpes simplex virus type 1 infection.","volume":"30","author":"Engelberg","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R441","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/QAD.0000000000000646","article-title":"Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.","volume":"29","author":"Masese","year":"2015","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R442","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2017.12.006","article-title":"Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens.","volume":"99-100","author":"Sam","year":"2018","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R443","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1086\/379043","article-title":"Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.","volume":"188","author":"Wald","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R444","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1128\/JCM.01685-12","article-title":"Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test.","volume":"50","author":"Van Der Pol","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R445","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jcv.2017.02.006","article-title":"Automated processing, extraction and detection of herpes simplex virus types 1 and 2: a comparative evaluation of three commercial platforms using clinical specimens.","volume":"89","author":"Binnicker","year":"2017","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R446","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.diagmicrobio.2015.07.018","article-title":"Clinical evaluation of a helicase-dependant amplification (HDA)-based commercial assay for the simultaneous detection of HSV-1 and HSV-2.","volume":"83","author":"Teo","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R447","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1128\/JCM.01413-13","article-title":"Comparison of Simplexa HSV 1 & 2 PCR with culture, immunofluorescence, and laboratory-developed TaqMan PCR for detection of herpes simplex virus in swab specimens.","volume":"51","author":"Gitman","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R448","doi-asserted-by":"publisher","first-page":"973","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention.","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R449","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcv.2010.06.006","article-title":"Direct immunofluorescence assay compared to cell culture for the diagnosis of mucocutaneous herpes simplex virus infections in children.","volume":"49","author":"Caviness","year":"2010","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R450","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/sti.2003.006783","article-title":"HSV type specific serology in sexual health clinics: use, benefits, and who gets tested.","volume":"80","author":"Song","year":"2004","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R451","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00007435-200102000-00007","article-title":"Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics.","volume":"28","author":"Whittington","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R452","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.olq.0000143089.77493.c2","article-title":"Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults.","volume":"31","author":"Zimet","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R453","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/00007435-200207000-00011","article-title":"Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.","volume":"29","author":"Turner","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R454","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/JCM.40.2.407-413.2002","article-title":"Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.","volume":"40","author":"Eing","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R455","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/01.olq.0000175377.88358.f3","article-title":"Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic.","volume":"32","author":"Golden","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R456","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2334-5-84","article-title":"Use of \u201cbiokit HSV-2 Rapid Assay\u201d to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.","volume":"5","author":"Morrow","year":"2005","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R457","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CVI.00437-06","article-title":"Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.","volume":"15","author":"Ngo","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R458","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/OLQ.0000000000000689","article-title":"Performance of commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting.","volume":"44","author":"Agyemang","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R459","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1469-0691.2006.01370.x","article-title":"Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.","volume":"12","author":"Morrow","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R460","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/01.aids.0000222078.75867.77","article-title":"Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.","volume":"20","author":"Ameli","year":"2006","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R461","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/infdis\/jit458","article-title":"Seroprevalence of herpes simplex virus types 1 and 2\u2014United States, 1999\u20132010.","volume":"209","author":"Bradley","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R462","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R463","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1086\/339326","article-title":"Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.","volume":"34","author":"Leone","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R464","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1086\/339325","article-title":"Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.","volume":"34","author":"Wald","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R465","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1086\/498521","article-title":"Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.","volume":"42","author":"Aoki","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R466","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1365-2133.2001.04139.x","article-title":"Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.","volume":"144","author":"Chosidow","year":"2001","journal-title":"Br J Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R467","first-page":"110","article-title":"Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial.","volume":"73","author":"Bodsworth","year":"1997","journal-title":"Genitourin Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R468","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00007435-199709000-00007","article-title":"Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial.","volume":"24","author":"Fife","year":"1997","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R469","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jama.280.10.887","article-title":"Collaborative Famciclovir Genital Herpes Research Group. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial.","volume":"280","author":"Diaz-Mitoma","year":"1998","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R470","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archinte.1997.00440240109016","article-title":"Collaborative Famciclovir Genital Herpes Research Group. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial.","volume":"157","author":"Mertz","year":"1997","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R471","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1086\/515385","article-title":"Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study.","volume":"178","author":"Reitano","year":"1998","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R472","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00007435-200303000-00010","article-title":"Patients\u2019 preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.","volume":"30","author":"Romanowski","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R473","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa035144","article-title":"Once-daily valacyclovir to reduce the risk of transmission of genital herpes.","volume":"350","author":"Corey","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R474","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1086\/342966","article-title":"Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years\u2019 experience with acyclovir.","volume":"186","author":"Tyring","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R475","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jcv.2008.06.004","article-title":"Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.","volume":"43","author":"Bartlett","year":"2008","journal-title":"J Clin Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R476","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1001\/jama.2011.420","article-title":"Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.","volume":"305","author":"Tronstein","year":"2011","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R477","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/infdis\/jiv317","article-title":"Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: a double-blind, randomized, cross-over trial.","volume":"212","author":"Bender Ignacio","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R478","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/01.olq.0000204723.15765.91","article-title":"Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.","volume":"33","author":"Wald","year":"2006","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R479","first-page":"A42","article-title":"Natural history of genital and oral herpes simplex virus-1 (HSV-1) shedding after first episode genital HSV-1 infection.","volume":"95","author":"Johnston","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R480","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/313616","article-title":"Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret\u2019s meningitis.","volume":"30","author":"Tang","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R481","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1086\/508281","article-title":"Recurrent benign lymphocytic meningitis.","volume":"43","author":"Shalabi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R482","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.amjmed.2009.02.017","article-title":"Herpes simplex type-2 meningitis: presentation and lack of standardized therapy.","volume":"122","author":"Landry","year":"2009","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R483","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cid\/cis031","article-title":"Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.","volume":"54","author":"Aurelius","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R484","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1080\/14767058.2018.1527311","article-title":"A literature review of herpes simplex virus hepatitis in pregnancy.","volume":"33","author":"Magawa","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R485","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5582\/irdr.2017.01013","article-title":"A fatal case of herpes simplex virus hepatitis in a pregnant patient.","volume":"6","author":"Masadeh","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R486","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/archinternmed.2009.177","article-title":"A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.","volume":"169","author":"Martin","year":"2009","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R487","doi-asserted-by":"publisher","first-page":"707","DOI":"10.7326\/0003-4819-143-10-200511150-00007","article-title":"The relationship between condom use and herpes simplex virus acquisition.","volume":"143","author":"Wald","year":"2005","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R488","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1001\/jama.285.24.3100","article-title":"Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.","volume":"285","author":"Wald","year":"2001","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R489","first-page":"456","article-title":"Effect of condom use on per-act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples.","volume":"62","author":"Magaret","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R490","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/infdis\/jit371","article-title":"Medical male circumcision and herpes simplex virus 2 acquisition: posttrial surveillance in Kisumu, Kenya.","volume":"208","author":"Mehta","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R491","doi-asserted-by":"publisher","first-page":"e1113","DOI":"10.1016\/S2214-109X(17)30369-8","article-title":"Association between male circumcision and women\u2019s biomedical health outcomes: a systematic review.","volume":"5","author":"Grund","year":"2017","journal-title":"Lancet Glob Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R492","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7326\/M13-2471","article-title":"Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.","volume":"161","author":"Celum","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R493","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1410649","article-title":"Tenofovir gel to prevent HSV-2 infection.","volume":"373","author":"Abdool Karim","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R494","doi-asserted-by":"publisher","first-page":"e91513","DOI":"10.1371\/journal.pone.0091513","article-title":"Daily oral emtricitabine\/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.","volume":"9","author":"Marcus","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R495","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/infdis\/jix029","article-title":"Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: results from the ACTG A5175 PEARLS Study.","volume":"215","author":"Celum","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R496","first-page":"51","article-title":"Genital herpes education and counselling: testing a one-page \u2018FAQ\u2019 intervention.","volume":"15","author":"Gilbert","year":"2009","journal-title":"Herpes"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R497","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/sti.2005.016311","article-title":"The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.","volume":"82","author":"Rosenthal","year":"2006","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R498","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/01.olq.0000137901.71284.6b","article-title":"The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2.","volume":"31","author":"Miyai","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R499","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/sextrans-2011-050099","article-title":"Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review.","volume":"87","author":"Ross","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R500","first-page":"386","article-title":"Successful oral acyclovir desensitization.","volume":"70","author":"Henry","year":"1993","journal-title":"Ann Allergy"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R501","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijid.2015.02.002","article-title":"Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.","volume":"33","author":"Leeyaphan","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R502","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/infdis\/jiz203","article-title":"Impact of herpes simplex virus type 2 and human immunodeficiency virus dual infection on female genital tract mucosal immunity and the vaginal microbiome.","volume":"220","author":"Keller","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R503","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1086\/422755","article-title":"Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.","volume":"190","author":"Posavad","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R504","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/infdis\/jit252","article-title":"Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.","volume":"208","author":"Tobian","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R505","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/infdis\/jit333","article-title":"Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2\/HIV-1 coinfected persons: a randomized controlled trial.","volume":"208","author":"Mujugira","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R506","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/0956462414546504","article-title":"The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.","volume":"26","author":"Van Wagoner","year":"2015","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R507","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/archinte.163.1.76","article-title":"Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics.","volume":"163","author":"Reyes","year":"2003","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R508","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJM199108223250805","article-title":"A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome.","volume":"325","author":"Safrin","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R509","doi-asserted-by":"publisher","first-page":"S248","DOI":"10.1086\/422364","article-title":"Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.","volume":"39","author":"Levin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R510","doi-asserted-by":"publisher","first-page":"e12479","DOI":"10.1111\/dth.12479","article-title":"Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.","volume":"30","author":"Tandon","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R511","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/sti.2010.047431","article-title":"Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.","volume":"87","author":"Perkins","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R512","first-page":"324","article-title":"Topical cidofovir for treatment of resistant viral infections.","volume":"10","author":"McElhiney","year":"2006","journal-title":"Int J Pharm Compd"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R513","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1086\/518938","article-title":"Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease.","volume":"196","author":"Erard","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R514","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199708213370801","article-title":"The acquisition of herpes simplex virus during pregnancy.","volume":"337","author":"Brown","year":"1997","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R515","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0032-1332802","article-title":"Maternal and neonatal herpes simplex virus infections.","volume":"30","author":"Pinninti","year":"2013","journal-title":"Am J Perinatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R516","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1056\/NEJM199105023241804","article-title":"Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.","volume":"324","author":"Brown","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R517","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R518","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/ppe.12064","article-title":"Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997\u20132007.","volume":"27","author":"Ahrens","year":"2013","journal-title":"Paediatr Perinat Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R519","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984\u20131999.","volume":"70","author":"Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R520","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jama.2010.1206","article-title":"Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects.","volume":"304","author":"Pasternak","year":"2010","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R521","first-page":"126","article-title":"Placental histopathology of congenital syphilis.","volume":"100","author":"Sheffield","year":"2002","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R522","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery.","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R523","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1155\/S1064744902000054","article-title":"Acyclovir suppression to prevent recurrent genital herpes at delivery.","volume":"10","author":"Scott","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R524","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpeds.2011.12.053","article-title":"Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series.","volume":"161","author":"Pinninti","year":"2012","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R525","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/01.AOG.0000263902.31953.3e","article-title":"ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy.","volume":"109","author":"ACOG Committee on Practice Bulletins","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R526","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","article-title":"Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.","volume":"20","author":"Winer","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R527","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1016\/S0140-6736(15)60992-8","article-title":"Donovanosis causing lymphadenitis, mastoiditis, and meningitis in a child.","volume":"385","author":"Ahmed","year":"2015","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R528","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/0956462416665996","article-title":"Donovanosis and squamous cell carcinoma: the relationship conundrum!","volume":"28","author":"Arora","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R529","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.jpag.2011.10.002","article-title":"Hypertrophic donavanosis in a young pregnant woman.","volume":"25","author":"Liverani","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R530","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1590\/abd1806-4841.20187948","article-title":"Donovanosis in a child victim of sexual abuse: response to doxycycline treatment.","volume":"93","author":"Magalh\u00e3es","year":"2018","journal-title":"An Bras Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R531","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/0253-7184.192130","article-title":"Nonhealing genital ulcer in AIDS: a diagnostic dilemma!","volume":"37","author":"Marfatia","year":"2016","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R532","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1258\/ijsa.2012.012096","article-title":"Genital elephantiasis due to donovanosis: forgotten but not gone yet.","volume":"23","author":"Narang","year":"2012","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R533","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/0253-7184.132433","article-title":"Granuloma inguinale mimicking as squamous cell carcinoma of penis.","volume":"35","author":"Pilani","year":"2014","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R534","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/DAD.0b013e3182540ccb","article-title":"Infantile donovanosis presenting as external auditory canal polyps: a diagnostic trap.","volume":"34","author":"Ramdial","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R535","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/0970-9371.117638","article-title":"Donovanosis: an incidental finding on Pap test.","volume":"30","author":"Wahal","year":"2013","journal-title":"J Cytol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R536","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/sti.2004.013227","article-title":"Donovanosis in Australia: going, going.","volume":"81","author":"Bowden","year":"2005","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R537","first-page":"E584","article-title":"National Notifiable Diseases Surveillance System surveillance report: sexually transmissible infections in Aboriginal and Torres Strait Islander people.","volume":"39","author":"Bright","year":"2015","journal-title":"Commun Dis Intell Q Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R538","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/sti.78.6.452","article-title":"Donovanosis.","volume":"78","author":"O\u2019Farrell","year":"2002","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R539","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/sti.78.2.90","article-title":"Lymphogranuloma venereum.","volume":"78","author":"Mabey","year":"2002","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R540","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/QCO.0b013e328320a8ae","article-title":"Manifestations and management of lymphogranuloma venereum.","volume":"22","author":"White","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R541","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/0956462413516100","article-title":"2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens.","volume":"25","author":"de Vries","year":"2014","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R542","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1086\/509922","article-title":"Lymphogranuloma venereum in the United kingdom.","volume":"44","author":"Ward","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R543","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10096-010-0959-2","article-title":"Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries.","volume":"29","author":"Martin-Iguacel","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R544","doi-asserted-by":"publisher","first-page":"920","DOI":"10.15585\/mmwr.mm6534a6","article-title":"Notes from the field: cluster of lymphogranuloma venereum cases among men who have sex with men\u2014Michigan, August 2015\u2013April 2016.","volume":"65","author":"de Voux","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R545","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/sextrans-2013-051401","article-title":"Clinical predictors of rectal lymphogranuloma venereum infection: results from a multicentre case-control study in the U.K.","volume":"90","author":"Pallawela","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R546","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1586\/14787210.2014.901169","article-title":"Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review.","volume":"12","author":"de Vrieze","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R547","doi-asserted-by":"publisher","first-page":"20561","DOI":"10.2807\/1560-7917.ES2013.18.34.20561","article-title":"Lymphogranuloma venereum among men who have sex with men in the Netherlands: regional differences in testing rates lead to underestimation of the incidence, 2006\u20132012.","volume":"18","author":"Koper","year":"2013","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R548","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3201\/eid1903.121028","article-title":"Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, Germany.","volume":"19","author":"Haar","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R549","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/sextrans-2018-053787","article-title":"Lymphogranuloma venereum presenting as an ulcer on the tongue.","volume":"95","author":"Riera-Monroig","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R550","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/milmed\/139.2.99","article-title":"Oral lymphogranuloma venereum and cervical lymphadenopathy. Case report.","volume":"139","author":"Andrada","year":"1974","journal-title":"Mil Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R551","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3201\/eid2511.190819","article-title":"Orolabial lymphogranuloma venereum, Michigan, USA.","volume":"25","author":"Ilyas","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R552","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/OLQ.0000000000000667","article-title":"Laboratory processes for confirmation of lymphogranuloma venereum infection during a 2015 investigation of a cluster of cases in the United States.","volume":"44","author":"Kersh","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R553","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014.","volume":"63","author":"CDC","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R554","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/OLQ.0000000000000921","article-title":"Lymphogranuloma venereum: an increasingly common anorectal infection among men who have sex with men attending New York City sexual health clinics.","volume":"46","author":"Pathela","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R555","first-page":"A229","article-title":"P494 Diagnosis and management of lymphogranuloma venereum (LGV) in a municipal STD clinic, San Francisco, 2016\u201318.","volume":"95","author":"Cohen","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R556","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3201\/eid2210.160986","article-title":"Systematic review and meta-analysis of doxycycline efficacy for rectal lymphogranuloma venereum in men who have sex with men.","volume":"22","author":"Leeyaphan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R557","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/OLQ.0000000000000459","article-title":"Anorectal lymphogranuloma venereum in Madrid: a persistent emerging problem in men who have sex with men.","volume":"43","author":"Cabello \u00dabeda","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R558","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/OLQ.0000000000000772","article-title":"Observed treatment responses to short-course doxycycline therapy for rectal lymphogranuloma venereum in men who have sex with men.","volume":"45","author":"Simons","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R559","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/0956462413501158","article-title":"Bubonic lymphogranuloma venereum with multidrug treatment failure.","volume":"25","author":"Vall-Mayans","year":"2014","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R560","unstructured":"Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23\u201326, 2015."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R561","doi-asserted-by":"publisher","first-page":"e0174372","DOI":"10.1371\/journal.pone.0174372","article-title":"Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men.","volume":"12","author":"Kong","year":"2017","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R562","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1258\/ijsa.2011.011134","article-title":"Seven days of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection.","volume":"22","author":"Elgalib","year":"2011","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R563","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.diagmicrobio.2018.09.015","article-title":"How safe is doxycycline for young children or for pregnant or breastfeeding women?","volume":"93","author":"Wormser","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R564","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/sextrans-2015-052219","article-title":"Painful and multiple anogenital lesions are common in men with Treponema pallidum PCR-positive primary syphilis without herpes simplex virus coinfection: a cross-sectional clinic-based study.","volume":"92","author":"Towns","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R565","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/cid\/ciaa176","article-title":"Molecular and direct detection tests for Treponema pallidum subspecies pallidum: a review of the literature, 1964\u20132017.","volume":"71","author":"Theel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R566","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1093\/cid\/ciaa306","article-title":"Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests.","volume":"71","author":"Tuddenham","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R567","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/cid\/ciaa349","article-title":"Sensitivity and specificity of treponemal-specific tests for the diagnosis of syphilis.","volume":"71","author":"Park","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R568","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1093\/cid\/ciaa350","article-title":"Clinical test performance of a rapid point-of-care syphilis treponemal antibody test: a systematic review and meta-analysis.","volume":"71","author":"Bristow","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R569","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/095646249500600404","article-title":"Are you sure it\u2019s syphilis? A review of false positive serology.","volume":"6","author":"Nandwani","year":"1995","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R570","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-114-12-1005","article-title":"Serologic response to treatment of infectious syphilis.","volume":"114","author":"Romanowski","year":"1991","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R571","first-page":"872","article-title":"Syphilis testing algorithms using treponemal tests for initial screening\u2014four laboratories, New York City, 2005\u20132006.","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R572","first-page":"133","article-title":"Discordant results from reverse sequence syphilis screening\u2014five laboratories, United States, 2006\u20132010.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R573","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/INF.0b013e31825d3152","article-title":"Epidemiological surveillance of congenital syphilis in Spain, 2000\u20132010.","volume":"31","author":"Ortiz-Lopez","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R574","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/cid\/ciaa307","article-title":"The traditional or reverse algorithm for diagnosis of syphilis: pros and cons.","volume":"71","author":"Ortiz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R575","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/OLQ.0000000000000524","article-title":"Use of treponemal screening assay strength of signal to avoid unnecessary confirmatory testing.","volume":"43","author":"Berry","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R576","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/infdis\/jir524","article-title":"Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.","volume":"204","author":"Park","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R577","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1128\/CVI.05335-11","article-title":"Analysis of bioplex syphilis IgG quantitative results in different patient populations.","volume":"18","author":"Loeffelholz","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R578","doi-asserted-by":"publisher","first-page":"e01165-17","DOI":"10.1128\/JCM.01165-17","article-title":"Correlation of treponemal immunoassay signal strength values with reactivity of confirmatory treponemal testing.","volume":"56","author":"Fakile","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R579","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/OLQ.0b013e318205491a","article-title":"Evaluation of an IgM\/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population.","volume":"38","author":"Wong","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R580","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/OLQ.0000000000000066","article-title":"Improved reverse screening algorithm for Treponema pallidum antibody using signal-to-cutoff ratios from chemiluminescence microparticle immunoassay.","volume":"41","author":"Dai","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R581","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0004563215623806","article-title":"Screening for antibodies against Treponema pallidum with chemiluminescent microparticle immunoassay: analysis of discordant serology results and clinical characterization.","volume":"53","author":"Li","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R582","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1128\/CVI.05066-11","article-title":"Identification of false-positive syphilis antibody results using a semiquantitative algorithm.","volume":"18","author":"Yen-Lieberman","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R583","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.otohns.2006.08.026","article-title":"Otosyphilis: a review of 85 cases.","volume":"136","author":"Yimtae","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R584","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1288\/00005537-199211000-00010","article-title":"Otosyphilis: a diagnostic and therapeutic dilemma.","volume":"102","author":"Gleich","year":"1992","journal-title":"Laryngoscope"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R585","doi-asserted-by":"publisher","first-page":"855","DOI":"10.7326\/0003-4819-109-11-855","article-title":"Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.","volume":"109","author":"Lukehart","year":"1988","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R586","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/OLQ.0b013e31824c0e62","article-title":"The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: a systematic review.","volume":"39","author":"Harding","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R587","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archinte.1978.03630260050016","article-title":"Tests for treponemal antibody in CSF.","volume":"138","author":"Jaffe","year":"1978","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R588","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1086\/381227","article-title":"Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.","volume":"189","author":"Marra","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R589","first-page":"217","article-title":"Inadvertent use of Bicillin C-R to treat syphilis infection\u2014Los Angeles, California, 1999\u20132004.","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R590","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4269\/ajtmh.16-0434","article-title":"The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis.","volume":"96","author":"Butler","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R591","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199707313370504","article-title":"A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection.","volume":"337","author":"Rolfs","year":"1997","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R592","doi-asserted-by":"publisher","first-page":"e109667","DOI":"10.1371\/journal.pone.0109667","article-title":"One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study.","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R593","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/cid\/ciu888","article-title":"A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis.","volume":"60","author":"Ganesan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R594","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/sti.2006.021402","article-title":"Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics.","volume":"83","author":"Ghanem","year":"2007","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R595","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/cir671","article-title":"Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis.","volume":"53","author":"Se\u00f1a","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R596","doi-asserted-by":"publisher","first-page":"e0175477","DOI":"10.1371\/journal.pone.0175477","article-title":"Molecular subtyping of Treponema pallidum and associated factors of serofast status in early syphilis patients: identified novel genotype and cytokine marker.","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R597","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12879-015-1209-0","article-title":"A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy.","volume":"15","author":"Se\u00f1a","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R598","doi-asserted-by":"publisher","first-page":"e70102","DOI":"10.1371\/journal.pone.0070102","article-title":"Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis.","volume":"8","author":"Tong","year":"2013","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R599","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/cid\/cis918","article-title":"Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin.","volume":"56","author":"Se\u00f1a","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R600","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1086\/500406","article-title":"Doxycycline compared with benzathine penicillin for the treatment of early syphilis.","volume":"42","author":"Ghanem","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R601","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.amjmed.2008.04.042","article-title":"Primary syphilis: serological treatment response to doxycycline\/tetracycline versus benzathine penicillin.","volume":"121","author":"Wong","year":"2008","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R602","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00007435-200208000-00010","article-title":"A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis.","volume":"29","author":"Hook","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R603","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/cid\/cix611","article-title":"A multicenter study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu, China.","volume":"65","author":"Cao","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R604","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJMoa044284","article-title":"Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.","volume":"353","author":"Riedner","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R605","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1086\/652239","article-title":"A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis.","volume":"201","author":"Hook","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R606","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa040216","article-title":"Macrolide resistance in Treponema pallidum in the United States and Ireland.","volume":"351","author":"Lukehart","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R607","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1086\/498899","article-title":"Azithromycin-resistant syphilis infection: San Francisco, California, 2000\u20132004.","volume":"42","author":"Mitchell","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R608","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/OLQ.0b013e31826f36de","article-title":"Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in Treponema pallidum in the United States, 2007 to 2009.","volume":"39","author":"A2058G Prevalence Workgroup","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R609","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199707313370504","article-title":"A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection.","volume":"337","author":"Rolfs","year":"1997","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R610","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/sti.56.6.355","article-title":"Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.","volume":"56","author":"Collart","year":"1980","journal-title":"Br J Vener Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R611","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000238397","article-title":"Penicillin concentrations in serum following weekly injections of benzathine penicillin G.","volume":"32","author":"Hagdrup","year":"1986","journal-title":"Chemotherapy"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R612","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF02014334","article-title":"Penicillin concentrations in blood and spinal fluid after a single intramuscular injection of penicillin G benzathine.","volume":"3","author":"Frentz","year":"1984","journal-title":"Eur J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R613","first-page":"338","article-title":"Penicillin levels following the administration of benzathine penicillin G in pregnancy.","volume":"82","author":"Nathan","year":"1993","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R614","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1086\/591534","article-title":"Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis.","volume":"47","author":"Marra","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R615","doi-asserted-by":"publisher","first-page":"9911","DOI":"10.1038\/s41598-017-10387-x","article-title":"Serological response predicts normalization of cerebrospinal fluid abnormalities at six months after treatment in HIV-negative neurosyphilis patients.","volume":"7","author":"Xiao","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R616","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00007435-198607000-00018","article-title":"Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy.","volume":"13","author":"Hook","year":"1986","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R617","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/sti.79.5.415","article-title":"Treatment of neurosyphilis with ceftriaxone.","volume":"79","author":"Shann","year":"2003","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R618","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000333553","article-title":"Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy.","volume":"158","author":"Ahmed","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R619","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000314367","article-title":"Increased adverse drug reactions to cephalosporins in penicillin allergy patients with positive penicillin skin test.","volume":"153","author":"Park","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R620","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1365-2222.2001.00992.x","article-title":"Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins.","volume":"31","author":"Novalbos","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R621","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.otohns.2006.10.007","article-title":"Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis.","volume":"136","author":"Pichichero","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R622","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/archderm.141.4.431","article-title":"Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus.","volume":"141","author":"Kingston","year":"2005","journal-title":"Arch Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R623","first-page":"625","article-title":"Symptomatic early neurosyphilis among HIV-positive men who have sex with men\u2014four cities, United States, January 2002\u2013June 2004.","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R624","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/QAD.0b013e32830184df","article-title":"Neurosyphilis in a clinical cohort of HIV-1-infected patients.","volume":"22","author":"Ghanem","year":"2008","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R625","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1086\/589295","article-title":"Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.","volume":"47","author":"Ghanem","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R626","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/sextrans-2016-052938","article-title":"Screening for asymptomatic neurosyphilis in HIV patients after treatment of early syphilis: an observational study.","volume":"94","author":"Tomkins","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R627","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1086\/599616","article-title":"Sensitivity and specificity of lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms.","volume":"49","author":"Yang","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R628","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/313725","article-title":"A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals.","volume":"30","author":"Marra","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R629","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0002-9343(92)90574-U","article-title":"Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus.","volume":"93","author":"Dowell","year":"1992","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R630","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/095646240401500511","article-title":"Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin.","volume":"15","author":"Smith","year":"2004","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R631","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000333553","article-title":"Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy.","volume":"158","author":"Ahmed","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R632","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AOG.0000000000003000","article-title":"National trends and reported risk factors among pregnant women with syphilis in the United States, 2012\u20132016.","volume":"133","author":"Trivedi","year":"2019","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R633","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/OLQ.0000000000000782","article-title":"Characteristics associated with delivery of an infant with congenital syphilis and missed opportunities for prevention\u2014California, 2012 to 2014.","volume":"45","author":"Biswas","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R634","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.15585\/mmwr.mm6739a3","article-title":"Factors contributing to congenital syphilis cases\u2014New York City, 2010\u20132016.","volume":"67","author":"Slutsker","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R635","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/OLQ.0000000000000783","article-title":"Social vulnerability in congenital syphilis case mothers: qualitative assessment of cases in Indiana, 2014 to 2016.","volume":"45","author":"DiOrio","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R636","doi-asserted-by":"publisher","first-page":"661","DOI":"10.15585\/mmwr.mm6922a1","article-title":"Missed opportunities for prevention of congenital syphilis\u2014United States, 2018.","volume":"69","author":"Kimball","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R637","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/infdis\/jir524","article-title":"Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.","volume":"204","author":"Park","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R638","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/cid\/civ445","article-title":"Discordant syphilis immunoassays in pregnancy: perinatal outcomes and implications for clinical management.","volume":"61","author":"Mmeje","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R639","first-page":"5","article-title":"Efficacy of treatment for syphilis in pregnancy.","volume":"93","author":"Alexander","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"3","key":"key-10.15585\/mmwr.rr7004a1-202107211802-R640","first-page":"CD001143","article-title":"Antibiotics for syphilis diagnosed during pregnancy.","author":"Walker","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R641","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1086\/342108","article-title":"Treatment of syphilis in pregnancy and prevention of congenital syphilis.","volume":"35","author":"Wendel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R642","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.ijid.2009.09.009","article-title":"Maternal and congenital syphilis in Shanghai, China, 2002 to 2006.","volume":"14","author":"Zhu","year":"2010","journal-title":"Int J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R643","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1473-3099(11)70104-9","article-title":"Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis.","volume":"11","author":"Hawkes","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R644","first-page":"947","article-title":"Fetal syphilis: clinical and laboratory characteristics.","volume":"97","author":"Hollier","year":"2001","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R645","doi-asserted-by":"publisher","first-page":"426.e1","DOI":"10.1016\/j.ajog.2014.05.049","article-title":"Progression of ultrasound findings of fetal syphilis after maternal treatment.","volume":"211","author":"Rac","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R646","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.olq.0000170443.70739.cd","article-title":"A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.","volume":"32","author":"Zhou","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R647","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3201\/eid2305.161936","article-title":"Amoxicillin and ceftriaxone as treatment alternatives to penicillin for maternal syphilis.","volume":"23","author":"Katanami","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R648","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1542\/peds.2009-1181","article-title":"Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants.","volume":"125","author":"Kestenbaum","year":"2010","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R649","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jhm.711","article-title":"Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants.","volume":"6","author":"Shah","year":"2011","journal-title":"J Hosp Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R650","doi-asserted-by":"publisher","first-page":"e20173405","DOI":"10.1542\/peds.2017-3405","article-title":"Cerebrospinal fluid reference values for young infants undergoing lumbar puncture.","volume":"141","author":"Thomson","year":"2018","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R651","unstructured":"Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red book: 2018 report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R652","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis.","volume":"135","author":"Macy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R653","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.anai.2018.07.041","article-title":"Who needs penicillin allergy testing?","volume":"121","author":"Macy","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R654","first-page":"167","article-title":"Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy.","volume":"74","author":"Ann\u00e8","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R655","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2500\/aap.2014.35.3791","article-title":"Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population.","volume":"35","author":"Albin","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R656","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy.","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R657","doi-asserted-by":"publisher","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects.","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R658","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review.","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R659","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.1993.03510200062033","article-title":"Clinical experience with penicillin skin testing in a large inner-city STD clinic.","volume":"270","author":"Gadde","year":"1993","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R660","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaip.2013.02.002","article-title":"Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin.","volume":"1","author":"Macy","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R661","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.anai.2014.06.019","article-title":"Multinational experience with hypersensitivity drug reactions in Latin America.","volume":"113","author":"Jares","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R662","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: A cohort study.","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R663","doi-asserted-by":"publisher","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R664","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk.","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R665","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jaip.2017.01.023","article-title":"Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits.","volume":"5","author":"Tucker","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R666","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1081-1206(10)60402-4","article-title":"Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy.","volume":"100","author":"Goldberg","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R667","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaip.2018.05.008","article-title":"Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing.","volume":"7","author":"Iammatteo","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R668","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jtcvs.2014.01.019","article-title":"Penicillin skin testing in cardiac surgery.","volume":"147","author":"Cook","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R669","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.arth.2017.01.012","article-title":"Screening for beta-lactam allergy in joint arthroplasty patients to improve surgical prophylaxis practice.","volume":"32","author":"McDanel","year":"2017","journal-title":"J Arthroplasty"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R670","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/cid\/cix244","article-title":"Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation.","volume":"65","author":"Trubiano","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R671","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK tertiary centre.","volume":"7","author":"Siew","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R672","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jaip.2016.09.045","article-title":"A proactive approach to penicillin allergy testing in hospitalized patients.","volume":"5","author":"Chen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R673","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/cid\/cix512","article-title":"Point-of-care \u03b2-lactam allergy skin testing by antimicrobial stewardship programs: a pragmatic multicenter prospective evaluation.","volume":"65","author":"Leis","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R674","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11882-019-0854-6","article-title":"Evaluating penicillin allergies without skin testing.","volume":"19","author":"Banks","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R675","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.anai.2017.03.013","article-title":"Penicillin desensitization: treatment of syphilis in pregnancy in penicillin-allergic patients.","volume":"118","author":"Pham","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R676","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/archinte.1992.00400170105020","article-title":"Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults.","volume":"152","author":"Sogn","year":"1992","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R677","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jaip.2019.02.040","article-title":"Penicillin allergy evaluation: a prospective, multicenter, open-label evaluation of a comprehensive penicillin skin test kit.","volume":"7","author":"Solensky","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R678","doi-asserted-by":"publisher","first-page":"ofw155","DOI":"10.1093\/ofid\/ofw155","article-title":"Implementation of an infectious disease fellow-managed penicillin allergy skin testing service.","volume":"3","author":"Heil","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R679","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/jac\/dky575","article-title":"Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital.","volume":"74","author":"du Plessis","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R680","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaip.2017.07.033","article-title":"Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?","volume":"6","author":"Macy","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R681","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam allergy.","volume":"6","author":"Zagursky","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R682","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.anai.2015.05.011","article-title":"Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy.","volume":"115","author":"Blumenthal","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R683","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.surg.2018.05.054","article-title":"Perioperative use of cefazolin without preliminary skin testing in patients with reported penicillin allergy.","volume":"165","author":"Kuruvilla","year":"2019","journal-title":"Surgery"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R684","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jac\/dkm315","article-title":"Results of a UK survey of fatal anaphylaxis after oral amoxicillin.","volume":"60","author":"Lee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R685","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jaip.2017.02.019","article-title":"Addressing inpatient beta-lactam allergies: a multihospital implementation.","volume":"5","author":"Blumenthal","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R686","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial.","volume":"7","author":"Mustafa","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R687","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/pharmacy7030112","article-title":"Antimicrobial desensitization: a review of published protocols.","volume":"7","author":"Chastain","year":"2019","journal-title":"Pharmacy (Basel)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R688","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1056\/NEJM198505093121905","article-title":"Penicillin allergy and desensitization in serious infections during pregnancy.","volume":"312","author":"Wendel","year":"1985","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R689","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0091-6749(87)90037-6","article-title":"Intravenous desensitization to beta-lactam antibiotics.","volume":"80","author":"Borish","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R690","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jcf.2009.08.002","article-title":"A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity.","volume":"8","author":"Legere","year":"2009","journal-title":"J Cyst Fibros"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R691","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2105\/AJPH.2005.074062","article-title":"Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection.","volume":"97","author":"Manhart","year":"2007","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R692","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/sti.2005.017368","article-title":"Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment.","volume":"82","author":"Ross","year":"2006","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R693","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1258\/095646204322637209","article-title":"Mycoplasma genitalium in chronic non-gonococcal urethritis.","volume":"15","author":"Taylor-Robinson","year":"2004","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R694","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1086\/376990","article-title":"Detection and quantification of Mycoplasma genitalium in male patients with urethritis.","volume":"37","author":"Dupin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R695","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1128\/JCM.34.12.3120-3128.1996","article-title":"Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis.","volume":"34","author":"Krieger","year":"1996","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R696","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/OLQ.0000000000000540","article-title":"Quantitative real-time polymerase chain reaction for the diagnosis of Mycoplasma genitalium infection in South African men with and without symptoms of urethritis.","volume":"44","author":"le Roux","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R697","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1093\/cid\/ciaa293","article-title":"Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations and symptom resolution following treatment of urethritis.","volume":"71","author":"Bachmann","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R698","doi-asserted-by":"publisher","first-page":"188.e1","DOI":"10.1016\/j.ajog.2008.10.005","article-title":"Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.","volume":"200","author":"Nye","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R699","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1086\/499434","article-title":"Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure.","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R700","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/OLQ.0b013e3182753327","article-title":"Evidence for the long-term stability of HIV transmission-associated sexual behavior after HIV diagnosis.","volume":"40","author":"Dombrowski","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R701","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1128\/JCM.00899-14","article-title":"Characteristics of acute nongonococcal urethritis in men differ by sexual preference.","volume":"52","author":"Rane","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R702","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/cid\/cit752","article-title":"High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.","volume":"58","author":"Pond","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R703","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0956462414539464","article-title":"Prevalence of Trichomonas vaginalis, Mycoplasma genitalium and Ureaplasma urealyticum in men with urethritis attending an urban sexual health clinic.","volume":"26","author":"Khatib","year":"2015","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R704","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/0956462415597620","article-title":"Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting.","volume":"27","author":"Cox","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R705","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciz294","article-title":"Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance.","volume":"70","author":"Li","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R706","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/iju.13044","article-title":"Male non-gonococcal urethritis: from microbiological etiologies to demographic and clinical features.","volume":"23","author":"Ito","year":"2016","journal-title":"Int J Urol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R707","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jdv.15146","article-title":"Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?\u2014A position statement from the European STI Guidelines Editorial Board.","volume":"32","author":"Horner","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R708","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/sextrans-2015-052118","article-title":"Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands.","volume":"92","author":"van der Veer","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R709","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/sextrans-2012-050702","article-title":"Prevalence and morbidity of urethral Trichomonas vaginalis in Japanese men with or without urethritis.","volume":"89","author":"Seike","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R710","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.diagmicrobio.2015.03.016","article-title":"Detection of Mycoplasma genitalium from male primary urine specimens: an epidemiologic dichotomy with Trichomonas vaginalis.","volume":"82","author":"Napierala","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R711","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/sextrans-2014-051771","article-title":"Epidemiology and laboratory characteristics of Trichomonas vaginalis infection in Croatian men with and without urethritis syndrome: a case-control study.","volume":"91","author":"Sviben","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R712","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/OLQ.0000000000000696","article-title":"The etiology of male urethral discharge in Zimbabwe: results from the Zimbabwe STI Etiology Study.","volume":"45","author":"Rietmeijer","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R713","doi-asserted-by":"publisher","first-page":"550","DOI":"10.15585\/mmwr.mm6521a5","article-title":"Notes from the field: increase in Neisseria meningitidis-associated urethritis among men at two sentinel clinics\u2014Columbus, Ohio, and Oakland County, Michigan, 2015.","volume":"65","author":"Bazan","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R714","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3201\/eid2501.171102","article-title":"Orogenital transmission of Neisseria meningitidis causing acute urethritis in men who have sex with men.","volume":"25","author":"Jannic","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R715","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3201\/eid2009.140349","article-title":"Urethritis caused by novel Neisseria meningitidis serogroup W in man who has sex with men, Japan.","volume":"20","author":"Hayakawa","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R716","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/OLQ.0000000000001079","article-title":"Repeat episodes of symptomatic urethritis due to a uropathogenic meningococcal clade.","volume":"47","author":"Bazan","year":"2020","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R717","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/OLQ.0000000000000547","article-title":"Clinical characteristics of herpes simplex virus urethritis compared with chlamydial urethritis among men.","volume":"44","author":"Ong","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R718","first-page":"109","article-title":"When should adenoviral non-gonococcal urethritis be suspected? Two case reports.","volume":"37","author":"Avolio","year":"2014","journal-title":"New Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R719","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.micpath.2016.02.022","article-title":"The first report: an analysis of bacterial flora of the first voided urine specimens of patients with male urethritis using the 16S ribosomal RNA gene-based clone library method.","volume":"95","author":"You","year":"2016","journal-title":"Microb Pathog"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R720","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jiac.2017.05.009","article-title":"Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and\/or epididymitis.","volume":"23","author":"Deguchi","year":"2017","journal-title":"J Infect Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R721","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/OLQ.0000000000000573","article-title":"Haemophilus influenzae isolated from men with acute urethritis: its pathogenic roles, responses to antimicrobial chemotherapies, and antimicrobial susceptibilities.","volume":"44","author":"Ito","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R722","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jiac.2017.08.007","article-title":"\u2018Haemophilus quentini\u2019 in the urethra of men complaining of urethritis symptoms.","volume":"24","author":"Horie","year":"2018","journal-title":"J Infect Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R723","doi-asserted-by":"publisher","first-page":"e0214425","DOI":"10.1371\/journal.pone.0214425","article-title":"Detection of ureaplasmas and bacterial vaginosis associated bacteria and their association with non-gonococcal urethritis in men.","volume":"14","author":"Fr\u00f8lund","year":"2019","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R724","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/sextrans-2015-052135","article-title":"Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in urethral exudates from men with acute urethritis: a descriptive study of 52 cases.","volume":"92","author":"Deza","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R725","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.adengl.2018.11.011","article-title":"Haemophilus species isolated in urethral exudates as a possible causative agent in acute urethritis: a study of 38 cases","volume":"110","author":"Magdaleno-Tapial","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R726","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/OLQ.0000000000000027","article-title":"Corynebacterium propinquum associated with acute, nongonococcal urethritis.","volume":"40","author":"Abdolrasouli","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R727","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1556\/AMicr.61.2014.1.8","article-title":"Isolation of Kurthia gibsonii from non-gonorrheal urethritis: implications for the pathomechanism upon surveying the literature.","volume":"61","author":"Ongr\u00e1di","year":"2014","journal-title":"Acta Microbiol Immunol Hung"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R728","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.idcr.2015.03.001","article-title":"Corynebacterium glucuronolyticum causing genitourinary tract infection: case report and review of the literature.","volume":"2","author":"Gherardi","year":"2015","journal-title":"IDCases"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R729","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s15010-018-1211-8","article-title":"A microbial game of whack-a-mole: clinical case series of the urethral uncloaking phenomenon caused by Corynebacterium glucuronolyticum in men treated for Chlamydia trachomatis urethritis.","volume":"47","author":"Me\u0161trovi\u0107","year":"2019","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R730","first-page":"43","article-title":"Urethritis due to corynebacterium striatum: an emerging germ.","volume":"93","author":"Frikh","year":"2015","journal-title":"Tunis Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R731","doi-asserted-by":"publisher","first-page":"136147","DOI":"10.1155\/2015\/136147","article-title":"Necrotizing urethritis due to Aerococcus urinae.","volume":"2015","author":"Babaeer","year":"2015","journal-title":"Case Rep Urol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R732","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/OLQ.0000000000000532","article-title":"Acute urethritis and balonoposthitis associated to Neisseria elongata.","volume":"43","author":"Grandolfo","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R733","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2340\/00015555-2314","article-title":"Urethritis-associated pathogens in urine from men with non-gonococcal urethritis: a case-control study.","volume":"96","author":"Fr\u00f8lund","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R734","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/sextrans-2018-053634","article-title":"Cross-sectional study of urethral exposures at last sexual episode associated with non-gonococcal urethritis among STD clinic patients.","volume":"95","author":"Chambers","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R735","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/OLQ.0000000000000054","article-title":"Bacterial vaginosis-associated bacteria in men: association of Leptotrichia\/Sneathia spp. with nongonococcal urethritis.","volume":"40","author":"Manhart","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R736","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1089\/lap.2017.0064","article-title":"Preliminary experience with instillation of triamcinolone acetonide into the urethra for idiopathic urethritis: a prospective pilot study.","volume":"27","author":"Ashraf","year":"2017","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R737","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/OLQ.0b013e318225f7c2","article-title":"Comparison of methylene blue\/gentian violet stain to Gram\u2019s stain for the rapid diagnosis of gonococcal urethritis in men.","volume":"38","author":"Taylor","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R738","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/OLQ.0b013e3182354da3","article-title":"Recalibrating the Gram stain diagnosis of male urethritis in the era of nucleic acid amplification testing.","volume":"39","author":"Rietmeijer","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R739","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/01.olq.0000175390.45315.a1","article-title":"Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on Gram stain: implications for diagnostic approach and management.","volume":"32","author":"Geisler","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R740","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0956462416630675","article-title":"Prevalence of Mycoplasma genitalium in men with urethritis and in high risk asymptomatic males in Tel Aviv: a prospective study.","volume":"28","author":"Gottesman","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R741","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jramc-2015-000488","article-title":"The prevalence of causative organisms of community-acquired urethritis in an age group at high risk for sexually transmitted infections in Korean soldiers.","volume":"163","author":"Kim","year":"2017","journal-title":"J R Army Med Corps"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R742","doi-asserted-by":"publisher","first-page":"e0196217","DOI":"10.1371\/journal.pone.0196217","article-title":"Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: an observational, cross-sectional study.","volume":"13","author":"Libois","year":"2018","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R743","doi-asserted-by":"publisher","first-page":"S763","DOI":"10.1093\/cid\/civ755","article-title":"Advances in the understanding and treatment of male urethritis.","volume":"61","author":"Bachmann","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R744","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/sextrans-2015-052243","article-title":"Characteristics of adenovirus urethritis among heterosexual men and men who have sex with men: a review of clinical cases.","volume":"92","author":"Samaraweera","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R745","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462415586675","article-title":"2015 UK National Guideline on the management of non-gonococcal urethritis.","volume":"27","author":"Horner","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R746","doi-asserted-by":"publisher","first-page":"e13143","DOI":"10.1111\/and.13143","article-title":"Microscopy of Gram-stained urethral smear in the diagnosis of urethritis: which threshold value should be selected?","volume":"50","author":"Sarier","year":"2018","journal-title":"Andrologia"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R747","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11255-019-02140-2","article-title":"Classification of non-gonococcal urethritis: a review.","volume":"51","author":"Sarier","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R748","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/cid\/ciu220","article-title":"Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials.","volume":"59","author":"Kong","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R749","doi-asserted-by":"publisher","first-page":"CD010871","DOI":"10.1002\/14651858.CD010871.pub2","article-title":"Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.","volume":"1","author":"P\u00e1ez-Canro","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R750","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/OLQ.0000000000001009","article-title":"Men who have sex with men with Mycoplasma genitalium-positive nongonococcal urethritis are more likely to have macrolide resistant strains than men with only female partners: a prospective study.","volume":"46","author":"McIver","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R751","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/cid\/civ644","article-title":"The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis.","volume":"61","author":"Lau","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R752","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/OLQ.0000000000001030","article-title":"Mycoplasma genitalium nongonococcal urethritis is likely to increase in men who have sex with men who practice unsafe sex: what should we do?","volume":"46","author":"Horner","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R753","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature.","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R754","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/sti.2006.024059","article-title":"Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting.","volume":"83","author":"Fung","year":"2007","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R755","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/OLQ.0000000000000489","article-title":"Azithromycin treatment failure for Chlamydia trachomatis among heterosexual men with nongonococcal urethritis.","volume":"43","author":"Kissinger","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R756","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/ciq074","article-title":"Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens\u2014a randomized clinical trial.","volume":"52","author":"Schwebke","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R757","doi-asserted-by":"publisher","first-page":"A29","DOI":"10.1136\/sextrans-2013-051184.0091","article-title":"O02.3 Treatment outcomes for persistent Mycoplasma genitalium-associated NGU: evidence of moxifloxacin treatment failures.","volume":"89","author":"Manhart","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R758","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/cid\/ciy843","article-title":"Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis.","volume":"69","author":"Romano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R759","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation.","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R760","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1258\/0956462001915507","article-title":"Symptomatic and asymptomatic chlamydial non-gonococcal urethritis in Jamaica: the potential for HIV transmission.","volume":"11","author":"Dowe","year":"2000","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R761","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/sextrans-2015-052332","article-title":"Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics.","volume":"92","author":"Lusk","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R762","first-page":"49","article-title":"Cervicitis: a review.","volume":"21","author":"Lusk","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R763","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1086\/511423","article-title":"Management of women with cervicitis.","volume":"44","author":"Marrazzo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R764","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1258\/095646203765371277","article-title":"Sensitivity of microscopy for the rapid diagnosis of gonorrhoea in men and women and the role of gonorrhoea serovars.","volume":"14","author":"Manavi","year":"2003","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R765","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/cid\/ciy922","article-title":"Mycoplasma genitalium infections in women attending a sexually transmitted disease clinic in New Orleans.","volume":"69","author":"Lillis","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R766","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis.","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R767","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1071\/SH12168","article-title":"Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic.","volume":"10","author":"Oliphant","year":"2013","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R768","doi-asserted-by":"publisher","first-page":"A240","DOI":"10.1136\/sextrans-2013-051184.0749","article-title":"P3.294 Association of Mycoplasma genitalium with cervicitis in North Indian women attending gynecologic clinics.","volume":"89","author":"Sethi","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R769","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/OLQ.0b013e31828bfcb1","article-title":"Prevalence and treatment outcome of cervicitis of unknown etiology.","volume":"40","author":"Taylor","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R770","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/OLQ.0b013e318255de03","article-title":"Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors.","volume":"39","author":"Mobley","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R771","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1086\/500149","article-title":"Risk factors for cervicitis among women with bacterial vaginosis.","volume":"193","author":"Marrazzo","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R772","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/OLQ.0b013e3181b01948","article-title":"Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics.","volume":"36","author":"Gaydos","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R773","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jadohealth.2004.03.009","article-title":"Group B streptococcal vaginitis in postpubertal adolescent girls.","volume":"36","author":"Clark","year":"2005","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R774","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jpag.2018.12.004","article-title":"A clinical conundrum: chronic cervicitis.","volume":"32","author":"Hester","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R775","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3109\/00365548.2014.922696","article-title":"High bacterial loads of Ureaplasma may be associated with non-specific cervicitis.","volume":"46","author":"Liu","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R776","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jmii.2017.05.004","article-title":"Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study.","volume":"51","author":"Leli","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R777","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/OLQ.0b013e3181b9d825","article-title":"Has the time come to systematically test for Mycoplasma genitalium?","volume":"36","author":"Manhart","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R778","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00404-017-4327-7","article-title":"Comorbidity profiles among women with postcoital bleeding: a nationwide health insurance database.","volume":"295","author":"Liu","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R779","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/QAD.0b013e328012b838","article-title":"Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts.","volume":"21","author":"Coleman","year":"2007","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R780","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/OLQ.0b013e3181812d15","article-title":"The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis.","volume":"35","author":"Johnson","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R781","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00002030-200101050-00015","article-title":"Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.","volume":"15","author":"McClelland","year":"2001","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R782","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1258\/ijsa.2010.010320","article-title":"Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding.","volume":"22","author":"Gatski","year":"2011","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R783","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1097\/QAD.0b013e32833f9f43","article-title":"Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.","volume":"24","author":"Gitau","year":"2010","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R784","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/OLQ.0000000000001382","article-title":"Estimates of the prevalence and incidence of chlamydia and gonorrhea among US men and women, 2018.","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R785","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/sextrans-2014-051607","article-title":"Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study.","volume":"90","author":"Aghaizu","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R786","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/OLQ.0b013e31823e3009","article-title":"Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population.","volume":"39","author":"Scholes","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R787","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00007435-199609000-00007","article-title":"Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden.","volume":"23","author":"Kamwendo","year":"1996","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R788","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/OLQ.0b013e31816938ba","article-title":"Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature.","volume":"35","author":"Rietmeijer","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R789","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1097\/OLQ.0b013e3181723dba","article-title":"The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature.","volume":"35","author":"Gift","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R790","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1097\/OLQ.0b013e31818b64ac","article-title":"The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.","volume":"35","author":"Gift","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R791","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/OLQ.0000000000000023","article-title":"Cost-effectiveness of screening men in Maricopa County jails for chlamydia and gonorrhea to avert infections in women.","volume":"40","author":"Gopalappa","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R792","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1128\/JCM.02387-08","article-title":"Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.","volume":"47","author":"Masek","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R793","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/00007435-200211000-00006","article-title":"Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas.","volume":"29","author":"Knox","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R794","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/01.olq.0000190092.59482.96","article-title":"Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.","volume":"32","author":"Schachter","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R795","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1258\/ijsa.2008.008056","article-title":"Acceptability of chlamydia screening using self-taken vaginal swabs.","volume":"19","author":"Doshi","year":"2008","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R796","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/sextrans-2012-050573","article-title":"Self-collected swabs of the urinary meatus diagnose more Chlamydia trachomatis and Neisseria gonorrhoeae infections than first catch urine from men.","volume":"89","author":"Chernesky","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R797","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.diagmicrobio.2016.07.018","article-title":"Performance of self-collected penile-meatal swabs compared to clinician-collected urethral swabs for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium by nucleic acid amplification assays.","volume":"86","author":"Dize","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R798","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1099\/jmm.0.000428","article-title":"Comparison of self-collected meatal swabs with urine specimens for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men.","volume":"66","author":"Berry","year":"2017","journal-title":"J Med Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R799","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1128\/JCM.00013-07","article-title":"Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.","volume":"45","author":"Chernesky","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R800","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/OLQ.0b013e31817bdd7e","article-title":"Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men.","volume":"35","author":"Schachter","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R801","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/OLQ.0b013e31816471ae","article-title":"Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men.","volume":"35","author":"Mimiaga","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R802","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1128\/JCM.01581-08","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections.","volume":"47","author":"Bachmann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R803","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1128\/JCM.02398-09","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.","volume":"48","author":"Bachmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R804","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1128\/JCM.00616-17","article-title":"Use of nucleic acid amplification testing for diagnosis of extragenital sexually transmitted infections.","volume":"55","author":"Cosentino","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R805","unstructured":"Food and Drug Administration. Microbiology Devices Panel of the Medical Devices Advisory Committee meeting annoucement [Internet]. Silver Spring, MD: US Department of Agriculture, Food and Drug Administration; 2019. https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/march-8-2019-microbiology-devices-panel-medical-devices-advisory-committee-meeting-announcement#event-materials"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R806","first-page":"70","article-title":"How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men?","volume":"62","author":"Sexton","year":"2013","journal-title":"J Fam Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R807","doi-asserted-by":"publisher","first-page":"4386127","DOI":"10.1155\/2016\/4386127","article-title":"A systematic review of point of care testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.","volume":"2016","author":"Herbst de Cortina","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R808","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.diagmicrobio.2016.10.019","article-title":"Impact of rapid diagnostic testing for chlamydia and gonorrhea on appropriate antimicrobial utilization in the emergency department.","volume":"87","author":"Rivard","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R809","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/sextrans-2014-051580","article-title":"Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation.","volume":"90","author":"Wingrove","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R810","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/OLQ.0b013e318151497d","article-title":"The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment.","volume":"35","author":"Geisler","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R811","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/cid\/ciz050","article-title":"Treatment effectiveness of azithromycin and doxycycline in uncomplicated rectal and vaginal Chlamydia trachomatis infections in women: a multicentre observational study (FemCure).","volume":"69","author":"Dukers-Muijrers","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R812","doi-asserted-by":"publisher","first-page":"ciab153","DOI":"10.1093\/cid\/ciab153","article-title":"Doxycycline versus azithromycin for the treatment of rectal chlamydia in men who have sex with men: a randomized controlled trial.","author":"Dombrowski","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R813","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12879-015-1280-6","article-title":"What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion.","volume":"15","author":"Dukers-Muijrers","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R814","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/OLQ.0b013e3182029008","article-title":"Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra.","volume":"38","author":"Marcus","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R815","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1177\/0956462415614723","article-title":"Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.","volume":"27","author":"Manavi","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R816","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/cid\/civ079","article-title":"An alternative scenario to explain rectal positivity in Chlamydia-infected individuals.","volume":"60","author":"Rank","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R817","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/cid\/cis291","article-title":"Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial.","volume":"55","author":"Geisler","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R818","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1071\/SH10030","article-title":"Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.","volume":"8","author":"Renault","year":"2011","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R819","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/0956462416680438","article-title":"A recommendation for timing of repeat Chlamydia trachomatis test following infection and treatment in pregnant and nonpregnant women.","volume":"28","author":"Lazenby","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R820","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/OLQ.0b013e31817247b2","article-title":"Rate and predictors of repeat Chlamydia trachomatis infection among men.","volume":"35","author":"Dunne","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R821","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/sti.76.3.169","article-title":"Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks\u2019 prospective follow up study.","volume":"76","author":"Kjaer","year":"2000","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R822","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00007435-200102000-00011","article-title":"Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study.","volume":"28","author":"Whittington","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R823","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/JCM.02483-14","article-title":"Investigating the epidemiology of repeat Chlamydia trachomatis detection after treatment by using C. trachomatis OmpA genotyping.","volume":"53","author":"Kapil","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R824","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1067\/mob.2001.115050","article-title":"A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy.","volume":"184","author":"Jacobson","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R825","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/S1064744901000321","article-title":"A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy.","volume":"9","author":"Kacmar","year":"2001","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R826","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.olq.0000187226.32145.ea","article-title":"An observational cohort study of Chlamydia trachomatis treatment in pregnancy.","volume":"33","author":"Rahangdale","year":"2006","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R827","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1701-2163(16)34683-7","article-title":"Repeat screening for sexually transmitted infection in adolescent obstetric patients.","volume":"32","author":"Aggarwal","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R828","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.micinf.2012.07.017","article-title":"Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB\/c mice.","volume":"14","author":"Phillips Campbell","year":"2012","journal-title":"Microbes Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R829","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1086\/652394","article-title":"Chlamydia trachomatis persistence in vitro: an overview.","volume":"201","author":"Wyrick","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R830","doi-asserted-by":"publisher","first-page":"e0212212","DOI":"10.1371\/journal.pone.0212212","article-title":"Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: a systematic review and meta-analysis.","volume":"14","author":"Fan","year":"2019","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R831","doi-asserted-by":"publisher","first-page":"m331","DOI":"10.1136\/bmj.m331","article-title":"Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.","volume":"368","author":"Fan","year":"2020","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R832","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40264-019-00884-5","article-title":"Prenatal exposure to macrolides and risk of congenital malformations: a meta-analysis.","volume":"43","author":"Mallah","year":"2020","journal-title":"Drug Saf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R833","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1056\/NEJM198903233201204","article-title":"Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis.","volume":"320","author":"Hammerschlag","year":"1989","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R834","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1093\/jpids\/piy060","article-title":"Treatment of neonatal chlamydial conjunctivitis: a systematic review and meta-analysis.","volume":"7","author":"Zikic","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R835","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00006454-198211000-00007","article-title":"Longitudinal studies on chlamydial infections in the first year of life.","volume":"1","author":"Hammerschlag","year":"1982","journal-title":"Pediatr Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R836","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.63.2.198","article-title":"Treatment of chlamydial pneumonia of infancy.","volume":"63","author":"Beem","year":"1979","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R837","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jpeds.2018.10.038","article-title":"Caution is required when using non-Food and Drug Administration-cleared assays to diagnose sexually transmitted infections in children.","volume":"206","author":"Brownell","year":"2019","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R838","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/OLQ.0000000000001355","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018.","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R839","doi-asserted-by":"publisher","first-page":"e0132776","DOI":"10.1371\/journal.pone.0132776","article-title":"Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis.","volume":"10","author":"Lunny","year":"2015","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R840","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/sextrans-2014-051842","article-title":"A mixed methods approach to assess the likelihood of testing for STI using self-collected samples among behaviourally bisexual women.","volume":"91","author":"Schick","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R841","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/OLQ.0000000000000636","article-title":"Prevalence and risk factors for rectal and urethral sexually transmitted infections from self-collected samples among young men who have sex with men participating in the Keep It Up! 2.0 randomized controlled trial.","volume":"44","author":"Mustanski","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R842","doi-asserted-by":"publisher","first-page":"e0189515","DOI":"10.1371\/journal.pone.0189515","article-title":"Comparing mail-in self-collected specimens sent via United States Postal Service versus clinic-collected specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in extra-genital sites.","volume":"12","author":"Salow","year":"2017","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R843","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/JCM.43.3.1301-1303.2005","article-title":"Comparison of Easy-Flow Copan Liquid Stuart\u2019s and Starplex Swab transport systems for recovery of fastidious aerobic bacteria.","volume":"43","author":"Drake","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R844","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1128\/JCM.41.4.1720-1721.2003","article-title":"Survival of six auxotypes of Neisseria gonorrhoeae in transport media.","volume":"41","author":"Wade","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R845","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0732-8893(99)00134-0","article-title":"Evaluation of four commercial transport media for the survival of Neisseria gonorrhoeae.","volume":"36","author":"Arbique","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R846","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/cid\/ciy271","article-title":"A brief history of evolving diagnostics and therapy for gonorrhea: lessons learned.","volume":"67","author":"Hook","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R847","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1517\/14728214.2015.1039981","article-title":"Future treatment of gonorrhea\u2014novel emerging drugs are essential and in progress?","volume":"20","author":"Unemo","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R848","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41564-019-0501-y","article-title":"The impact of antimicrobials on gonococcal evolution.","volume":"4","author":"S\u00e1nchez-Bus\u00f3","year":"2019","journal-title":"Nat Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R849","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.1990.03450110059027","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R850","first-page":"332","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R851","unstructured":"CDC. Sexually transmitted disease surveillance 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. https:\/\/www.cdc.gov\/std\/stats\/archive\/Surv2013-Print.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R852","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1128\/AAC.45.12.3603-3606.2001","article-title":"Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.","volume":"45","author":"Muratani","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R853","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea.","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R854","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R855","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.","volume":"9","author":"Deguchi","year":"2003","journal-title":"J Infect Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R856","doi-asserted-by":"crossref","first-page":"19792","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R857","doi-asserted-by":"publisher","first-page":"19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R858","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R859","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R860","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1258\/ijsa.2009.009191","article-title":"Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations.","volume":"22","author":"Forsyth","year":"2011","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R861","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dkt034","article-title":"Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.","volume":"68","author":"Lewis","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R862","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1086\/597586","article-title":"Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.","volume":"48","author":"Ota","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R863","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R864","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.","volume":"68","author":"Chen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R865","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","article-title":"Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.","volume":"58","author":"Tapsall","year":"2009","journal-title":"J Med Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R866","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R867","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R868","first-page":"590","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R869","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/cid\/cix249","article-title":"Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin.","volume":"65","author":"Wind","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R870","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jac\/dky548","article-title":"Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review.","volume":"74","author":"Kong","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R871","unstructured":"CDC. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R872","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020.","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R873","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. Clinical and Laboratory Standards Institute document M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010."},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R874","unstructured":"CDC. Cephalosporin-resistant\n                      Neisseria gonorrhoeae\n                      public health response plan. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. https:\/\/www.cdc.gov\/std\/treatment\/Ceph-R-ResponsePlanJuly30-2012.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R875","doi-asserted-by":"publisher","first-page":"1900528","DOI":"10.2807\/1560-7917.ES.2019.24.36.1900528","article-title":"Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019.","volume":"24","author":"Poncin","year":"2019","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R876","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.eimc.2011.11.010","article-title":"First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.","volume":"30","author":"Carnicer-Pont","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R877","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.","volume":"67","author":"C\u00e1mara","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R878","doi-asserted-by":"publisher","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R879","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1473-3099(20)30055-4","article-title":"Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia.","volume":"20","author":"Fifer","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R880","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R881","doi-asserted-by":"publisher","first-page":"e01644-18","DOI":"10.1128\/AAC.01644-18","article-title":"Pharmacokinetic data are predictive of in vivo efficacy for cefixime and ceftriaxone against susceptible and resistant Neisseria gonorrhoeae strains in the gonorrhea mouse model.","volume":"63","author":"Connolly","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R882","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1120009X.2004.11782371","article-title":"The role of PK\/PD parameters to avoid selection and increase of resistance: mutant prevention concentration.","volume":"16","author":"Blondeau","year":"2004","journal-title":"J Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R883","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","article-title":"Drugs of choice for the treatment of uncomplicated gonococcal infections.","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R884","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-4939-9496-0_3","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea.","volume":"1997","author":"Unemo","year":"2019","journal-title":"Methods Mol Biol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R885","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R886","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/S0140-6736(18)32817-4","article-title":"Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.","volume":"393","author":"Ross","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R887","doi-asserted-by":"publisher","first-page":"e0193678","DOI":"10.1371\/journal.pone.0193678","article-title":"In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R888","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/00007435-200108000-00008","article-title":"Intersecting epidemics and educable moments: sexually transmitted disease risk assessment and screening in men who have sex with men.","volume":"28","author":"Mayer","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R889","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1258\/ijsa.2008.008127","article-title":"Sexually transmitted infections among brothel-based sex workers in Tel-Aviv area, Israel: high prevalence of pharyngeal gonorrhoea.","volume":"19","author":"Linhart","year":"2008","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R890","doi-asserted-by":"publisher","first-page":"321","DOI":"10.15585\/mmwr.mm6814a1","article-title":"Extragenital chlamydia and gonorrhea among community venue-attending men who have sex with men\u2014five cities, United States, 2017.","volume":"68","author":"Johnson Jones","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R891","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/sextrans-2018-053957","article-title":"Prevalence of genital and oropharyngeal chlamydia and gonorrhoea among female sex workers in Melbourne, Australia, 2015\u20132017: need for oropharyngeal testing.","volume":"95","author":"Chow","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R892","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/sextrans-2018-053803","article-title":"Evidence for a new paradigm of gonorrhoea transmission: cross-sectional analysis of Neisseria gonorrhoeae infections by anatomical site in both partners in 60 male couples.","volume":"95","author":"Cornelisse","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R893","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/OLQ.0b013e3181a4d147","article-title":"Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men.","volume":"36","author":"Kissinger","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R894","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3201\/eid2509.190407","article-title":"Genetic characterization and enhanced surveillance of ceftriaxone-resistant Neisseria gonorrhoeae strain, Alberta, Canada, 2018.","volume":"25","author":"Berenger","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R895","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cmi.2019.08.004","article-title":"Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.","volume":"26","author":"Rob","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R896","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jaci.2010.06.052","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems.","volume":"126","author":"Romano","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R897","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/AOG.0000000000002300","article-title":"Committee opinion No. 717: sulfonamides, nitrofurantoin, and risk of birth defects.","volume":"130","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Obstetric Practice","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R898","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0002-9394(89)90495-9","article-title":"Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone.","volume":"107","author":"Haimovici","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R899","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/AOG.0b013e318244eda9","article-title":"Disseminated gonococcal infection in women.","volume":"119","author":"Bleich","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R900","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/sextrans-2013-051119","article-title":"Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009\u20132011.","volume":"89","author":"Belkacem","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R901","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4269\/ajtmh.19-0288","article-title":"Characteristics and impact of disseminated gonococcal infection in the \u201cTop End\u201d of Australia.","volume":"101","author":"Birrell","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R902","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/cid\/ciy958","article-title":"Disseminated gonococcal infections in patients receiving eculizumab: a case series.","volume":"69","author":"Crew","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R903","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jama.2018.21367","article-title":"Ocular prophylaxis for gonococcal ophthalmia neonatorum: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"321","author":"Curry","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R904","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/OLQ.0000000000000613","article-title":"Keeping an eye on chlamydia and gonorrhea conjunctivitis in infants in the United States, 2010\u20132015.","volume":"44","author":"Kreisel","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R905","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ophtha.2011.11.037","article-title":"Povidone-iodine and ophthalmia neonatorum.","volume":"119","author":"Scott","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R906","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ophtha.2010.12.003","article-title":"Efficacy comparison between povidone iodine 2.5% and tetracycline 1% in prevention of ophthalmia neonatorum.","volume":"118","author":"David","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R907","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jpeds.2009.11.060","article-title":"Periocular ulcerative dermatitis associated with gentamicin ointment prophylaxis in newborns.","volume":"156","author":"Binenbaum","year":"2010","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R908","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/INF.0b013e3181f6c2e5","article-title":"Severe ocular reactions after neonatal ocular prophylaxis with gentamicin ophthalmic ointment.","volume":"30","author":"Nathawad","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R909","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from chrysalis to multicolored butterfly.","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R910","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/infdis\/jis356","article-title":"Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy.","volume":"206","author":"Se\u00f1a","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R911","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/OLQ.0b013e31815abac6","article-title":"Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women.","volume":"35","author":"Huppert","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R912","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/343829","article-title":"Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans.","volume":"35","author":"Mena","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R913","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2340\/00015555-0924","article-title":"The overall agreement of proposed definitions of mucopurulent cervicitis in women at high risk of Chlamydia infection.","volume":"90","author":"Falk","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R914","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/sti.2004.012062","article-title":"Mycoplasma genitalium: prevalence, clinical significance, and transmission.","volume":"81","author":"Anagrius","year":"2005","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R915","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1086\/367992","article-title":"Mucopurulent cervicitis and Mycoplasma genitalium.","volume":"187","author":"Manhart","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R916","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/sti.2010.045138","article-title":"Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population.","volume":"87","author":"Lusk","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R917","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/OLQ.0000000000000621","article-title":"The immunopathogenesis of Mycoplasma genitalium infections in women: a narrative review.","volume":"44","author":"Dehon","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R918","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1471-0528.2009.02455.x","article-title":"The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy.","volume":"117","author":"Bjartling","year":"2010","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R919","doi-asserted-by":"publisher","first-page":"476.e1","DOI":"10.1016\/j.ajog.2012.02.036","article-title":"Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service.","volume":"206","author":"Bjartling","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R920","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/sextrans-2017-053376","article-title":"Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response Against Chlamydia (TRAC) Study.","volume":"94","author":"Taylor","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R921","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/sti.2005.015701","article-title":"Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.","volume":"81","author":"Cohen","year":"2005","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R922","doi-asserted-by":"publisher","first-page":"30184","DOI":"10.1155\/IDOG\/2006\/30184","article-title":"Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.","volume":"2006","author":"Haggerty","year":"2006","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R923","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1086\/594123","article-title":"Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease.","volume":"48","author":"Short","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R924","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/sti.79.2.154","article-title":"Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease.","volume":"79","author":"Simms","year":"2003","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R925","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1086\/656739","article-title":"Is Mycoplasma genitalium in women the \u201cNew Chlamydia?\u201d A community-based prospective cohort study.","volume":"51","author":"Oakeshott","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R926","doi-asserted-by":"publisher","first-page":"A34","DOI":"10.1136\/sextrans-2013-051184.0106","article-title":"Mycoplasma genitalium\u2014is it a pathogen in acute pelvic inflammatory disease (PID)?","volume":"89","author":"Wiesenfeld","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R927","first-page":"417","article-title":"Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium.","volume":"66","author":"M\u00f8ller","year":"1985","journal-title":"Br J Exp Pathol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R928","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1093\/infdis\/jix198","article-title":"Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen.","volume":"216","author":"Wiesenfeld","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R929","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/humrep\/16.9.1866","article-title":"Serological investigation of Mycoplasma genitalium in infertile women.","volume":"16","author":"Clausen","year":"2001","journal-title":"Hum Reprod"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R930","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.fertnstert.2006.12.056","article-title":"Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility\u2014a prospective study.","volume":"90","author":"Svenstrup","year":"2008","journal-title":"Fertil Steril"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R931","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/sextrans-2015-052011","article-title":"Mycoplasma genitalium serum antibodies in infertile couples and fertile women.","volume":"91","author":"Idahl","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R932","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/00207170600712071","article-title":"Assessing the relationship between preterm delivery and various microorganisms recovered from the lower genital tract.","volume":"19","author":"Edwards","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R933","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/OLQ.0b013e31824b1cf3","article-title":"Clinical characteristics associated with Mycoplasma genitalium infection among women at high risk of HIV and other STI in Uganda.","volume":"39","author":"Vandepitte","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R934","doi-asserted-by":"publisher","first-page":"71.e1","DOI":"10.1016\/j.ajog.2017.02.051","article-title":"Microbial invasion of the amniotic cavity in midtrimester pregnancies using molecular microbiology.","volume":"217","author":"Rowlands","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R935","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/sti.2007.024752","article-title":"A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy.","volume":"83","author":"Jurstrand","year":"2007","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R936","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12879-015-1313-1","article-title":"Prevalence of 7 sexually transmitted organisms by multiplex real-time PCR in Fallopian tube specimens collected from Saudi women with and without ectopic pregnancy.","volume":"15","author":"Ashshi","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R937","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cmi.2015.11.016","article-title":"The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men.","volume":"22","author":"Bissessor","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R938","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/OLQ.0000000000000793","article-title":"Clinical characteristics of anorectal Mycoplasma genitalium infection and microbial cure in men who have sex with men.","volume":"45","author":"Ong","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R939","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3201\/eid2504.181258","article-title":"symptoms, sites, and significance of Mycoplasma genitalium in men who have sex with men.","volume":"25","author":"Read","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R940","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/sextrans-2018-053823","article-title":"Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis.","volume":"95","author":"Cina","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R941","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis.","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R942","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/sextrans-2013-051467","article-title":"Association between Mycoplasma genitalium infection and HIV acquisition among female sex workers in Uganda: evidence from a nested case-control study.","volume":"90","author":"Vandepitte","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R943","doi-asserted-by":"publisher","first-page":"1560.e1","DOI":"10.1016\/j.cmi.2019.04.015","article-title":"Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.","volume":"25","author":"Ferr\u00e9","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R944","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/QAD.0b013e32834ff690","article-title":"The association between Mycoplasma genitalium and HIV-1 acquisition in African women.","volume":"26","author":"Mavedzenge","year":"2012","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R945","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cid\/ciu217","article-title":"Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey.","volume":"59","author":"Salado-Rasmussen","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R946","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/jdv.12963","article-title":"Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR.","volume":"29","author":"Wold","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R947","first-page":"e96","article-title":"Mycoplasma genitalium in Toronto, Ont: estimates of prevalence and macrolide resistance.","volume":"62","author":"Gesink","year":"2016","journal-title":"Can Fam Physician"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R948","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1128\/JCM.00012-16","article-title":"5\u2019 nuclease genotyping assay for identification of macrolide-resistant Mycoplasma genitalium in clinical specimens.","volume":"54","author":"Kristiansen","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R949","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jac\/dkw584","article-title":"High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands.","volume":"72","author":"Braam","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R950","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium.","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R951","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/OLQ.0000000000000617","article-title":"Mycoplasma genitalium antibiotic resistance-mediating mutations in Canadian women with or without Chlamydia trachomatis infection.","volume":"44","author":"Chernesky","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R952","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/OLQ.0000000000000631","article-title":"Mycoplasma genitalium macrolide and fluoroquinolone resistance: prevalence and risk factors among a 2013\u20132014 cohort of patients in Barcelona, Spain.","volume":"44","author":"Barber\u00e1","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R953","doi-asserted-by":"publisher","first-page":"e01555-18","DOI":"10.1128\/JCM.01555-18","article-title":"Levels of Mycoplasma genitalium antimicrobial resistance differ by both region and gender in the state of Queensland, Australia: implications for treatment guidelines.","volume":"57","author":"Sweeney","year":"2019","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R954","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/ciu1162","article-title":"Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.","volume":"60","author":"Bissessor","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R955","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.eimc.2018.10.003","article-title":"Guided antibiotic therapy for Mycoplasma genitalium infections: analysis of mutations associated with resistance to macrolides and fluoroquinolones","volume":"37","author":"Pi\u00f1eiro","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R956","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/cid\/cix853","article-title":"High prevalence of multidrug-resistant Mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama.","volume":"66","author":"Dionne-Odom","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R957","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/sextrans-2017-053164","article-title":"Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services in England.","volume":"94","author":"Pitt","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R958","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cmi.2017.09.006","article-title":"Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M.\u00a0genitalium prevalence and antimicrobial resistance in M.\u00a0genitalium in Denmark, Norway and Sweden in 2016.","volume":"24","author":"Unemo","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R959","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1128\/JCM.01087-17","article-title":"Mycoplasma genitalium macrolide and fluoroquinolone resistance detection and clinical implications in a selected cohort in New Zealand.","volume":"55","author":"Anderson","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R960","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.","volume":"36","author":"Shimada","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R961","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12879-019-3797-6","article-title":"Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007\u20132014.","volume":"19","author":"Muller","year":"2019","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R962","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/OLQ.0000000000001035","article-title":"Lack of association between the S83I ParC mutation in Mycoplasma genitalium and treatment outcomes among men who have sex with men with nongonococcal urethritis.","volume":"46","author":"Chambers","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R963","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/cid\/ciz1031","article-title":"Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability.","volume":"71","author":"Durukan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R964","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0956462416688562","article-title":"Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.","volume":"28","author":"Li","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R965","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12879-018-3523-9","article-title":"Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem.","volume":"18","author":"Mondeja","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R966","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/0956462418816757","article-title":"Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline.","volume":"30","author":"Glaser","year":"2019","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R967","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/OLQ.0000000000000891","article-title":"Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-associated mutations in heterosexual African American couples in Alabama.","volume":"46","author":"Xiao","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R968","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3201\/eid2311.170998","article-title":"Mycoplasma genitalium infection in adults reporting sexual contact with infected partners, Australia, 2008\u20132016.","volume":"23","author":"Slifirski","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R969","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jama.291.11.1368","article-title":"Evaluation of vaginal complaints.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R970","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","article-title":"Adherent biofilms in bacterial vaginosis.","volume":"106","author":"Swidsinski","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R971","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1086\/657320","article-title":"Bacterial vaginosis assessed by Gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.","volume":"202","author":"Brotman","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R972","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","article-title":"High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis.","volume":"46","author":"Peebles","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R973","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/sextrans-2016-052652","article-title":"Association between bacterial vaginosis and partner concurrency: a longitudinal study.","volume":"94","author":"Kenyon","year":"2018","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R974","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.ajog.2004.06.089","article-title":"Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.","volume":"191","author":"Sanchez","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R975","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00007435-200104000-00010","article-title":"Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study.","volume":"28","author":"Ness","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R976","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/sextrans-2019-054191","article-title":"Novel bacterial vaginosis-associated organisms mediate the relationship between vaginal douching and pelvic inflammatory disease.","volume":"96","author":"Gondwe","year":"2020","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R977","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1177\/0956462415616038","article-title":"Prevalent bacterial vaginosis infection\u2014a risk factor for incident sexually transmitted infections in women in Durban, South Africa.","volume":"27","author":"Abbai","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R978","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fpubh.2019.00004","article-title":"Does male circumcision reduce women\u2019s risk of sexually transmitted infections, cervical cancer, and associated conditions?","volume":"7","author":"Morris","year":"2019","journal-title":"Front Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R979","doi-asserted-by":"publisher","first-page":"e10197","DOI":"10.1371\/journal.pone.0010197","article-title":"Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis.","volume":"5","author":"Srinivasan","year":"2010","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R980","doi-asserted-by":"publisher","first-page":"132ra52","DOI":"10.1126\/scitranslmed.3003605","article-title":"Temporal dynamics of the human vaginal microbiota.","volume":"4","author":"Gajer","year":"2012","journal-title":"Sci Transl Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R981","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/648092","article-title":"Early sexual experiences and risk factors for bacterial vaginosis.","volume":"200","author":"Fethers","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R982","doi-asserted-by":"publisher","first-page":"622.e1","DOI":"10.1016\/j.ajog.2018.02.017","article-title":"Impact of contraceptive initiation on vaginal microbiota.","volume":"218","author":"Achilles","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R983","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41598-019-39879-8","article-title":"Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial.","volume":"9","author":"Vodstrcil","year":"2019","journal-title":"Sci Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R984","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.contraception.2016.11.006","article-title":"Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.","volume":"95","author":"Brooks","year":"2017","journal-title":"Contraception"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R985","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1089\/jwh.2017.6804","article-title":"Serum 25-hydroxyvitamin D and risk of self-reported bacterial vaginosis in a prospective cohort study of young African American women.","volume":"27","author":"Moore","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R986","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/aje\/kwx043","article-title":"Association of recent bacterial vaginosis with acquisition of Mycoplasma genitalium.","volume":"186","author":"Lokken","year":"2017","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R987","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","article-title":"Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis.","volume":"221","author":"Brusselaers","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R988","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1007\/s10461-017-1924-1","article-title":"Prevalent herpes simplex virus-2 increases the risk of incident bacterial vaginosis in women from South Africa.","volume":"22","author":"Abbai","year":"2018","journal-title":"AIDS Behav"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R989","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/14767058.2011.565390","article-title":"Association of bacterial vaginosis with adverse fetomaternal outcome in women with spontaneous preterm labor: a prospective cohort study.","volume":"25","author":"Laxmi","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R990","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.olq.0000218869.52753.c7","article-title":"The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology.","volume":"33","author":"Cherpes","year":"2006","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R991","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1515\/JPM.2009.026","article-title":"Preterm labor and bacterial vaginosis-associated bacteria among urban women.","volume":"37","author":"Nelson","year":"2009","journal-title":"J Perinat Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R992","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":"Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.","volume":"22","author":"Atashili","year":"2008","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R993","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","article-title":"Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women.","volume":"46","author":"Gosmann","year":"2017","journal-title":"Immunity"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R994","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1473-3099(18)30058-6","article-title":"Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.","volume":"18","author":"McClelland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R995","first-page":"A148","article-title":"P239 Genital HSV-2 suppression is not associated with alterations in the vaginal microbiome: a one-way, cross-over study.","volume":"95","author":"Johnston","year":"2019","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R996","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40168-016-0161-6","article-title":"Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis.","volume":"4","author":"Zozaya","year":"2016","journal-title":"Microbiome"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R997","doi-asserted-by":"publisher","first-page":"e00589","DOI":"10.1128\/mBio.00589-15","article-title":"Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda.","volume":"6","author":"Liu","year":"2015","journal-title":"MBio"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R998","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/OLQ.0b013e3182631d89","article-title":"Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women.","volume":"39","author":"Mehta","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R999","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.","volume":"74","author":"Amsel","year":"1983","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1000","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation.","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1001","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0029-7844(96)00233-5","article-title":"Validity of the vaginal Gram stain for the diagnosis of bacterial vaginosis.","volume":"88","author":"Schwebke","year":"1996","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1002","doi-asserted-by":"publisher","first-page":"e00342-18","DOI":"10.1128\/JCM.00342-18","article-title":"Molecular diagnosis of bacterial vaginosis: an update.","volume":"56","author":"Coleman","year":"2018","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1003","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1128\/JCM.41.5.1925-1928.2003","article-title":"BVBlue test for diagnosis of bacterial vaginosis.","volume":"41","author":"Myziuk","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1004","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/JCM.43.3.1304-1308.2005","article-title":"Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis.","volume":"43","author":"Bradshaw","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1005","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00007435-200306000-00003","article-title":"Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in The Gambia.","volume":"30","author":"West","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1006","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1128\/JCM.01272-07","article-title":"Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.","volume":"45","author":"Fredricks","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1007","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/AOG.0000000000002090","article-title":"Clinical validation of a test for the diagnosis of vaginitis.","volume":"130","author":"Gaydos","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1008","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/JCM.00506-12","article-title":"Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis.","volume":"50","author":"Cartwright","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1009","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1128\/JCM.03104-15","article-title":"Development and validation of a highly accurate quantitative real-time PCR assay for diagnosis of bacterial vaginosis.","volume":"54","author":"Hilbert","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1010","doi-asserted-by":"publisher","first-page":"517.e1","DOI":"10.1016\/j.ajog.2007.02.048","article-title":"A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases.","volume":"196","author":"Schwebke","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1011","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.4045\/tidsskr.14.0081","article-title":"Is combining metronidazole and alcohol really hazardous?","volume":"134","author":"Fjeld","year":"2014","journal-title":"Tidsskr Nor Laegeforen"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1012","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/AOG.0000000000002135","article-title":"Secnidazole treatment of bacterial vaginosis: a randomized controlled trial.","volume":"130","author":"Hillier","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1013","doi-asserted-by":"publisher","first-page":"678.e1","DOI":"10.1016\/j.ajog.2017.08.017","article-title":"A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.","volume":"217","author":"Schwebke","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1014","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/jwh.2017.6500","article-title":"A phase 3, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis.","volume":"27","author":"Chavoustie","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1015","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/01.AOG.0000275282.60506.3d","article-title":"Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial.","volume":"110","author":"Livengood","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1016","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/323034","article-title":"Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.","volume":"33","author":"Sobel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1017","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/LGT.0000000000000062","article-title":"Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study.","volume":"19","author":"Chavoustie","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1018","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/OLQ.0000000000000300","article-title":"A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis.","volume":"42","author":"Schwebke","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1019","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10647440500148321","article-title":"The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis.","volume":"13","author":"Faro","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1020","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/cid\/ciy554","article-title":"Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, single-blind, phase 2, controlled trial.","volume":"68","author":"Marrazzo","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1021","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1086\/598686","article-title":"Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.","volume":"199","author":"Antonio","year":"2009","journal-title":"J Infect Dis"},{"issue":"4","key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1022","doi-asserted-by":"publisher","first-page":"CD006289","DOI":"10.1002\/14651858.CD006289.pub2","article-title":"Probiotics for the treatment of bacterial vaginosis.","author":"Senok","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1023","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1179\/joc.2009.21.3.243","article-title":"The role of Lactobacillus probiotics in the treatment or prevention of urogenital infections\u2014a systematic review.","volume":"21","author":"Abad","year":"2009","journal-title":"J Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1024","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1469-0691.2008.02112.x","article-title":"Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.","volume":"15","author":"Mastromarino","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1025","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/OLQ.0b013e3181e50026","article-title":"Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.","volume":"37","author":"Hemmerling","year":"2010","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1026","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/OLQ.0b013e3181af6cfd","article-title":"The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis.","volume":"36","author":"Bunge","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1027","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/OLQ.0000000000000123","article-title":"High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study.","volume":"41","author":"Aguin","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1028","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ajog.2005.11.041","article-title":"Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.","volume":"194","author":"Sobel","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1029","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/OLQ.0b013e3181b08456","article-title":"Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis.","volume":"36","author":"Reichman","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1030","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1086\/587490","article-title":"Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.","volume":"197","author":"McClelland","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1031","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ajog.2019.10.087","article-title":"Results of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of astodrimer gel for prevention of recurrent bacterial vaginosis.","volume":"221","author":"Schwebke","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1032","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","article-title":"Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis.","volume":"382","author":"Cohen","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1033","doi-asserted-by":"publisher","first-page":"479.e1","DOI":"10.1016\/j.ajog.2014.06.023","article-title":"A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis.","volume":"211","author":"Turner","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1034","doi-asserted-by":"publisher","first-page":"e0190199","DOI":"10.1371\/journal.pone.0190199","article-title":"Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples\u2014a pilot study.","volume":"13","author":"Plummer","year":"2018","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1035","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1903","article-title":"Treatment of male sexual partners of women with bacterial vaginosis (BV): a randomized, double-blind, placebo-controlled trial.","author":"Schwebke","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1036","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00007435-200105000-00011","article-title":"Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda.","volume":"28","author":"Koumans","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1037","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJM199512283332603","article-title":"Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.","volume":"333","author":"Hauth","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1038","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0002-9378(94)70033-8","article-title":"Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study.","volume":"171","author":"Morales","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1039","first-page":"527","article-title":"Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial.","volume":"102","author":"Yudin","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1040","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.AOG.0000130068.21566.4e","article-title":"Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin.","volume":"104","author":"Ugwumadu","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1041","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0002-9378(95)90567-7","article-title":"Safety of metronidazole in pregnancy: a meta-analysis.","volume":"172","author":"Burtin","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1042","first-page":"348","article-title":"Prenatal use of metronidazole and birth defects: no association.","volume":"82","author":"Piper","year":"1993","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1043","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2174\/157488631002150515124548","article-title":"The use of metronidazole during pregnancy: a review of evidence.","volume":"10","author":"Sheehy","year":"2015","journal-title":"Curr Drug Saf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1044","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajog.2011.03.047","article-title":"Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.","volume":"205","author":"Lamont","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1045","first-page":"231","article-title":"Preterm labour\u2014is bacterial vaginosis involved?","volume":"92","author":"Odendaal","year":"2002","journal-title":"S Afr Med J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1046","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJM200002243420802","article-title":"Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis.","volume":"342","author":"Carey","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1047","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1471-0528.1999.tb08363.x","article-title":"Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial.","volume":"106","author":"Vermeulen","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1048","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/j.1471-0528.1997.tb11009.x","article-title":"Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial.","volume":"104","author":"McDonald","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1049","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(03)12823-1","article-title":"Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.","volume":"361","author":"Ugwumadu","year":"2003","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1050","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/S0140-6736(18)31617-9","article-title":"Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.","volume":"392","author":"Subtil","year":"2018","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1051","first-page":"48","article-title":"Metronidazole in breast milk.","volume":"57","author":"Erickson","year":"1981","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1052","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2125.1988.tb03362.x","article-title":"Metronidazole excretion in human milk and its effect on the suckling neonate.","volume":"26","author":"Passmore","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1053","unstructured":"United Kingdom National Health Service. Medicines Q&A: metronidazole\u2014is it safe to use with breastfeeding? [Internet]. London, England: United Kingdom National Health Service, UK Medicines Information; 2012. https:\/\/studylib.net\/doc\/7341270\/metronidazole-in-breastfeeding-mothers"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1054","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/00006250-200110000-00023","article-title":"Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study.","volume":"98","author":"Jamieson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1055","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1056","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/OLQ.0b013e31827c08c3","article-title":"A Trich-y question: should Trichomonas vaginalis infection be reportable?","volume":"40","author":"Hoots","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1057","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1097\/OLQ.0000000000001013","article-title":"Prevalence of Trichomonas vaginalis among civilian, noninstitutionalized male and female population aged 14 to 59 years: United States, 2013 to 2016.","volume":"46","author":"Flagg","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1058","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/cid\/ciy499","article-title":"Prevalence of Trichomonas vaginalis infection among US males, 2013\u20132016.","volume":"68","author":"Daugherty","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1059","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/sextrans-2015-052010","article-title":"The incidence of Trichomonas vaginalis infection in women attending nine sexually transmitted diseases clinics in the USA.","volume":"92","author":"Alcaide","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1060","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/cid\/ciu446","article-title":"Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.","volume":"59","author":"Muzny","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1061","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/OLQ.0000000000000038","article-title":"Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.","volume":"40","author":"Meites","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1062","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/JCM.00748-12","article-title":"Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.","volume":"50","author":"Ginocchio","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1063","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00007435-199807000-00006","article-title":"Rates of and risk factors for trichomoniasis among pregnant inmates in New York City.","volume":"25","author":"Shuter","year":"1998","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1064","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1258\/0956462053057594","article-title":"Screening for sexually transmitted diseases and hepatitis in 18\u201329-year-old men recently released from prison: feasibility and acceptability.","volume":"16","author":"Sosman","year":"2005","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1065","doi-asserted-by":"publisher","first-page":"e90548","DOI":"10.1371\/journal.pone.0090548","article-title":"Epidemiology of undiagnosed trichomoniasis in a probability sample of urban young adults.","volume":"9","author":"Rogers","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1066","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/OLQ.0b013e31823b1922","article-title":"Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions.","volume":"39","author":"Mayer","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1067","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1086\/511144","article-title":"Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.","volume":"44","author":"Se\u00f1a","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1068","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/OLQ.0b013e318264248b","article-title":"Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men.","volume":"39","author":"Kelley","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1069","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1086\/522532","article-title":"The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001\u20132004.","volume":"45","author":"Sutton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1070","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1086\/595706","article-title":"Persistent, undetected Trichomonas vaginalis infections?","volume":"48","author":"Peterman","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1071","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.1989.03420040109029","article-title":"Clinical manifestations of vaginal trichomoniasis.","volume":"261","author":"W\u00f8lner-Hanssen","year":"1989","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1072","doi-asserted-by":"publisher","first-page":"42.e1","DOI":"10.1016\/j.ajog.2008.07.069","article-title":"The effects of male circumcision on female partners\u2019 genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda.","volume":"200","author":"Gray","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1073","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/sti.2008.032334","article-title":"Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention.","volume":"85","author":"Sobngwi-Tambekou","year":"2009","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1074","doi-asserted-by":"publisher","first-page":"38.e1","DOI":"10.1016\/j.ajog.2008.06.026","article-title":"Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents.","volume":"200","author":"Tsai","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1075","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/OLQ.0000000000000134","article-title":"Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis.","volume":"41","author":"Silver","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1076","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2018.06.031","article-title":"Trichomonas vaginalis infection-associated risk of cervical cancer: a meta-analysis.","volume":"228","author":"Yang","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1077","doi-asserted-by":"publisher","first-page":"103752","DOI":"10.1016\/j.micpath.2019.103752","article-title":"Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis.","volume":"137","author":"Najafi","year":"2019","journal-title":"Microb Pathog"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1078","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1086\/319287","article-title":"The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.","volume":"183","author":"Wang","year":"2001","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1079","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/OLQ.0b013e318186decf","article-title":"Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.","volume":"36","author":"Kissinger","year":"2009","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1080","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0002-9378(84)90392-2","article-title":"Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.","volume":"150","author":"Minkoff","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1081","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00007435-199707000-00008","article-title":"Trichomonas vaginalis associated with low birth weight and preterm delivery.","volume":"24","author":"Cotch","year":"1997","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1082","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1086\/338399","article-title":"Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.","volume":"34","author":"Moodley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1083","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/OLQ.0b013e318177ec39","article-title":"Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005\u20132006.","volume":"35","author":"Francis","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1084","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jpag.2010.03.004","article-title":"Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs.","volume":"23","author":"Hollman","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1085","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/OLQ.0b013e318203e3ce","article-title":"Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations.","volume":"38","author":"Roth","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1086","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/sextrans-2013-051057","article-title":"Modern diagnosis of Trichomonas vaginalis infection.","volume":"89","author":"Hobbs","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1087","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1258\/095646203321043228","article-title":"\u2018Shelf life\u2019 of Trichomonas vaginalis.","volume":"14","author":"Kingston","year":"2003","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1088","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1128\/JCM.01291-11","article-title":"Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.","volume":"49","author":"Schwebke","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1089","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1086\/518851","article-title":"Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women.","volume":"45","author":"Huppert","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1090","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1128\/JCM.02966-13","article-title":"Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system.","volume":"52","author":"Van Der Pol","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1091","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1128\/JCM.01766-16","article-title":"Combined testing for chlamydia, gonorrhea, and trichomonas by use of the BD Max CT\/GC\/TV assay with genitourinary specimen types.","volume":"55","author":"Van Der Pol","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1092","doi-asserted-by":"publisher","first-page":"e01091-17","DOI":"10.1128\/JCM.01091-17","article-title":"Clinical evaluation of the Cepheid Xpert TV Assay for detection of Trichomonas vaginalis with prospectively collected specimens from men and women.","volume":"56","author":"Schwebke","year":"2018","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1093","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1128\/JCM.00671-08","article-title":"Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection.","volume":"46","author":"Campbell","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1094","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/sti.2009.042168","article-title":"Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians.","volume":"86","author":"Huppert","year":"2010","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1095","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ajem.2018.10.022","article-title":"The OSOM\u00ae Trichomonas Test is unable to accurately diagnose Trichomonas vaginalis from urine in men.","volume":"37","author":"Sheele","year":"2019","journal-title":"Am J Emerg Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1096","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/14737159.2017.1282823","article-title":"Clinical performance of the Solana\u00ae Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.","volume":"17","author":"Gaydos","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1097","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/OLQ.0000000000000447","article-title":"Rapid diagnosis of Trichomonas vaginalis by testing vaginal swabs in an isothermal helicase-dependent AmpliVue Assay.","volume":"43","author":"Gaydos","year":"2016","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1098","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0974-777X.93756","article-title":"Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, In Pouch TV culture system, and PCR.","volume":"4","author":"Patil","year":"2012","journal-title":"J Glob Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1099","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1128\/JCM.38.10.3585-3588.2000","article-title":"Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.","volume":"38","author":"Lawing","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1100","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/sti.77.1.78","article-title":"Urine proves a poor specimen for culture of Trichomonas vaginalis in women.","volume":"77","author":"Mohamed","year":"2001","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1101","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1128\/JCM.02006-13","article-title":"Diagnostic rates differ on the basis of the number of read days with the use of the InPouch culture system for Trichomonas vaginalis screening.","volume":"51","author":"Rivers","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1102","first-page":"223","article-title":"Validity of the Papanicolaou smear in the diagnosis of Candida spp., Trichomonas vaginalis, and bacterial vaginosis.","volume":"5","author":"Audisio","year":"2001","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1103","first-page":"90","article-title":"Clinical significance of Trichomonas vaginalis detected in Papanicolaou smear: a survey in female Social Hygiene Clinic.","volume":"15","author":"Loo","year":"2009","journal-title":"Hong Kong Med J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1104","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/OLQ.0000000000000537","article-title":"Single-dose compared with multidose metronidazole for the treatment of trichomoniasis in women: a meta-analysis.","volume":"44","author":"Howe","year":"2017","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1105","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/QAI.0b013e3181eda955","article-title":"A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.","volume":"55","author":"Kissinger","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1106","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/sti.51.1.51","article-title":"Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.","volume":"51","author":"Wood","year":"1975","journal-title":"Br J Vener Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1107","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/AAC.28.6.812","article-title":"Concentrations of metronidazole and tinidazole in male genital tissues.","volume":"28","author":"Viitanen","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1108","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/030006058201000212","article-title":"Single dose treatment of trichomoniasis.","volume":"10","author":"Gabriel","year":"1982","journal-title":"J Int Med Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1109","first-page":"883","article-title":"The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth.","volume":"51","author":"Mati","year":"1974","journal-title":"East Afr Med J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1110","first-page":"438","article-title":"Single-dose treatment of trichomonal vaginitis: a comparison of tinidazole and metronidazole.","volume":"5","author":"Anjaeyulu","year":"1977","journal-title":"J Int Med Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1111","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2165\/00003495-197800151-00009","article-title":"Tinidazole in the treatment of trichomoniasis, giardiasis and amoebiasis. Report of a multicentre study.","volume":"15","author":"Apte","year":"1978","journal-title":"Drugs"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1112","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007435-199209000-00011","article-title":"Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis.","volume":"19","author":"O-Prasertsawat","year":"1992","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1113","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/sti.54.2.81","article-title":"Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men.","volume":"54","author":"Kawamura","year":"1978","journal-title":"Br J Vener Dis"},{"issue":"2","key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1114","first-page":"CD000218","article-title":"Interventions for treating trichomoniasis in women.","author":"Forna","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1115","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1086\/340264","article-title":"Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection.","volume":"34","author":"Cu-Uvin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1116","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1128\/AAC.00814-06","article-title":"Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.","volume":"50","author":"Schwebke","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1117","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1086\/498217","article-title":"Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.","volume":"192","author":"Van Der Pol","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1118","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3201\/eid1806.111590","article-title":"Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009\u20132010.","volume":"18","author":"Kirkcaldy","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1119","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/AAC.47.4.1407-1409.2003","article-title":"In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.","volume":"47","author":"Crowell","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1120","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ajog.2019.10.079","article-title":"A comparison of 2 g single-dose versus 7-day 500 mg twice daily metronidazole for the treatment trichomoniasis in women by selected clinical factors.","volume":"221","author":"Muzny","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1121","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/323034","article-title":"Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.","volume":"33","author":"Sobel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1122","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/OLQ.0b013e31822037e4","article-title":"Resistant trichomoniasis: successful treatment with combination therapy.","volume":"38","author":"Nyirjesy","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1123","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1071\/SH11114","article-title":"Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid.","volume":"9","author":"Muzny","year":"2012","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1124","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1701-2163(16)32714-1","article-title":"Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification.","volume":"30","author":"Aggarwal","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1125","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/NMD.0b013e31802f5d9a","article-title":"Failure of nitazoxanide to cure trichomoniasis in three women.","volume":"34","author":"Dan","year":"2007","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1126","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/14787210.2014.887440","article-title":"Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.","volume":"12","author":"Se\u00f1a","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1127","doi-asserted-by":"publisher","first-page":"370.e1","DOI":"10.1016\/j.ajog.2007.10.795","article-title":"Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity.","volume":"198","author":"Helms","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1128","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2500\/ar.2014.5.0080","article-title":"Modified oral metronidazole desensitization protocol.","volume":"5","author":"Gendelman","year":"2014","journal-title":"Allergy Rhinol (Providence)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1129","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1086\/513951","article-title":"Difficult-to-treat trichomoniasis: results with paromomycin cream.","volume":"26","author":"Nyirjesy","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1130","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMoa003329","article-title":"Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.","volume":"345","author":"Klebanoff","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1131","first-page":"58","article-title":"Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth.","volume":"100","author":"Stringer","year":"2010","journal-title":"S Afr Med J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1132","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-2125.1997.00660.x","article-title":"Is metronidazole teratogenic? A meta-analysis.","volume":"44","author":"Caro-Pat\u00f3n","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1133","first-page":"CD000220","article-title":"Interventions for trichomoniasis in pregnancy.","author":"G\u00fclmezoglu","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1134","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ajog.2006.01.004","article-title":"The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth.","volume":"194","author":"Goldenberg","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1135","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/jwh.2008.0964","article-title":"Treatment of trichomoniasis in pregnancy and preterm birth: an observational study.","volume":"18","author":"Mann","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1136","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.2008.78.17","article-title":"Neonatal respiratory tract involvement by Trichomonas vaginalis: a case report and review of the literature.","volume":"78","author":"Carter","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1137","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1258\/ijsa.2010.010174","article-title":"Neonatal Trichomonas vaginalis infection: a case report and review of literature.","volume":"21","author":"Trintis","year":"2010","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1138","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/OLQ.0b013e31816b1fb8","article-title":"HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs.","volume":"35","author":"Miller","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1139","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/OLQ.0b013e31825725ad","article-title":"Effect of trichomoniasis therapy on genital HIV viral burden among African women.","volume":"39","author":"Anderson","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1140","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2334-11-307","article-title":"A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.","volume":"11","author":"Masese","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1141","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/OLQ.0b013e31828fce34","article-title":"A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.","volume":"40","author":"Balkus","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1142","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/jp.2010.31","article-title":"Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting.","volume":"30","author":"Gumbo","year":"2010","journal-title":"J Perinatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1143","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.","volume":"48","author":"Br\u00fcggemann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1144","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2009.03.021","article-title":"Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.","volume":"64","author":"Shahid","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1145","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","article-title":"Fluconazole-resistant Candida albicans vulvovaginitis.","volume":"120","author":"Marchaim","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1146","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review.","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1147","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/LGT.0000000000000413","article-title":"Long-term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance antifungal therapy.","volume":"22","author":"Crouss","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1148","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11908-010-0137-9","article-title":"Vulvovaginal candidiasis caused by non-albicansCandida species: new insights.","volume":"12","author":"Kennedy","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1149","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1067\/S0002-9378(03)00726-9","article-title":"Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.","volume":"189","author":"Sobel","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1150","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.2015.17844","article-title":"Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth.","volume":"315","author":"M\u00f8lgaard-Nielsen","year":"2016","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1151","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.1503\/cmaj.180963","article-title":"Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.","volume":"191","author":"B\u00e9rard","year":"2019","journal-title":"CMAJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1152","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/375746","article-title":"Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.","volume":"188","author":"Ohmit","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1153","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00006250-200303000-00022","article-title":"Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: risk factors and severity.","volume":"101","author":"Duerr","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1154","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1086\/322641","article-title":"Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.","volume":"33","author":"Vazquez","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1155","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/OLQ.0000000000000028","article-title":"Pelvic inflammatory disease: identifying research gaps\u2014proceedings of a workshop sponsored by Department of Health and Human Services\/National Institutes of Health\/National Institute of Allergy and Infectious Diseases, November 3\u20134, 2011.","volume":"40","author":"Darville","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1156","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/01.olq.0000154508.26532.6a","article-title":"Comparison of acute and subclinical pelvic inflammatory disease.","volume":"32","author":"Wiesenfeld","year":"2005","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1157","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/AOG.0b013e31825a6bc9","article-title":"Subclinical pelvic inflammatory disease and infertility.","volume":"120","author":"Wiesenfeld","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1158","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.","volume":"186","author":"Ness","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1159","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ajem.2011.07.014","article-title":"Laboratory-confirmed gonorrhea and\/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis.","volume":"30","author":"Burnett","year":"2012","journal-title":"Am J Emerg Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1160","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/cid\/ciaa101","article-title":"A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease.","volume":"72","author":"Wiesenfeld","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1161","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/aje\/kwi243","article-title":"A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.","volume":"162","author":"Ness","year":"2005","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1162","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","article-title":"Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.","volume":"334","author":"Scholes","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1163","doi-asserted-by":"publisher","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":"Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention of Pelvic Infection) trial.","volume":"340","author":"Oakeshott","year":"2010","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1164","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1067\/mob.2001.113847","article-title":"Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease.","volume":"184","author":"Peipert","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1165","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1155\/S1064744902000194","article-title":"Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease.","volume":"10","author":"Gait\u00e1n","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1166","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.prp.2011.08.007","article-title":"Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research.","volume":"207","author":"Vicetti Miguel","year":"2011","journal-title":"Pathol Res Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1167","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/0002-9378(69)90132-X","article-title":"Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy.","volume":"105","author":"Jacobson","year":"1969","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1168","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0002-9378(91)90639-9","article-title":"The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease.","volume":"164","author":"Sellors","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1169","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1471-0528.1995.tb11294.x","article-title":"Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort.","volume":"102","author":"Bevan","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1170","doi-asserted-by":"publisher","first-page":"753037","DOI":"10.1155\/2011\/753037","article-title":"A practical approach to the diagnosis of pelvic inflammatory disease.","volume":"2011","author":"Jaiyeoba","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1171","doi-asserted-by":"publisher","first-page":"561909","DOI":"10.1155\/2011\/561909","article-title":"Treatment of acute pelvic inflammatory disease.","volume":"2011","author":"Sweet","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1172","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/01.olq.0000225321.61049.13","article-title":"Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies.","volume":"34","author":"Smith","year":"2007","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1173","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.anaerobe.2019.02.005","article-title":"Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents.","volume":"56","author":"Petrina","year":"2019","journal-title":"Anaerobe"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1174","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1067\/mob.2003.87","article-title":"Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.","volume":"188","author":"Haggerty","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1175","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/sextrans-2015-052285","article-title":"Identification of novel microbes associated with pelvic inflammatory disease and infertility.","volume":"92","author":"Haggerty","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1176","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2105\/AJPH.94.8.1327","article-title":"Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease.","volume":"94","author":"Ness","year":"2004","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1177","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/00006250-199406000-00020","article-title":"Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.","volume":"83","author":"McGregor","year":"1994","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1178","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease.","volume":"31","author":"Bevan","year":"2003","journal-title":"J Int Med Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1179","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1258\/ijsa.2008.008495","article-title":"A randomized double-blind comparison of moxifloxacin and doxycycline\/metronidazole\/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.","volume":"20","author":"Heystek","year":"2009","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1180","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1258\/ijsa.2009.009374","article-title":"A comparison of treatment outcomes for moxifloxacin versus ofloxacin\/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease.","volume":"21","author":"Boothby","year":"2010","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1181","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/j.1471-0528.2010.02687.x","article-title":"Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.","volume":"117","author":"Judlin","year":"2010","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1182","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/apc.1998.12.431","article-title":"Pelvic inflammatory disease in women infected with HIV.","volume":"12","author":"Korn","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1183","first-page":"525","article-title":"Influence of human immunodeficiency virus infection on pelvic inflammatory disease.","volume":"95","author":"Irwin","year":"2000","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1184","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0002-9378(99)70378-9","article-title":"Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy.","volume":"181","author":"Bukusi","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1185","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/01.AOG.0000207597.70524.e8","article-title":"Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.","volume":"107","author":"Mugo","year":"2006","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1186","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection.","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1187","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1155\/2005\/376830","article-title":"Microbiology profile in women with pelvic inflammatory disease in relation to IUD use.","volume":"13","author":"Viberga","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1188","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.contraception.2016.10.006","article-title":"The safety of intrauterine devices among young women: a systematic review.","volume":"95","author":"Jatlaoui","year":"2017","journal-title":"Contraception"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1189","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ijgo.12064","article-title":"Development, updates, and future directions of the World Health Organization Selected Practice Recommendations for Contraceptive Use.","volume":"136","author":"Chen","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1190","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.contraception.2012.08.011","article-title":"Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1191","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1097\/OLQ.0000000000000901","article-title":"Treatment of acute epididymitis: a systematic review and discussion of the implications for treatment based on etiology.","volume":"45","author":"Louette","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1192","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2014.12.005","article-title":"Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations.","volume":"68","author":"Pilatz","year":"2015","journal-title":"Eur Urol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1193","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/iju.13236","article-title":"Novel algorithm for management of acute epididymitis.","volume":"24","author":"Hongo","year":"2017","journal-title":"Int J Urol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1194","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses.","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1195","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1196","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States.","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1197","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"Carcinogenicity of human papillomaviruses.","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1198","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers\u2014United States, 2012\u20132016.","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1199","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1200","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010.","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1201","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination.","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1202","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jadohealth.2019.07.003","article-title":"Declines in vaccine-type human papillomavirus prevalence in females across racial\/ethnic groups: data from a national survey.","volume":"65","author":"McClung","year":"2019","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1203","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1204","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1542\/peds.2013-2822","article-title":"Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents.","volume":"133","author":"Mayhew","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1205","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1186\/s12889-019-7134-1","article-title":"HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women.","volume":"19","author":"Brouwer","year":"2019","journal-title":"BMC Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1206","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1207","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2105\/AJPH.2017.304119","article-title":"Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006\u20132014.","volume":"108","author":"Flagg","year":"2018","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1208","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/aje\/kwx253","article-title":"Human papillomavirus vaccine effectiveness against incident genital warts among female health-plan enrollees, United States.","volume":"187","author":"Hariri","year":"2018","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1209","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/21645515.2016.1172754","article-title":"Impact of HPV vaccination on anogenital warts and respiratory papillomatosis.","volume":"12","author":"Wangu","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1210","doi-asserted-by":"publisher","first-page":"e93393","DOI":"10.1371\/journal.pone.0093393","article-title":"Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men.","volume":"9","author":"Swedish","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1211","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2340\/00015555-1721","article-title":"A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women\u2014an ecological study.","volume":"94","author":"Sand\u00f8","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1212","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.vaccine.2018.02.097","article-title":"Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.","volume":"36","author":"Herweijer","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1213","doi-asserted-by":"publisher","first-page":"e105967","DOI":"10.1371\/journal.pone.0105967","article-title":"Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study.","volume":"9","author":"Harrison","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1214","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/sextrans-2016-052626","article-title":"Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16\/18) vaccination programme in England: an ecological analysis.","volume":"93","author":"Canvin","year":"2017","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1215","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","article-title":"Ongoing decline in genital warts among young heterosexuals 7\u2005years after the Australian human papillomavirus (HPV) vaccination programme.","volume":"91","author":"Chow","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1216","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/0009922816660541","article-title":"Human papillomavirus vaccination and age at first sexual activity, National Health and Nutrition Examination Survey.","volume":"56","author":"Petrosky","year":"2017","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1217","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/OLQ.0b013e31815ea8d1","article-title":"Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis.","volume":"35","author":"Gotovtseva","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1218","doi-asserted-by":"publisher","first-page":"806105","DOI":"10.1155\/2011\/806105","article-title":"Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.","volume":"2011","author":"Baker","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1219","first-page":"74","article-title":"Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.","volume":"33","author":"Mashiah","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1220","first-page":"276","article-title":"Imiquimod reactivation of lichen planus.","volume":"89","author":"Domingues","year":"2012","journal-title":"Cutis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1221","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2133.2010.10124.x","article-title":"Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism.","volume":"164","author":"Patel","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1222","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/sextrans-2011-050025","article-title":"Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation.","volume":"87","author":"Kumar","year":"2011","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1223","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1365-2133.2008.08520.x","article-title":"Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.","volume":"158","author":"Stockfleth","year":"2008","journal-title":"Br J Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1224","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/j.1468-3083.2007.02441.x","article-title":"A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II\/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts.","volume":"21","author":"Gross","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1225","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/AOG.0b013e3181719b60","article-title":"Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial.","volume":"111","author":"Tatti","year":"2008","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1226","unstructured":"National Institute for Occupational Safety and Health. Control of smoke from laser\/electric surgical procedures. Washington, DC: US Department of Health and Human Services, CDC, National Institute for Occupational Safety and Health; 1996. https:\/\/www.cdc.gov\/niosh\/docs\/hazardcontrol\/pdfs\/hc11.pdf?id=10.26616\/NIOSHPUB96128"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1227","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.32.3.308","article-title":"Neurologic manifestations of podophyllin toxicity.","volume":"32","author":"Filley","year":"1982","journal-title":"Neurology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1228","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1213\/00000539-199008000-00013","article-title":"Delayed recognition of podophyllum toxicity in a patient receiving epidural morphine.","volume":"71","author":"Conard","year":"1990","journal-title":"Anesth Analg"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1229","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/15563658008989950","article-title":"Podophyllum: suspected teratogenicity from topical application.","volume":"16","author":"Karol","year":"1980","journal-title":"Clin Toxicol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1230","first-page":"645","article-title":"Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis.","volume":"101","author":"Silverberg","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1231","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/QAD.0b013e3283021aa3","article-title":"Incidence and risk factors for verrucae in women.","volume":"22","author":"Dolev","year":"2008","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1232","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00007435-200208000-00001","article-title":"The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.","volume":"29","author":"Silverberg","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1233","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00007435-200203000-00001","article-title":"Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls.","volume":"29","author":"De Panfilis","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1234","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0140-6736(02)07368-3","article-title":"HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study.","volume":"359","author":"Conley","year":"2002","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1235","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1086\/653426","article-title":"Frequency of occult high-grade squamous intraepithelial neoplasia and invasive cancer within anal condylomata in men who have sex with men.","volume":"51","author":"Schlecht","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1236","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/PAS.0b013e318263cda6","article-title":"Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients.","volume":"37","author":"Maniar","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1237","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/AOG.0b013e31821a0f4d","article-title":"Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection.","volume":"118","author":"Massad","year":"2011","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1238","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases.","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1239","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1240","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/AOG.0000000000001699","article-title":"Practice Bulletin No. 168 Summary: Cervical cancer screening and prevention.","volume":"128","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2016","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1241","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/jwh.2020.8918","article-title":"Summary of current guidelines for cervical cancer screening and management of abnormal test results: 2016\u20132020.","volume":"30","author":"Perkins","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1242","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US Preventive Services Task Force.","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1243","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamainternmed.2019.0299","article-title":"Estimated quality of life and economic outcomes associated with 12 cervical cancer screening strategies: a cost-effectiveness analysis.","volume":"179","author":"Sawaya","year":"2019","journal-title":"JAMA Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1244","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1245","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG Practice Bulletin No. 131: Screening for cervical cancer.","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1246","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.2105\/AJPH.2014.302272","article-title":"Cervical cancer screening in a sexually transmitted disease clinic: screening adoption experiences from a midwestern clinic.","volume":"105","author":"Meyerson","year":"2015","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1247","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1248","first-page":"269","article-title":"Self-reported Papanicolaou smears and hysterectomies among women in the United States.","volume":"98","author":"Saraiya","year":"2001","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1249","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1001\/jama.291.24.2990","article-title":"Cervical cancer screening among women without a cervix.","volume":"291","author":"Sirovich","year":"2004","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1250","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1471-0528.2006.01099.x","article-title":"Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature.","volume":"113","author":"Stokes-Lampard","year":"2006","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1251","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2303.2007.00464.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.","volume":"18","author":"Arbyn","year":"2007","journal-title":"Cytopathology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1252","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/jwh.2012.3667","article-title":"Confusion about Pap smears: lack of knowledge among high-risk women.","volume":"22","author":"Daley","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1253","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1254","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/sextrans-2011-050289","article-title":"Confusion regarding cervical cancer screening and chlamydia screening among sexually active young women.","volume":"88","author":"Ogbechie","year":"2012","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1255","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1093\/cid\/cir703","article-title":"Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.","volume":"53","author":"Dunne","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1256","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1089\/jwh.2009.1862","article-title":"Pap smear versus speculum examination: can we teach providers to educate patients?","volume":"19","author":"Fry","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1257","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jech.57.8.589","article-title":"Randomised controlled trial of the effect of evidence based information on women\u2019s willingness to participate in cervical cancer screening.","volume":"57","author":"Adab","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1258","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/pon.2003","article-title":"The psychosocial impact of an abnormal cervical smear result.","volume":"21","author":"Drolet","year":"2012","journal-title":"Psychooncology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1259","doi-asserted-by":"publisher","first-page":"b4491","DOI":"10.1136\/bmj.b4491","article-title":"Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.","volume":"340","author":"McCaffery","year":"2010","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1260","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1359105309351249","article-title":"The psychosocial burden of HPV: a mixed-method study of knowledge, attitudes and behaviors among HPV+ women.","volume":"15","author":"Daley","year":"2010","journal-title":"J Health Psychol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1261","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/sti.2009.037028","article-title":"The psychosocial burden of human papillomavirus related disease and screening interventions.","volume":"85","author":"Pirotta","year":"2009","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1262","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pmedr.2015.05.006","article-title":"Communication practices about HPV testing among providers in Federally Qualified Health Centers.","volume":"2","author":"Lin","year":"2015","journal-title":"Prev Med Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1263","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/aje\/kwn354","article-title":"Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.","volume":"169","author":"Kapeu","year":"2009","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1264","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1023\/B:CACO.0000003811.98261.3e","article-title":"Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study.","volume":"14","author":"Plummer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1265","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection.","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1266","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1158\/1055-9965.EPI-11-0284","article-title":"Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case-control studies.","volume":"20","author":"Louie","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1267","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1007\/s11606-020-06020-9","article-title":"Effectiveness of patient navigation to increase cancer screening in populations adversely affected by health disparities: a meta-analysis.","volume":"35","author":"Nelson","year":"2020","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1268","first-page":"159","article-title":"The effectiveness and safety of two cervical cytologic techniques during pregnancy.","volume":"45","author":"Stillson","year":"1997","journal-title":"J Fam Pract"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1269","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0091-2182(96)00013-4","article-title":"Use of the Cytobrush for Papanicolaou smear screens in pregnant women.","volume":"41","author":"Foster","year":"1996","journal-title":"J Nurse Midwifery"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1270","first-page":"539","article-title":"Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women.","volume":"84","author":"Paraiso","year":"1994","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1271","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/AOG.0000000000002371","article-title":"Human immunodeficiency virus (HIV)- and non-HIV-associated immunosuppression and risk of cervical neoplasia.","volume":"131","author":"Silverberg","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1272","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0956462418792653","article-title":"Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.","volume":"30","author":"Videla","year":"2019","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1273","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1274","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2020.12488","article-title":"Managing minimally abnormal cervical cancer screening test results.","volume":"324","author":"Sawaya","year":"2020;","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1275","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/cir1012","article-title":"Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.","volume":"54","author":"Silverberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1276","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00384-018-3167-7","article-title":"Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience.","volume":"34","author":"Tomassi","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1277","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JCO.2017.74.9291","article-title":"Anal cancer risk among people with HIV infection in the United States.","volume":"36","author":"Col\u00f3n-L\u00f3pez","year":"2018","journal-title":"J Clin Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1278","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1071\/SH12043","article-title":"The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men.","volume":"9","author":"Machalek","year":"2012","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1279","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001\u20132015.","volume":"112","author":"Deshmukh","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1280","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1470-2045(07)70043-8","article-title":"Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study.","volume":"8","author":"Edgren","year":"2007","journal-title":"Lancet Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1281","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1282","doi-asserted-by":"publisher","first-page":"e181999","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in risks for second primary cancers associated with index human papillomavirus-associated cancers.","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1283","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/LGT.0000000000000458","article-title":"International Anal Neoplasia Society guidelines for the practice of digital anal rectal examination.","volume":"23","author":"Hillman","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1284","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0969141315604658","article-title":"Baseline findings from the Anal Cancer Examination (ACE) study: screening using digital ano-rectal examination in HIV-positive men who have sex with men.","volume":"23","author":"Ong","year":"2016","journal-title":"J Med Screen"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1285","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/hiv.12035","article-title":"Acceptability of digital anal cancer screening examinations in HIV-positive homosexual men.","volume":"14","author":"Read","year":"2013","journal-title":"HIV Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1286","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cncy.21702","article-title":"The performance of anal cytology as a screening test for anal HSILs in homosexual men.","volume":"124","author":"Jin","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1287","doi-asserted-by":"publisher","first-page":"109","DOI":"10.17235\/reed.2018.5678\/2018","article-title":"Anal cytology, histopathology and anoscopy in an anal dysplasia screening program: is anal cytology enough?","volume":"110","author":"Silva","year":"2018","journal-title":"Rev Esp Enferm Dig"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1288","doi-asserted-by":"publisher","first-page":"242","DOI":"10.17235\/reed.2017.4274\/2016","article-title":"Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain","volume":"109","author":"Iribarren D\u00edaz","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1289","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1097\/QAD.0000000000001605","article-title":"The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.","volume":"31","author":"Burgos","year":"2017","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1290","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10147-015-0804-9","article-title":"Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus.","volume":"20","author":"Cheng","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1291","doi-asserted-by":"publisher","first-page":"e0123590","DOI":"10.1371\/journal.pone.0123590","article-title":"The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males.","volume":"10","author":"Hidalgo-Tenorio","year":"2015","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1292","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1470-2045(13)70067-6","article-title":"Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.","volume":"14","author":"Richel","year":"2013","journal-title":"Lancet Oncol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1293","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/DCR.0000000000000058","article-title":"Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer.","volume":"57","author":"Goldstone","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1294","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/infdis\/jiu461","article-title":"Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions.","volume":"211","author":"Tong","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1295","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1097\/QAD.0b013e3283633111","article-title":"Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men.","volume":"27","author":"Tong","year":"2013","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1296","doi-asserted-by":"publisher","first-page":"a031708","DOI":"10.1101\/cshperspect.a031708","article-title":"Natural history, clinical manifestations, and pathogenesis of hepatitis A.","volume":"8","author":"Shin","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1297","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1","article-title":"Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020.","volume":"69","author":"Nelson","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1298","doi-asserted-by":"publisher","first-page":"413","DOI":"10.15585\/mmwr.mm6818a2","article-title":"Increase in hepatitis A virus infections\u2014United States, 2013\u20132018.","volume":"68","author":"Foster","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1299","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1086\/315701","article-title":"Duration of viremia in hepatitis A virus infection.","volume":"182","author":"Bower","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1300","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/infdis\/171.Supplement_1.S44","article-title":"Clinical experience with an inactivated hepatitis A vaccine.","volume":"171","author":"Clemens","year":"1995","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1301","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/hep.25687","article-title":"Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.","volume":"56","author":"Sharapov","year":"2012","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1302","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/jmv.25197","article-title":"Hepatitis A vaccine immune response 22 years after vaccination.","volume":"90","author":"Mosites","year":"2018","journal-title":"J Med Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1303","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1016\/j.vaccine.2015.07.008","article-title":"Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions.","volume":"33","author":"Theeten","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1304","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.vaccine.2013.10.088","article-title":"Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults.","volume":"32","author":"Hens","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1305","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1016\/j.vaccine.2020.05.069","article-title":"Immunogenicity of the hepatitis A vaccine 20\u00a0years after infant immunization.","volume":"38","author":"Mosites","year":"2020","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1306","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.1093\/cid\/ciaa298","article-title":"Susceptibility to hepatitis A virus infection in the United States, 2007\u20132016.","volume":"71","author":"Yin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1307","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1016\/j.vaccine.2019.04.088","article-title":"Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007\u20132017.","volume":"37","author":"Moro","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1308","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/clinids\/14.2.580","article-title":"Immunoglobulin prophylaxis for hepatitis A.","volume":"14","author":"Winokur","year":"1992","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1309","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1128\/IAI.16.3.928-933.1977","article-title":"Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.","volume":"16","author":"Alter","year":"1977","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1310","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJM197412262912602","article-title":"Role of saliva, urine and feces in the transmission of type B hepatitis.","volume":"291","author":"Villarejos","year":"1974","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1311","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00430-014-0369-7","article-title":"Natural history of chronic hepatitis B virus infection.","volume":"204","author":"Busch","year":"2015","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1312","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review.","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1313","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact.","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1314","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-150-1-200901060-00007","article-title":"Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998\u20132008.","volume":"150","author":"Thompson","year":"2009","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1315","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(89)92876-6","article-title":"Horizontal transmission of hepatitis B virus.","volume":"1","author":"Davis","year":"1989","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1316","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/oxfordjournals.aje.a009474","article-title":"Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana.","volume":"147","author":"Martinson","year":"1998","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1317","unstructured":"CDC. Healthcare-associated hepatitis B and C outbreaks (\u22652 cases) reported to the CDC 2008\u20132019. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/pdfs\/HealthcareInvestigationTable.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1318","doi-asserted-by":"publisher","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1319","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1016\/j.vaccine.2011.07.030","article-title":"Hepatitis B vaccination coverage among high-risk adults 18\u201349 years, U.S., 2009.","volume":"29","author":"Lu","year":"2011","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1320","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015.","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1321","first-page":"509","article-title":"Hepatitis B vaccination coverage among adults\u2014United States, 2004.","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1322","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2105\/AJPH.91.6.965","article-title":"Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men.","volume":"91","author":"MacKellar","year":"2001","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1323","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1324","unstructured":"Ezeanolue E, Harriman K, Hunter P, Kroger A, Pellegrini C. General best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP) [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC, Advisory Committee on Immunization Practices; 2020. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/downloads\/general-recs.pdf"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1325","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose.","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1326","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.","volume":"54","author":"McMahon","year":"2011","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1327","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/infdis\/jiw142","article-title":"A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen.","volume":"214","author":"Simons","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1328","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents.","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1329","doi-asserted-by":"publisher","first-page":"14S","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.","volume":"87","author":"Andr\u00e9","year":"1989","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1330","doi-asserted-by":"publisher","first-page":"794","DOI":"10.7326\/M17-1106","article-title":"Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention.","volume":"167","author":"Abara","year":"2017","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1331","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/0016-5085(87)90431-8","article-title":"Efficacy of commercial condoms in the prevention of hepatitis B virus infection.","volume":"93","author":"Minuk","year":"1987","journal-title":"Gastroenterology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1332","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016.","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1333","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/QCO.0000000000000515","article-title":"Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.","volume":"32","author":"Lockart","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1334","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/hep.26164","article-title":"Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study.","volume":"57","author":"Terrault","year":"2013","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1335","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/infdis\/jiy670","article-title":"Sexually acquired hepatitis C infection in HIV-uninfected men who have sex with men using preexposure prophylaxis against HIV.","volume":"219","author":"Price","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1336","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/cid\/cir991","article-title":"Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.","volume":"54","author":"Tohme","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1337","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1182\/blood.V80.2.540.540","article-title":"The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study.","volume":"80","author":"Brettler","year":"1992","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1338","first-page":"2087","article-title":"Transmission of hepatitis C virus between spouses: the important role of exposure duration.","volume":"91","author":"Kao","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1339","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/cid\/cis538","article-title":"Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men.","volume":"55","author":"Fierer","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1340","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1086\/518796","article-title":"Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission.","volume":"196","author":"van de Laar","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1341","doi-asserted-by":"publisher","first-page":"e25348","DOI":"10.1002\/jia2.25348","article-title":"Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men.","volume":"22","author":"Nijmeijer","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1342","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ijantimicag.2019.02.002","article-title":"High clustering of acute HCV infections and high rate of associated STIs among Parisian HIV-positive male patients.","volume":"53","author":"Todesco","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1343","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1071\/SH16141","article-title":"Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review.","volume":"14","author":"Jin","year":"2017","journal-title":"Sex Health"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1344","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/0956462416651229","article-title":"Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics.","volume":"28","author":"Hegazi","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1345","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7861\/clinmedicine.16-2-189","article-title":"Hepatitis C and sex.","volume":"16","author":"Page","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1346","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/QAI.0000000000000528","article-title":"Risk factors for HCV acquisition among HIV-positive MSM in Belgium.","volume":"68","author":"Apers","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1347","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/sextrans-2016-053029","article-title":"Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmission.","volume":"93","author":"Daskalopoulou","year":"2017","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1348","doi-asserted-by":"publisher","first-page":"ofv115","DOI":"10.1093\/ofid\/ofv115","article-title":"Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: a case-control study.","volume":"2","author":"Vanhommerig","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1349","doi-asserted-by":"crossref","first-page":"ofw057","DOI":"10.1093\/ofid\/ofw057","article-title":"Shedding of hepatitis C virus in semen of human immunodeficiency virus-infected men.","volume":"3","author":"Turner","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1350","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/cid\/ciw740","article-title":"Shedding of hepatitis C virus into the rectum of HIV-infected men who have sex with men.","volume":"64","author":"Foster","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1351","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.OLQ.0000091152.31366.E6","article-title":"Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997\u20132000.","volume":"30","author":"Hammer","year":"2003","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1352","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jmv.20146","article-title":"Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.","volume":"74","author":"Roy","year":"2004","journal-title":"J Med Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1353","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<111::AID-JMV4>3.0.CO;2-C","article-title":"Heterosexual transmission of hepatitis C in Italy.","volume":"57","author":"Mele","year":"1999","journal-title":"J Med Virol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1354","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1086\/431486","article-title":"Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.","volume":"41","author":"Rauch","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1355","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/sti.2003.008532","article-title":"Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?","volume":"80","author":"Browne","year":"2004","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1356","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.","volume":"21","author":"Danta","year":"2007","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1357","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1468-1293.2004.00225.x","article-title":"Acute hepatitis C in HIV-infected men who have sex with men.","volume":"5","author":"Ghosn","year":"2004","journal-title":"HIV Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1358","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men.","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1359","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/QAD.0000000000001522","article-title":"MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.","volume":"31","author":"Hoornenborg","year":"2017","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1360","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/QAD.0000000000002364","article-title":"Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.","volume":"34","author":"Gras","year":"2020","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1361","doi-asserted-by":"publisher","first-page":"15S","DOI":"10.1002\/hep.510260703","article-title":"Hepatitis C: the clinical spectrum of disease.","volume":"26","author":"Hoofnagle","year":"1997","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1362","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/jhep.2001.22112","article-title":"Acute hepatitis C.","volume":"33","author":"Orland","year":"2001","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1363","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1364","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1056\/NEJM199107113250205","article-title":"A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.","volume":"325","author":"Farci","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1365","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C.","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1366","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cld.2005.05.003","article-title":"Natural history of hepatitis C.","volume":"9","author":"Thomas","year":"2005","journal-title":"Clin Liver Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1367","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C.","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1368","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tmrv.2011.07.007","article-title":"Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.","volume":"26","author":"Zou","year":"2012","journal-title":"Transfus Med Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1369","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1111\/ajt.15352","article-title":"Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014\u20132017.","volume":"19","author":"Bixler","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1370","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians.","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1371","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/sti.79.2.160","article-title":"Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples.","volume":"79","author":"Marincovich","year":"2003","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1372","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1572-0241.2005.40879.x","article-title":"Sexual transmission of HCV between spouses.","volume":"100","author":"Tahan","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1373","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1572-0241.2004.04150.x","article-title":"Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study.","volume":"99","author":"Vandelli","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1374","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1086\/590430","article-title":"Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.","volume":"198","author":"Fierer","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1375","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7326\/0003-4819-158-2-201301150-00575","article-title":"Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force.","volume":"158","author":"Cottrell","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1376","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1086\/497701","article-title":"Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.","volume":"192","author":"Mast","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1377","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1111\/add.14731","article-title":"Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.","volume":"114","author":"Barbosa","year":"2019","journal-title":"Addiction"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1378","doi-asserted-by":"publisher","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1379","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep.27391","article-title":"HCV reinfection among HIV-positive men who have sex with men: a pragmatic approach.","volume":"61","author":"Martin","year":"2015","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1380","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jhep.2016.09.004","article-title":"HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.","volume":"66","author":"Ingiliz","year":"2017","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1381","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1097\/01.aids.0000189847.98569.2d","article-title":"Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin.","volume":"19","author":"Briat","year":"2005","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1382","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/OLQ.0000000000000022","article-title":"The etiology of infectious proctitis in men who have sex with men differs according to HIV status.","volume":"40","author":"Bissessor","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1383","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3201\/eid2303.161039","article-title":"Two cases of Neisseria meningitidis proctitis in HIV-positive men who have sex with men.","volume":"23","author":"Gutierrez-Fernandez","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1384","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijid.2018.08.004","article-title":"Delayed diagnosis of colorectal sexually transmitted diseases due to their resemblance to inflammatory bowel diseases.","volume":"75","author":"Levy","year":"2018","journal-title":"Int J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1385","first-page":"S4","article-title":"Syphilis presenting as colorectal cancer","volume":"41","author":"Lebari","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1386","doi-asserted-by":"publisher","first-page":"812","DOI":"10.15585\/mmwr.mm6531a5","article-title":"Notes from the field: shigellosis outbreak among men who have sex with men and homeless persons\u2014Oregon, 2015\u20132016.","volume":"65","author":"Hines","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1387","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/cid\/cix610","article-title":"Campylobacter fetus cluster among men who have sex with men, Montreal, Quebec, Canada, 2014\u20132016.","volume":"65","author":"Marchand-Sen\u00e9cal","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1388","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1086\/380838","article-title":"Etiology of clinical proctitis among men who have sex with men.","volume":"38","author":"Klausner","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1389","doi-asserted-by":"publisher","first-page":"S865","DOI":"10.1093\/cid\/civ756","article-title":"Lymphogranuloma venereum 2015: clinical presentation, diagnosis, and treatment.","volume":"61","author":"Stoner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1390","doi-asserted-by":"publisher","first-page":"19657","DOI":"10.7448\/IAS.17.4.19657","article-title":"Ongoing epidemic of lymphogranuloma venereum in HIV-positive men who have sex with men: how symptoms should guide treatment.","volume":"17","author":"Mohrmann","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1391","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s15010-013-0501-4","article-title":"High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM.","volume":"41","author":"Hoffmann","year":"2013","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1392","first-page":"132","article-title":"Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men\u2014United States, 2002\u20132013.","volume":"63","author":"Heiman","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1393","first-page":"109","article-title":"What\u2019s eating you? Pubic lice (Pthirus pubis).","volume":"81","author":"Galiczynski","year":"2008","journal-title":"Cutis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1394","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archderm.138.2.220","article-title":"Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States.","volume":"138","author":"Meinking","year":"2002","journal-title":"Arch Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1395","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archderm.139.8.994","article-title":"Permethrin-resistant human head lice, Pediculus capitis, and their treatment.","volume":"139","author":"Yoon","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1396","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jaad.2004.04.041","article-title":"Oral ivermectin for Phthirus pubis.","volume":"51","author":"Burkhart","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1397","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1258\/ijsa.2011.011114","article-title":"European guideline for the management of pediculosis pubis, 2010.","volume":"22","author":"Scott","year":"2011","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1398","first-page":"284","article-title":"Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies.","volume":"12","author":"Goldust","year":"2014","journal-title":"Skinmed"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1399","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0956462417740292","article-title":"Pubic hair removal and Phthirus pubis infestation.","volume":"29","author":"Veraldi","year":"2018","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1400","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1573396315666190717114131","article-title":"Scabies: a neglected global disease.","volume":"16","author":"Leung","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1401","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(19)31136-5","article-title":"The public health control of scabies: priorities for research and action.","volume":"394","author":"Engelman","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1402","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11908-013-0354-0","article-title":"Diagnosis, prevention, and treatment of scabies.","volume":"15","author":"Shimose","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1403","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/archdermatol.2011.51","article-title":"Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a resource-poor setting.","volume":"147","author":"Walter","year":"2011","journal-title":"Arch Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1404","doi-asserted-by":"publisher","first-page":"e0004691","DOI":"10.1371\/journal.pntd.0004691","article-title":"Scabies: advances in noninvasive diagnosis.","volume":"10","author":"Micali","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1405","first-page":"CD000320","article-title":"Interventions for treating scabies.","author":"Strong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1406","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/09546634.2016.1151855","article-title":"Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies.","volume":"27","author":"Abdel-Raheem","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1407","first-page":"79","article-title":"The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies.","volume":"61","author":"Alipour","year":"2015","journal-title":"Ann Parasitol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1408","first-page":"670","article-title":"Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies.","volume":"9","author":"Al Jaff","year":"2018","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1409","first-page":"79","article-title":"Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream.","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1410","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/dth.12310","article-title":"Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies.","volume":"29","author":"Ahmad","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1411","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies.","volume":"362","author":"Currie","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1412","unstructured":"Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545083\/"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1413","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1525-1470.2011.01519.x","article-title":"Lindane toxicity: a comprehensive review of the medical literature.","volume":"29","author":"Nolan","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1414","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/17460913.3.1.57","article-title":"Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance.","volume":"3","author":"Mounsey","year":"2008","journal-title":"Future Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1415","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","article-title":"Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities.","volume":"145","author":"Mounsey","year":"2009","journal-title":"Arch Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1416","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pt.2012.09.006","article-title":"Scratching the itch: new tools to advance understanding of scabies.","volume":"29","author":"Mounsey","year":"2013","journal-title":"Trends Parasitol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1417","doi-asserted-by":"publisher","first-page":"e0007182","DOI":"10.1371\/journal.pntd.0007182","article-title":"A systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions.","volume":"13","author":"van der Linden","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1418","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jinf.2004.08.033","article-title":"Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature.","volume":"50","author":"Roberts","year":"2005","journal-title":"J Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1419","first-page":"584","article-title":"Crusted scabies and multiple dosages of ivermectin.","volume":"12","author":"Ortega-Loayza","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1420","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/QCO.0b013e328336821b","article-title":"Scabies in healthcare settings.","volume":"23","author":"Bouvresse","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1421","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajic.2017.12.004","article-title":"Management of a family outbreak of scabies with high risk of spread to other community and hospital facilities.","volume":"46","author":"Marotta","year":"2018","journal-title":"Am J Infect Control"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1422","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease.","volume":"373","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1423","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ajog.2006.03.014","article-title":"Sexual assault victims: factors associated with follow-up care.","volume":"194","author":"Ackerman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1424","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/sti.79.4.349-a","article-title":"Follow up of patients who have been recently sexually assaulted.","volume":"79","author":"Parekh","year":"2003","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1425","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/OGX.0000000000000390","article-title":"Evaluation and management of female victims of sexual assault.","volume":"72","author":"Vrees","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1426","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1542\/peds.2010-2247","article-title":"Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study.","volume":"128","author":"Unger","year":"2011","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1427","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":"Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16\/18 vaccine.","volume":"103","author":"Kreimer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1428","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/095646249100200310","article-title":"Rape and HIV.","volume":"2","author":"Claydon","year":"1991","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1429","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/bmj.299.6701.718","article-title":"Rape and subsequent seroconversion to HIV.","volume":"299","author":"Murphy","year":"1989","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1430","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure.","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1431","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1086\/672271","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.","volume":"34","author":"Kuhar","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1432","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/OLQ.0b013e3181824f3c","article-title":"HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis.","volume":"35","author":"Du Mont","year":"2008","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1433","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/01.olq.0000225329.07765.d8","article-title":"Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center.","volume":"34","author":"Neu","year":"2007","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1434","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/135965350801300109","article-title":"Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors.","volume":"13","author":"Loutfy","year":"2008","journal-title":"Antivir Ther"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1435","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/hiv.12797","article-title":"Post-exposure prophylaxis for HIV infection in sexual assault victims.","volume":"21","author":"Inciarte","year":"2020","journal-title":"HIV Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1436","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6517a5","article-title":"Announcement: Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV\u2014United States, 2016.","volume":"65","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1437","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1093\/cid\/civ093","article-title":"Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic review.","volume":"60","author":"Ford","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1438","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1542\/peds.2013-1741","article-title":"The evaluation of children in the primary care setting when sexual abuse is suspected.","volume":"132","author":"Jenny","year":"2013","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1439","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1542\/peds.2008-2947","article-title":"Epidemiology of sexually transmitted infections in suspected child victims of sexual assault.","volume":"124","author":"Girardet","year":"2009","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1440","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/INF.0b013e31819b592e","article-title":"Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.","volume":"28","author":"Black","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1441","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jpag.2015.05.001","article-title":"Acute sexual assault in the pediatric and adolescent population.","volume":"29","author":"Trotman","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1442","first-page":"59","article-title":"Perinatal transmission of Trichomonas vaginalis: a case report.","volume":"53","author":"Schwandt","year":"2008","journal-title":"J Reprod Med"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1443","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1001\/jama.1992.03480030078041","article-title":"Chronic Chlamydia trachomatis infections in infants.","volume":"267","author":"Bell","year":"1992","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1444","doi-asserted-by":"publisher","first-page":"9315757","DOI":"10.1155\/2016\/9315757","article-title":"Chlamydia trachomatis infection in pregnancy: the global challenge of preventing adverse pregnancy and infant outcomes in sub-Saharan Africa and Asia.","volume":"2016","author":"Adachi","year":"2016","journal-title":"BioMed Res Int"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1445","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1001\/jama.1986.03370240044034","article-title":"Prospective study of perinatal transmission of Chlamydia trachomatis.","volume":"255","author":"Schachter","year":"1986","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1446","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/INF.0b013e318124a4ae","article-title":"Prevalence of human papillomavirus in the oral cavity\/oropharynx in a large population of children and adolescents.","volume":"26","author":"Smith","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1447","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jog.13248","article-title":"Possible non-sexual modes of transmission of human papilloma virus.","volume":"43","author":"Sabeena","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1448","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jpag.2017.12.011","article-title":"Interpretation of medical findings in suspected child sexual abuse: an update for 2018.","volume":"31","author":"Adams","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1449","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/PEC.0000000000001014","article-title":"Genital and extragenital gonorrhea and chlamydia in children and adolescents evaluated for sexual abuse.","volume":"34","author":"Kellogg","year":"2018","journal-title":"Pediatr Emerg Care"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1450","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1542\/peds.2011-0804","article-title":"Value of follow-up examinations of children and adolescents evaluated for sexual abuse and assault.","volume":"129","author":"Gavril","year":"2012","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1451","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/JCM.03101-12","article-title":"Development of PCR assays for detection of Trichomonas vaginalis in urine specimens.","volume":"51","author":"Bandea","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1452","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jpag.2008.12.006","article-title":"Diagnosis of Trichomonas vaginalis in female children and adolescents evaluated for possible sexual abuse: a comparison of the InPouch TV culture method and wet mount microscopy.","volume":"22","author":"Gallion","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1453","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1524838010378299","article-title":"Child sexual abuse, links to later sexual exploitation\/high-risk sexual behavior, and prevention\/treatment programs.","volume":"11","author":"Lalor","year":"2010","journal-title":"Trauma Violence Abuse"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1454","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.chiabu.2008.05.010","article-title":"HIV post-exposure prophylaxis in children and adolescents presenting for reported sexual assault.","volume":"33","author":"Girardet","year":"2009","journal-title":"Child Abuse Negl"},{"key":"key-10.15585\/mmwr.rr7004a1-202107211802-R1455","unstructured":"Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Washington, DC: US Department of Health and Human Services, National Institutes of Health, AIDSinfo; 2020. https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/pediatricguidelines.pdf"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:53:48Z","timestamp":1725468828000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/rr\/RR7004a1.htm?s_cid=RR7004a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":1455,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,7,23]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7004a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,23]]},"published":{"date-parts":[[2021,7,23]]}}}